data_2aiv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aiv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.747 0.308 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.561 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.601 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.435 ' H ' ' CG2' ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 1.049 ' HG2' HG21 ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.776 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.049 HG21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.676 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.977 ' HB2' HD22 ' A' ' 23' ' ' LEU . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.826 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.867 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.961 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.4 tp60 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.977 HD22 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.867 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.829 ' CG1' HD21 ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CG1' ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.417 ' C ' HG23 ' A' ' 31' ' ' VAL . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 30' ' ' VAL . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.921 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.921 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.53 HD11 ' CD1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.995 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' C ' ' A' ' 44' ' ' PRO . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.936 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.823 ' N ' HD23 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.634 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.868 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.733 HG13 ' CB ' ' A' ' 52' ' ' LEU . 11.4 tt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 60' ' ' ILE . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.63 ' OG1' HG22 ' A' ' 68' ' ' ILE . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' HE2' ' C ' ' A' ' 36' ' ' TYR . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.819 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.578 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.727 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' OG1' ' A' ' 61' ' ' THR . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.935 HD12 ' H ' ' A' ' 73' ' ' LEU . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.87 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.935 ' H ' HD12 ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.87 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.875 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.875 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HE2' ' CG ' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' PRO . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.616 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 26.2 m120 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.647 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.749 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.411 HD12 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' OH ' HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.551 ' CD1' ' HE2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG11 ' OH ' ' A' ' 131' ' ' TYR . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.551 ' HE2' ' CD1' ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.721 HD11 ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' ' 117' ' ' ILE . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.814 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.775 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.656 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.687 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 113' ' ' VAL . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.745 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.745 ' HB3' ' HD2' ' A' ' 132' ' ' ASP . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.814 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.749 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.656 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.499 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.67 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.689 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 30' ' ' VAL . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.86 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' H ' ' A' ' 30' ' ' VAL . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.99 ' HG2' HG23 ' A' ' 14' ' ' THR . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.982 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD11 HG13 ' A' ' 8' ' ' ILE . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.99 HG23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.072 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.471 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.602 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.072 HD21 ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.026 HG11 ' HG ' ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 36.6 t-80 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.026 ' HG ' HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.702 ' ND1' ' H ' ' A' ' 35' ' ' SER . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.702 ' H ' ' ND1' ' A' ' 33' ' ' HIS . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.785 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.815 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.865 HG21 ' CE2' ' A' ' 41' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.767 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.919 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.955 HG13 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.912 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' H ' ' C ' ' A' ' 50' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 59' ' ' ILE . 20.4 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 60' ' ' ILE . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.817 ' CZ ' HD12 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.965 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.785 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.729 ' NZ ' ' HB2' ' A' ' 94' ' ' CYS . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' A' ' 89' ' ' ILE . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.965 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' LEU . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.901 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.901 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.645 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.657 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG11 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.882 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.919 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.104 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' A' ' 67' ' ' CYS . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.815 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.719 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 21.8 t-20 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 1.018 ' HH ' HG21 ' A' ' 113' ' ' VAL . 6.4 t80 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.722 0.296 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 95' ' ' TYR . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 1.018 HG21 ' HH ' ' A' ' 95' ' ' TYR . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.684 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.809 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.919 HD12 ' CZ ' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 123' ' ' ASN . 1.6 m-80 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 120' ' ' LEU . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.78 ' OE1' HG23 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.809 ' CG ' HD13 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' ND2' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.919 ' CZ ' HD12 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.791 HG11 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.5 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 1.104 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 126' ' ' SER . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.882 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.692 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE2' HG12 ' A' ' 30' ' ' VAL . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.876 ' HG ' ' H ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.92 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.816 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.67 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.764 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.622 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' C ' HD11 ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 52.3 tp60 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.826 ' CD1' HD12 ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HE ' ' HB3' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.825 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.562 ' HE1' ' HE2' ' A' ' 40' ' ' GLU . 86.5 t60 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.876 ' H ' ' HG ' ' A' ' 9' ' ' SER . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.692 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 76.0 m80 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.75 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.007 HD12 HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.897 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.825 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.936 HG11 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.936 ' HG ' HG11 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.73 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.826 HD12 ' CD1' ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.995 ' HB2' HD11 ' A' ' 59' ' ' ILE . 84.6 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.995 HD11 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.654 ' O ' HG21 ' A' ' 60' ' ' ILE . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HB3' ' CD1' ' A' ' 39' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.583 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.956 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.583 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.932 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.714 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 1.04 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.59 ' OE1' ' HA ' ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 1.04 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.73 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 144' ' ' HIS . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.897 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.889 ' HD3' ' HE2' ' A' ' 129' ' ' GLU . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 1.007 HG13 HD12 ' A' ' 39' ' ' ILE . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.778 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.801 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.571 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.717 ' OH ' ' HB3' ' A' ' 111' ' ' GLN . 65.6 t80 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.717 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.453 HD11 ' HG2' ' A' ' 111' ' ' GLN . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 114' ' ' LYS . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 117' ' ' ILE . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.834 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.891 ' HE3' HD22 ' A' ' 143' ' ' ASN . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.831 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.889 ' HE2' ' HD3' ' A' ' 88' ' ' ARG . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.703 ' CE2' HD12 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' O ' ' A' ' 87' ' ' ALA . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.891 HD22 ' HE3' ' A' ' 127' ' ' LYS . 40.3 p-10 -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.543 ' HE2' HG21 ' A' ' 85' ' ' VAL . 33.1 p80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.973 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.806 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.782 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 22' ' ' GLN . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.699 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.111 HG11 HD11 ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.111 HD11 HG11 ' A' ' 26' ' ' VAL . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.973 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.447 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.968 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.806 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.13 HG22 ' HA ' ' A' ' 89' ' ' ILE . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 1.013 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 42' ' ' LEU . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.853 ' HB3' HG23 ' A' ' 85' ' ' VAL . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.645 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.981 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.845 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.981 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 1.056 HD12 ' HB ' ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 52' ' ' LEU . 16.6 tt . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.968 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.876 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.849 ' SG ' HD11 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.616 HG22 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.544 HG22 ' CZ ' ' A' ' 41' ' ' PHE . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.777 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 73' ' ' LEU . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.572 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.762 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.762 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.624 ' CB ' HG21 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG23 ' OD1' ' A' ' 46' ' ' ASP . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.807 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.788 HH21 ' CG1' ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 1.13 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.63 ' O ' HG21 ' A' ' 137' ' ' THR . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.4 ' CB ' ' HE2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.758 HD11 ' HE2' ' A' ' 116' ' ' HIS . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.758 ' HE2' HD11 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.781 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.781 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.979 ' CD2' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.919 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.446 ' O ' HG21 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.912 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 132' ' ' ASP . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.912 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 129' ' ' GLU . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.668 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.737 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 1.009 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.827 ' HH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 10' ' ' PRO . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.714 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.691 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CG ' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.014 ' HB2' HD23 ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.451 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.756 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 39.4 tp60 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 29' ' ' LEU . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.478 ' HE2' ' HE2' ' A' ' 40' ' ' GLU . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 26' ' ' VAL . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.714 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.851 ' O ' HG23 ' A' ' 39' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 1.009 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 74.1 t60 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.99 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.974 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.846 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.065 HD11 HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HE2' ' HE2' ' A' ' 28' ' ' HIS . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.663 ' CE1' HG13 ' A' ' 60' ' ' ILE . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.871 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.87 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.928 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.928 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 59' ' ' ILE . 60.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.685 HG12 HD22 ' A' ' 52' ' ' LEU . 86.1 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.974 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.871 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.431 ' HB2' HG23 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.706 HG23 ' CZ ' ' A' ' 70' ' ' TYR . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.927 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.928 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.927 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.928 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.967 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.967 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.904 ' H ' HD12 ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.87 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 ' H ' ' A' ' 80' ' ' GLY . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.871 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.803 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.807 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 1.065 HG12 HD11 ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.846 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.676 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.41 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.7 ' CG1' ' HH ' ' A' ' 131' ' ' TYR . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.575 HG21 ' N ' ' A' ' 118' ' ' GLU . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.575 ' N ' HG21 ' A' ' 117' ' ' ILE . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.49 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HH ' ' CG1' ' A' ' 113' ' ' VAL . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.677 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.694 HG11 ' OG1' ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.89 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.568 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.923 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.662 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HD22 ' A' ' 23' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 18' ' ' TYR . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.002 ' HB2' HD22 ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.514 ' HG ' ' CB ' ' A' ' 22' ' ' GLN . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.784 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.935 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.809 HG11 ' HG ' ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.84 ' CB ' ' HB2' ' A' ' 41' ' ' PHE . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 74.7 m80 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.799 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.848 ' CD1' HG21 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.996 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 1.078 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.787 ' O ' HG12 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.773 ' HD2' ' HB3' ' A' ' 81' ' ' GLU . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.02 HG22 HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 1.02 HD13 HG22 ' A' ' 50' ' ' ILE . 8.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 60' ' ' ILE . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.721 ' HG1' ' HA ' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.796 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.659 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.564 HG23 ' H ' ' A' ' 72' ' ' ASN . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HG1' ' A' ' 61' ' ' THR . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.547 ' ND2' HD13 ' A' ' 73' ' ' LEU . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 75' ' ' ASN . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.593 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.978 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HD2' ' A' ' 46' ' ' ASP . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.921 ' HA ' HG13 ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 1.038 HG11 HG13 ' A' ' 142' ' ' VAL . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.078 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.996 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.688 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.848 HG21 ' CD1' ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.742 ' O ' HG22 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.613 ' OH ' ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.758 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.512 HG12 ' OH ' ' A' ' 131' ' ' TYR . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.884 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.866 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.636 HD13 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.884 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.998 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.998 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 m120 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.441 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.859 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HD12 ' A' ' 141' ' ' ILE . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.859 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.854 ' CE2' HD13 ' A' ' 120' ' ' LEU . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.772 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 1.038 HG13 HG11 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.927 0.394 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.934 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 1.035 ' HB3' ' HD1' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.984 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.707 ' HG ' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.059 ' HB2' HD21 ' A' ' 23' ' ' LEU . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.807 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.059 HD21 ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.996 HG22 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.753 HD12 HG21 ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 1.091 HG12 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 1.035 ' HD1' ' HB3' ' A' ' 6' ' ' TYR . 82.8 t60 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.805 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.831 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.919 HG12 HG22 ' A' ' 89' ' ' ILE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.091 ' HG2' HG12 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.988 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.996 ' HA ' HG22 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.791 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.817 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.788 HG23 ' NH2' ' A' ' 79' ' ' ARG . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 50' ' ' ILE . 85.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 59' ' ' ILE . 15.9 tt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.666 0.27 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.723 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 1.002 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.002 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.769 ' SG ' HD13 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.626 HG12 ' CE2' ' A' ' 41' ' ' PHE . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.777 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.823 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.777 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.819 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.788 ' NH2' HG23 ' A' ' 50' ' ' ILE . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 144' ' ' HIS . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.988 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.828 HH21 HG22 ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 39' ' ' ILE . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.584 HG23 ' CG1' ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.831 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' HD13 ' A' ' 112' ' ' LEU . 57.6 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.98 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.98 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.735 HD12 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 120' ' ' LEU . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.974 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.735 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.828 HG22 HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.974 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 85' ' ' VAL . 75.4 m80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.44 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.491 ' CG ' ' CD2' ' A' ' 33' ' ' HIS . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD22 HG12 ' A' ' 60' ' ' ILE . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.779 HG21 ' CG ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.722 HD11 ' CE2' ' A' ' 18' ' ' TYR . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' TYR . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.976 ' HB2' HD22 ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.753 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.976 HD22 ' HB2' ' A' ' 18' ' ' TYR . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.085 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.783 ' CE1' HD21 ' A' ' 42' ' ' LEU . 57.6 m170 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 29' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.757 HG22 ' CG ' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' HA ' HD12 ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 73.6 m80 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 1.006 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.94 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.828 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 89' ' ' ILE . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.757 ' CG ' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 1.092 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.783 HD21 ' CE1' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.815 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 1.085 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.64 ' CG1' HD13 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.733 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.708 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 1.029 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.029 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 1.006 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.701 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.701 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.95 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.723 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.95 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.723 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.858 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.858 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.708 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.64 HD13 ' CG1' ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.662 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.762 HG22 ' HE2' ' A' ' 70' ' ' TYR . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.815 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 1.092 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.848 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 39' ' ' ILE . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.828 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.94 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.636 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.58 ' O ' HG21 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 114' ' ' LYS . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.553 ' N ' HG21 ' A' ' 117' ' ' ILE . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.815 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.815 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.784 ' HB2' HG23 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.848 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.784 HG23 ' HB2' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.045 0.45 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.973 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.948 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.521 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' TYR . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.971 ' HB2' HD23 ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.547 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.965 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.742 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.742 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.76 HG22 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.973 ' CE1' ' HB2' ' A' ' 5' ' ' ASN . 74.2 t60 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.843 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 1.068 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.426 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.821 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.947 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.97 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.965 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.726 ' HB3' HG22 ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.888 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.775 ' CG1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.888 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.775 HD23 ' CG1' ' A' ' 50' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.748 HD12 ' HB3' ' A' ' 52' ' ' LEU . 20.6 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.952 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.791 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.068 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 89' ' ' ILE . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.721 HD11 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.863 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.633 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.863 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.823 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.823 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.693 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.592 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.493 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.799 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.97 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 21.3 m120 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.628 ' HH ' ' C ' ' A' ' 111' ' ' GLN . 2.3 m-85 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.628 ' C ' ' HH ' ' A' ' 95' ' ' TYR . 57.0 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 1.081 HD21 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 1.081 ' HG3' HD21 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 114' ' ' LYS . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HE2' ' CD1' ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.893 ' CB ' HG13 ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.672 ' O ' HG11 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.547 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 132' ' ' ASP . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.652 ' CE1' HD12 ' A' ' 117' ' ' ILE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.893 HG13 ' CB ' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.961 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' OE2' ' A' ' 129' ' ' GLU . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.62 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 1.118 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CB ' ' CD2' ' A' ' 33' ' ' HIS . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 10' ' ' PRO . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.834 ' O ' HD23 ' A' ' 29' ' ' LEU . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.733 ' O ' HG22 ' A' ' 8' ' ' ILE . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 ' CG ' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.543 ' O ' HD21 ' A' ' 23' ' ' LEU . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.05 ' HB2' HD21 ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.631 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 69.9 tp60 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.05 HD21 ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' A' ' 22' ' ' GLN . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.661 ' HD1' ' CB ' ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 9' ' ' SER . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 6' ' ' TYR . 77.4 m80 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 1.118 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.62 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.967 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' HIS . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.849 HG22 HG22 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.892 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.661 ' CB ' ' HD1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.731 ' HE2' HD11 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.889 ' HA ' HG22 ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 83' ' ' ILE . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.582 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 47' ' ' LEU . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.885 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.73 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 88.8 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.73 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 48.4 mm . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.549 0.214 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.695 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.967 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.826 ' SG ' HD11 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 ' CA ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 1.068 ' HA ' HD12 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.498 ' CA ' HG21 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.695 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.911 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 78' ' ' LYS . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 1.03 ' HZ2' ' HA3' ' A' ' 82' ' ' GLY . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.849 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 1.03 ' HA3' ' HZ2' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 69' ' ' ILE . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.998 HG13 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.892 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.075 ' HG3' ' HE2' ' A' ' 129' ' ' GLU . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.849 HG22 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.618 ' HG1' HG21 ' A' ' 139' ' ' VAL . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.506 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.788 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.613 HG11 ' OH ' ' A' ' 131' ' ' TYR . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.577 ' HD1' HH21 ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.891 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.891 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.847 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.452 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.847 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.542 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.842 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 1.075 ' HE2' ' HG3' ' A' ' 88' ' ' ARG . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.783 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.884 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.783 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 1.005 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.998 ' HB ' HG13 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.831 HD21 ' HG2' ' A' ' 127' ' ' LYS . 82.1 m-20 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.507 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.861 0.362 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.834 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.673 ' CB ' HG22 ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.961 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.51 ' OG ' HD22 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.961 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.584 ' OG ' ' HG2' ' A' ' 22' ' ' GLN . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.875 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' C ' HD21 ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.584 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.806 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 15' ' ' LEU . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.866 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.809 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 1.016 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.806 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.751 ' HA ' HG13 ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.838 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.838 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.907 HD22 HG13 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.907 HG13 HD22 ' A' ' 52' ' ' LEU . 70.0 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 1.095 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.768 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.825 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.866 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.825 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 1.095 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.599 HD13 ' CE2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CE2' HD13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.954 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.681 HD11 ' C ' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.708 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.708 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.676 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 98.5 m-20 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.793 ' CG2' ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.89 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.819 ' CD ' ' HE2' ' A' ' 129' ' ' GLU . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.809 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.72 ' O ' HG21 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.785 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.425 ' SG ' ' HE1' ' A' ' 138' ' ' TYR . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HH ' ' H ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.841 0.353 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.766 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 117' ' ' ILE . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.75 ' CD2' HD12 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.689 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.482 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.75 HD12 ' CD2' ' A' ' 116' ' ' HIS . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.9 HD22 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.597 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.9 ' HG2' HD22 ' A' ' 123' ' ' ASN . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.808 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.819 ' HE2' ' CD ' ' A' ' 88' ' ' ARG . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.818 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HE1' ' CD2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.889 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 85' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.89 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.793 ' H ' ' CG2' ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.864 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.985 ' HD1' ' HB2' ' A' ' 33' ' ' HIS . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.481 ' HH ' ' HE3' ' A' ' 38' ' ' LYS . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.851 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.708 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.851 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.687 HG21 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.93 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.93 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.7 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG12 ' CD2' ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.879 ' CD2' HG12 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 39' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.985 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.784 ' H ' ' HD1' ' A' ' 33' ' ' HIS . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.923 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.933 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.875 HG22 ' CE2' ' A' ' 41' ' ' PHE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.999 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.876 ' HE2' HH21 ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.7 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' VAL . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.834 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.834 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.923 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.888 ' HG3' HD12 ' A' ' 68' ' ' ILE . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.841 ' SG ' HD11 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.888 HD12 ' HG3' ' A' ' 63' ' ' GLU . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.999 HD12 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 1.119 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.822 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 1.119 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.568 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.565 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.977 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.727 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.876 HH21 ' HE2' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.999 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.916 ' HA ' HG21 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.841 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.512 ' O ' ' HD1' ' A' ' 95' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.815 0.34 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' NE2' ' A' ' 116' ' ' HIS . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 114' ' ' LYS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.41 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.456 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.863 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.749 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.959 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.535 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.798 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.817 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.771 ' O ' HG11 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.863 ' CG ' HD13 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.959 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.817 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.916 HG21 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 86' ' ' ARG . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.825 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.648 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HA ' HD13 ' A' ' 8' ' ' ILE . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.981 ' HA ' HD13 ' A' ' 52' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 29' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.974 ' HB2' HD23 ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.754 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HD2' HD21 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.029 HG22 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HD2' HG21 ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.029 HD11 HG22 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.693 HG21 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.2 m80 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 1.022 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.799 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.853 ' HZ ' HD12 ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.781 ' HB2' HG13 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.643 ' C ' HG22 ' A' ' 83' ' ' ILE . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.786 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.686 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.786 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.981 HD13 ' HA ' ' A' ' 12' ' ' LEU . 89.5 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.05 HG21 HG12 ' A' ' 60' ' ' ILE . 48.5 mm . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG21 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.898 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.978 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.617 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' CD2' ' A' ' 47' ' ' LEU . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 42' ' ' LEU . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.935 ' H ' HD21 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.507 ' HH ' HG23 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.764 0.316 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.507 HG23 ' HH ' ' A' ' 95' ' ' TYR . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.577 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.826 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.79 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.79 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.79 HD13 ' OH ' ' A' ' 138' ' ' TYR . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.797 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.797 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' OH ' ' A' ' 138' ' ' TYR . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.852 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.462 ' HB2' ' HE2' ' A' ' 129' ' ' GLU . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.646 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.79 ' OH ' HD13 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 129' ' ' GLU . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.831 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 86.3 t60 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.666 ' HB3' ' HD1' ' A' ' 33' ' ' HIS . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.61 ' O ' HD22 ' A' ' 23' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 1.01 ' HB2' HD22 ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 48' ' ' ALA . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.823 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.0 tp60 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.01 HD22 ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.914 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.969 ' HB ' HD21 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.914 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.969 HD21 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 1.081 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 1.081 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.593 HD12 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 39' ' ' ILE . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 42' ' ' LEU . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.669 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 1.095 ' HG2' HD12 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.816 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 45' ' ' VAL . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.921 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.834 ' HB ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.834 HD21 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.792 HD13 ' OE2' ' A' ' 81' ' ' GLU . 20.2 tt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.6 0.238 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.486 ' N ' HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.939 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.055 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.925 ' HG3' ' ND2' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 39' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.733 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.792 ' OE2' HD13 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 1.095 HD12 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.593 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 1.063 HG22 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' H ' ' CG1' ' A' ' 85' ' ' VAL . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.566 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.624 ' O ' HG21 ' A' ' 89' ' ' ILE . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.984 ' HG1' HG11 ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.925 ' ND2' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t30 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.476 0.179 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG11 ' OH ' ' A' ' 131' ' ' TYR . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 1.005 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' CE2' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 1.005 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.876 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.876 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.739 ' CB ' HG21 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.82 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' OH ' HG11 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.914 ' CE2' HD21 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.984 HG11 ' HG1' ' A' ' 90' ' ' THR . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.873 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.731 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.739 HG21 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.593 ' CD2' ' HB3' ' A' ' 84' ' ' ASN . 87.8 m-70 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.855 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HE1' ' CG1' ' A' ' 30' ' ' VAL . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.836 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.709 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.475 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.803 HG22 ' CG ' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.556 ' HA ' HD11 ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.857 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.705 ' HG ' ' CB ' ' A' ' 22' ' ' GLN . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 23' ' ' LEU . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 1.099 HH21 ' HB3' ' A' ' 48' ' ' ALA . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.729 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.938 HG13 ' HB2' ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.3 t60 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.938 ' HB2' HG13 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.623 ' HB ' ' HE1' ' A' ' 41' ' ' PHE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.855 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 8.1 t60 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.795 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 ' CB ' ' A' ' 89' ' ' ILE . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.906 ' HG2' HG23 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.867 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 27' ' ' PRO . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.959 ' HE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.829 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 1.012 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB3' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.75 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 16' ' ' SER . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HG ' HD11 ' A' ' 47' ' ' LEU . 85.8 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 59' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.831 HG22 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.444 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.789 ' CG ' HD13 ' A' ' 68' ' ' ILE . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.85 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.709 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.52 ' SG ' HG23 ' A' ' 89' ' ' ILE . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.921 HD12 HG13 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.858 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 75' ' ' ASN . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.858 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.624 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.923 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 1.022 ' HB2' ' HH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.734 ' HA ' HG13 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.921 HG13 HD12 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.959 ' HB2' ' HE2' ' A' ' 43' ' ' GLU . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.926 ' HG2' HG12 ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.771 ' CB ' HG21 ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.685 ' H ' HG23 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.717 ' O ' HG22 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.654 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.504 ' SG ' ' HD3' ' A' ' 65' ' ' LYS . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.667 0.27 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD13 ' HE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.936 HG11 ' HH ' ' A' ' 131' ' ' TYR . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.427 ' NH1' ' HE2' ' A' ' 118' ' ' GLU . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.936 ' HE2' HD13 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.822 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HE2' ' NH1' ' A' ' 115' ' ' ARG . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.852 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.918 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.532 ' N ' HD11 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.852 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.691 ' CD1' HD12 ' A' ' 120' ' ' LEU . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.826 ' OE1' HG12 ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.936 ' HH ' HG11 ' A' ' 113' ' ' VAL . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.746 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.826 HG12 ' OE1' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.918 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.926 HG12 ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 144' ' ' HIS . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.641 ' H ' ' CG2' ' A' ' 85' ' ' VAL . 73.6 m80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.801 ' O ' ' HD2' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.027 -0.318 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.886 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -67.93 26.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.541 2.161 . . . . 0.0 112.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.537 ' H ' ' C ' ' A' ' 1' ' ' GLY . 14.8 t-20 -70.05 129.23 38.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.942 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.6 -39.37 93.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.561 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.435 ' H ' ' CG2' ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 1.049 ' HG2' HG21 ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.776 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.049 HG21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.676 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.977 ' HB2' HD22 ' A' ' 23' ' ' LEU . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.826 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.867 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.961 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.4 tp60 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.977 HD22 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.867 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.829 ' CG1' HD21 ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CG1' ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.417 ' C ' HG23 ' A' ' 31' ' ' VAL . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 30' ' ' VAL . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.921 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.886 ' HE2' ' HA ' ' A' ' 2' ' ' PRO . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.921 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.53 HD11 ' CD1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.995 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' C ' ' A' ' 44' ' ' PRO . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.936 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.823 ' N ' HD23 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.634 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.868 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' ILE . 3.2 mm? -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.38 -40.66 18.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.669 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.7 p -61.51 -41.26 97.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.951 0.405 . . . . 0.0 110.574 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -39.76 82.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.88 -104.46 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.403 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.93 -52.61 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.468 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.687 HG21 HG21 ' A' ' 61' ' ' THR . 29.3 m -70.31 -21.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.969 -0.136 . . . . 0.0 111.348 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.733 HG13 ' CB ' ' A' ' 52' ' ' LEU . 11.4 tt 62.07 -25.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.859 0.864 . . . . 0.0 112.84 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.565 ' H ' ' C ' ' A' ' 58' ' ' VAL . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.687 HG21 HG21 ' A' ' 58' ' ' VAL . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' HE2' ' C ' ' A' ' 36' ' ' TYR . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.819 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.578 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.727 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' OG1' ' A' ' 61' ' ' THR . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.935 HD12 ' H ' ' A' ' 73' ' ' LEU . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.87 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.935 ' H ' HD12 ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.87 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.875 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.875 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HE2' ' CG ' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' PRO . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.715 ' ND2' ' HB3' ' A' ' 145' ' ' ALA . 26.2 m120 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.647 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.749 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.411 HD12 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.915 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.759 ' CD1' HD12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -69.06 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 79.2 Cg_endo -85.78 36.38 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.232 1.955 . . . . 0.0 112.784 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 96' ' ' PRO . 9.8 p 51.05 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 123.841 0.713 . . . . 0.0 112.329 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.699 ' HD2' ' HB2' ' A' ' 100' ' ' SER . 57.6 t0 -98.49 111.96 24.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.318 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.58 -27.5 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.756 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.699 ' HB2' ' HD2' ' A' ' 98' ' ' ASP . 57.8 m -60.17 -41.28 92.5 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.8 p -119.69 -1.7 10.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.7 0.286 . . . . 0.0 111.682 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.648 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.1 mtt85 60.01 24.0 13.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.83 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 97' ' ' VAL . 12.3 tttp -69.54 93.45 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 112.491 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 11.0 Cg_endo -52.47 92.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 111.966 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.759 HD12 ' CD1' ' A' ' 95' ' ' TYR . 3.5 pt -95.82 120.33 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.551 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.595 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 56.6 tptt -140.58 44.04 1.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 109' ' ' ASN . 21.5 m-20 -145.36 161.08 43.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 55.4 Cg_endo -69.0 34.33 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.451 2.1 . . . . 0.0 112.523 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 107' ' ' ASP . 98.8 m-20 -61.6 -40.24 94.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.91 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 76.0 m80 58.27 39.0 26.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -60.71 -40.76 93.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.551 ' CD1' ' HE2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.91 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.551 ' HE2' ' CD1' ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.721 HD11 ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.619 ' N ' HG22 ' A' ' 117' ' ' ILE . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.814 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.775 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.656 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.687 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 113' ' ' VAL . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.745 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HA ' ' HE2' ' A' ' 110' ' ' HIS . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.745 ' HB3' ' HD2' ' A' ' 132' ' ' ASP . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.814 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.749 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.656 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.499 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 -111.33 17.99 19.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.715 ' HB3' ' ND2' ' A' ' 84' ' ' ASN . . . -60.3 -40.3 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.249 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.75 130.01 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -120.03 139.9 51.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.58 0.24 34.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.397 0.618 . . . . 0.0 111.858 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.844 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.51 31.36 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.623 2.215 . . . . 0.0 112.595 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -79.59 122.68 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.928 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.91 104.08 16.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.67 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.689 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 30' ' ' VAL . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.86 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' H ' ' A' ' 30' ' ' VAL . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.99 ' HG2' HG23 ' A' ' 14' ' ' THR . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.982 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.883 ' HG ' HG21 ' A' ' 58' ' ' VAL . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.99 HG23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.072 ' HB2' HD21 ' A' ' 23' ' ' LEU . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.471 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.602 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.072 HD21 ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.026 HG11 ' HG ' ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 36.6 t-80 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.026 ' HG ' HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.702 ' ND1' ' H ' ' A' ' 35' ' ' SER . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.702 ' H ' ' ND1' ' A' ' 33' ' ' HIS . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.785 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.815 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.865 HG21 ' CE2' ' A' ' 41' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.767 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.919 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.955 HG13 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.912 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.912 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 55' ' ' LEU . 84.7 mt -69.67 -27.98 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -47.87 -40.13 20.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.545 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.1 p -61.15 -40.02 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.21 0.529 . . . . 0.0 109.928 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.723 HD11 HD22 ' A' ' 52' ' ' LEU . 51.5 mt -63.11 -40.2 96.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.072 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.75 -96.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.477 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 12' ' ' LEU . . . -172.94 -54.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.484 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.949 HG13 HG12 ' A' ' 60' ' ' ILE . 61.0 t -129.85 129.86 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 59' ' ' ILE . 20.4 mt -71.24 41.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.949 HG12 HG13 ' A' ' 58' ' ' VAL . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.817 ' CZ ' HD12 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.965 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.785 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.729 ' NZ ' ' HB2' ' A' ' 94' ' ' CYS . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' A' ' 89' ' ' ILE . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.965 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' LEU . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.901 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.901 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.645 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.657 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG11 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.882 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.919 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.104 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' A' ' 67' ' ' CYS . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.815 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.719 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 21.8 t-20 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 1.018 ' HH ' HG21 ' A' ' 113' ' ' VAL . 6.4 t80 -42.71 -47.93 13.23 Favored Pre-proline 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.832 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 23.6 Cg_exo -64.28 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.153 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 95' ' ' TYR . 14.9 t -148.02 117.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.68 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.7 t0 -96.72 120.62 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.985 ' HZ2' ' HB2' ' A' ' 99' ' ' LYS . 10.0 mtmp? -69.36 -39.08 78.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -38.03 81.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.332 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -125.51 5.83 7.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 98' ' ' ASP . 41.2 mmt180 60.2 20.09 9.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.237 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.899 ' HZ2' HD11 ' A' ' 105' ' ' ILE . 44.5 tttt -62.79 134.08 95.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.655 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.679 ' HB2' ' HZ3' ' A' ' 106' ' ' LYS . 40.6 Cg_endo -111.28 82.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.3 2.667 . . . . 0.0 110.81 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.899 HD11 ' HZ2' ' A' ' 103' ' ' LYS . 54.1 mt -93.94 111.52 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.435 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.679 ' HZ3' ' HB2' ' A' ' 104' ' ' PRO . 13.3 mptt -109.69 66.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -147.32 150.95 39.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -96.74 45.87 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.159 2.573 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.11 -0.31 57.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 1.064 ' HA ' HG23 ' A' ' 113' ' ' VAL . 76.0 m80 57.21 41.05 27.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.982 0.42 . . . . 0.0 110.951 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.19 -40.6 86.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.786 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 95' ' ' TYR . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 1.064 HG23 ' HA ' ' A' ' 110' ' ' HIS . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.684 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.809 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.919 HD12 ' CZ ' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 123' ' ' ASN . 1.6 m-80 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 120' ' ' LEU . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.78 ' OE1' HG23 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.809 ' CG ' HD13 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' ND2' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.919 ' CZ ' HD12 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.791 HG11 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.5 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 1.104 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 126' ' ' SER . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.882 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -119.27 -3.32 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.658 ' HB2' ' HD3' ' A' ' 86' ' ' ARG . . . -60.37 -39.92 88.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 111.343 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.67 121.19 40.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.75 140.36 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.867 ' O ' HG22 ' A' ' 149' ' ' THR . 78.3 mt-30 -90.12 119.93 30.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.405 0.621 . . . . 0.0 109.953 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.867 HG22 ' O ' ' A' ' 148' ' ' GLN . 7.4 t . . . . . 0 C--O 1.25 1.094 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.009 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.857 ' HA3' ' CE1' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.195 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.632 ' HD3' ' H2 ' ' A' ' 1' ' ' GLY . 56.7 Cg_endo -70.42 38.76 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.251 1.967 . . . . 0.0 112.289 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.5 m-20 60.26 36.4 20.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.969 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' HG3' ' HG2' ' A' ' 2' ' ' PRO . 99.1 mt-10 -59.68 -39.97 86.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.692 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE2' HG12 ' A' ' 30' ' ' VAL . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.876 ' HG ' ' H ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.92 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.816 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.67 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.764 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.622 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD11 ' C ' ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 52.3 tp60 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.826 ' CD1' HD12 ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HE ' ' HB3' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.825 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.562 ' HE1' ' HE2' ' A' ' 40' ' ' GLU . 86.5 t60 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.876 ' H ' ' HG ' ' A' ' 9' ' ' SER . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.692 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 76.0 m80 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.857 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.007 HD12 HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.897 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.825 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.936 HG11 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.936 ' HG ' HG11 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.73 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.826 HD12 ' CD1' ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.995 ' HB2' HD11 ' A' ' 59' ' ' ILE . 84.6 mt -71.0 -32.17 68.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 t -47.82 -37.06 12.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.749 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -60.89 -39.54 89.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -38.96 77.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.85 -110.02 0.94 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.169 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.96 -59.75 0.08 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 59' ' ' ILE . 59.2 t -60.37 -39.8 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.744 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.995 HD11 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt 47.02 19.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.654 HG21 ' O ' ' A' ' 60' ' ' ILE . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.705 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HB3' ' CD1' ' A' ' 39' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.583 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.956 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.583 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.932 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.714 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 1.04 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.59 ' OE1' ' HA ' ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 1.04 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.73 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 144' ' ' HIS . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.897 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.889 ' HD3' ' HE2' ' A' ' 129' ' ' GLU . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 1.007 HG13 HD12 ' A' ' 39' ' ' ILE . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.778 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.801 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.571 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.927 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 65.6 t80 -45.45 -36.12 4.08 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.828 ' HA ' ' N ' ' A' ' 105' ' ' ILE . 42.7 Cg_endo -111.77 82.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.717 1.611 . . . . 0.0 114.491 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.802 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 47.8 t -160.53 68.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.592 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.901 ' HA ' ' HD3' ' A' ' 106' ' ' LYS . 51.6 t0 -64.64 129.19 38.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.215 0.531 . . . . 0.0 110.527 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.922 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.7 pttp -70.33 -25.56 63.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.603 ' HG ' ' H ' ' A' ' 101' ' ' THR . 80.6 p -68.96 -56.7 7.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.603 ' H ' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -128.09 19.81 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.832 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 27.9 mtm105 62.58 25.12 14.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.838 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.73 ' O ' HG13 ' A' ' 105' ' ' ILE . 13.7 mmtt -70.93 93.78 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 124.587 1.155 . . . . 0.0 111.446 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.832 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 38.9 Cg_exo -32.98 88.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.557 2.838 . . . . 0.0 115.166 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.828 ' N ' ' HA ' ' A' ' 96' ' ' PRO . 1.2 pp 173.32 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.917 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.922 ' HD3' ' H ' ' A' ' 99' ' ' LYS . 9.3 pttp 59.72 43.68 15.15 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.138 0.575 . . . . 0.0 111.623 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.927 ' HB2' ' HA ' ' A' ' 95' ' ' TYR . 1.2 m-20 -140.75 159.34 62.93 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.652 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 1.037 ' HB3' ' HB2' ' A' ' 116' ' ' HIS . 47.8 Cg_endo -97.5 33.1 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.01 2.473 . . . . 0.0 114.563 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.791 ' HB3' ' CD1' ' A' ' 95' ' ' TYR . 23.5 t-20 -60.57 -39.67 88.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 110.969 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.688 ' HD2' ' OD1' ' A' ' 109' ' ' ASN . 8.7 p80 -159.77 -62.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.717 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 -58.75 -40.37 83.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.234 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.807 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.728 ' HA ' ' HB2' ' A' ' 108' ' ' PRO . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 117' ' ' ILE . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 1.037 ' HB2' ' HB3' ' A' ' 108' ' ' PRO . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.834 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.891 ' HE3' HD22 ' A' ' 143' ' ' ASN . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.831 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.889 ' HE2' ' HD3' ' A' ' 88' ' ' ARG . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.74 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.703 ' CE2' HD12 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' O ' ' A' ' 87' ' ' ALA . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.891 HD22 ' HE3' ' A' ' 127' ' ' LYS . 40.3 p-10 -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.543 ' HE2' HG21 ' A' ' 85' ' ' VAL . 33.1 p80 -123.86 17.63 9.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.493 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.32 119.97 38.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.174 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.93 -39.49 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -100.68 110.92 23.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.32 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.697 -179.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.42 28.39 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.334 2.023 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.1 m120 -80.09 139.91 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 -96.83 109.64 22.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.973 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.806 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.782 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 22' ' ' GLN . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.699 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.111 HG11 HD11 ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.111 HD11 HG11 ' A' ' 26' ' ' VAL . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.973 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.447 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.968 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.806 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.13 HG22 ' HA ' ' A' ' 89' ' ' ILE . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 1.013 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 42' ' ' LEU . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.853 ' HB3' HG23 ' A' ' 85' ' ' VAL . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.645 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.981 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.845 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.981 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.056 HD12 ' HB ' ' A' ' 59' ' ' ILE . 84.7 mt -62.95 -25.29 68.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 ' HG1' ' N ' ' A' ' 54' ' ' SER . 13.9 p -47.94 -39.15 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.443 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.426 ' N ' ' HG1' ' A' ' 53' ' ' THR . 54.0 m -108.93 -34.22 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.884 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.773 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 86.8 mt -69.03 -40.69 78.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.98 1.51 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.508 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.18 -110.62 0.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.697 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 59' ' ' ILE . 31.3 m -78.48 -7.05 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 52' ' ' LEU . 16.6 tt 48.72 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.006 0.522 . . . . 0.0 112.073 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 58' ' ' VAL . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.968 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.876 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.013 ' HZ1' ' HG3' ' A' ' 96' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.849 ' SG ' HD11 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.616 HG22 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.544 HG22 ' CZ ' ' A' ' 41' ' ' PHE . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.777 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 73' ' ' LEU . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.572 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.762 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.762 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.624 ' CB ' HG21 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.508 HD12 ' OE1' ' A' ' 147' ' ' GLU . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.939 ' HB2' ' HB1' ' A' ' 146' ' ' ALA . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.807 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.788 HH21 ' CG1' ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 1.13 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.804 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.63 ' O ' HG21 ' A' ' 137' ' ' THR . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.4 ' CB ' ' HE2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.654 ' CE2' HD11 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -130.32 70.1 82.19 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 1.013 ' HG3' ' HZ1' ' A' ' 65' ' ' LYS . 67.9 Cg_endo -94.3 -83.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.697 2.265 . . . . 0.0 112.78 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 103' ' ' LYS . 12.9 p -130.26 139.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.75 0.309 . . . . 0.0 111.524 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.918 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.4 t0 -81.08 119.0 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 0.0 110.121 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.53 -40.49 91.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -58.55 -46.51 86.7 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.682 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 10.2 p -124.47 11.69 8.64 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 60.82 35.53 19.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 109.769 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.918 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 32.4 mmtt -63.06 136.03 96.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.286 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 40.4 Cg_endo -111.7 83.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.353 2.702 . . . . 0.0 110.401 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.654 HD11 ' CE2' ' A' ' 95' ' ' TYR . 20.1 mt -79.96 118.81 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.512 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -109.95 24.94 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.491 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 42.7 m-20 -144.81 173.03 4.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.419 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 35.2 Cg_endo -113.49 82.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.752 2.968 . . . . 0.0 112.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.73 ' ND2' HE21 ' A' ' 111' ' ' GLN . 59.8 t-20 -120.4 127.5 52.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.01 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.936 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 99.1 m-70 -67.09 28.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.73 HE21 ' ND2' ' A' ' 109' ' ' ASN . 79.5 mt-30 -58.57 -40.16 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.758 HD11 ' HE2' ' A' ' 116' ' ' HIS . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.936 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.758 ' HE2' HD11 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.781 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.781 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.979 ' CD2' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.919 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.446 ' O ' HG21 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.912 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.783 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 132' ' ' ASP . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.912 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 129' ' ' GLU . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.668 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.737 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.42 HG13 ' CB ' ' A' ' 145' ' ' ALA . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.763 ' CD2' ' HG2' ' A' ' 148' ' ' GLN . 70.8 m80 60.01 40.39 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 142' ' ' VAL . . . -60.0 -41.02 91.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.477 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.939 ' HB1' ' HB2' ' A' ' 84' ' ' ASN . . . -124.07 -49.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.812 0.339 . . . . 0.0 111.545 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.508 ' OE1' HD12 ' A' ' 83' ' ' ILE . 50.2 mt-10 -125.72 146.32 49.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.564 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.763 ' HG2' ' CD2' ' A' ' 144' ' ' HIS . 80.0 mt-30 -87.32 119.21 27.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.236 0.541 . . . . 0.0 111.026 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.954 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 27.99 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.315 2.01 . . . . 0.0 112.451 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.6 m-20 -79.69 139.93 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.15 104.21 16.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.772 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 1.009 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.827 ' HH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 10' ' ' PRO . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.714 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.691 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 53' ' ' THR . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CG ' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.014 ' HB2' HD23 ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.451 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.756 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 39.4 tp60 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.624 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 29' ' ' LEU . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.478 ' HE2' ' HE2' ' A' ' 40' ' ' GLU . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.87 ' HB2' HG12 ' A' ' 26' ' ' VAL . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.714 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.851 ' O ' HG23 ' A' ' 39' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 1.009 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 74.1 t60 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.99 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.974 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.846 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.065 HD11 HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HE2' ' HE2' ' A' ' 28' ' ' HIS . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.663 ' CE1' HG13 ' A' ' 60' ' ' ILE . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.803 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.871 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.87 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.928 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.928 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 59' ' ' ILE . 60.4 tp -61.3 -39.85 92.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.856 ' CA ' HD12 ' A' ' 59' ' ' ILE . 1.5 t -49.55 -29.92 7.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 55' ' ' LEU . 82.6 p -60.46 -36.5 78.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.766 ' HB3' HG23 ' A' ' 58' ' ' VAL . 86.7 mt -61.13 -40.6 94.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.31 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.646 ' CA ' HD11 ' A' ' 12' ' ' LEU . . . 81.86 131.42 1.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.083 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.42 -20.24 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.831 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.766 HG23 ' HB3' ' A' ' 55' ' ' LEU . 57.3 t -66.2 -48.14 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.856 HD12 ' CA ' ' A' ' 53' ' ' THR . 86.1 mt -70.18 -40.12 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.974 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.871 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.431 ' HB2' HG23 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.706 HG23 ' CZ ' ' A' ' 70' ' ' TYR . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.927 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.928 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.927 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.928 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.967 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.967 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.904 ' H ' HD12 ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.87 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 ' H ' ' A' ' 80' ' ' GLY . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.871 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.803 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.807 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 1.065 HG12 HD11 ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.846 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.676 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.41 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -63.39 99.13 0.17 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.694 ' O ' HG13 ' A' ' 97' ' ' VAL . 25.5 Cg_endo -115.16 82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.661 2.907 . . . . 0.0 113.047 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 96' ' ' PRO . 14.8 p 49.8 154.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 56.8 t0 -89.46 109.59 20.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.458 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -69.42 -20.56 63.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB2' ' HD2' ' A' ' 98' ' ' ASP . 58.0 m -60.08 -41.5 92.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.625 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 103' ' ' LYS . 12.2 p -125.92 8.58 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.682 0.277 . . . . 0.0 111.424 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 101' ' ' THR . 99.2 mtt180 73.0 -24.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.01 0.434 . . . . 0.0 110.235 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 52.1 mttt -60.98 139.99 93.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.639 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.61 ' HB3' ' CG2' ' A' ' 97' ' ' VAL . 48.1 Cg_endo -113.34 178.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.589 2.193 . . . . 0.0 112.852 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.98 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.384 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.07 28.7 8.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.805 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -145.08 159.94 47.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.28 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.59 47.97 2.71 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.481 2.121 . . . . 0.0 112.272 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -109.76 115.26 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.533 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.848 ' HD1' HG23 ' A' ' 113' ' ' VAL . 93.2 m-70 -74.54 55.31 0.64 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.429 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.47 -39.99 89.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.142 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.848 HG23 ' HD1' ' A' ' 110' ' ' HIS . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.575 HG21 ' N ' ' A' ' 118' ' ' GLU . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.575 ' N ' HG21 ' A' ' 117' ' ' ILE . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.49 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HH ' ' CG1' ' A' ' 113' ' ' VAL . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.677 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.694 HG11 ' OG1' ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.89 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.895 ' ND2' ' HB2' ' A' ' 146' ' ' ALA . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.84 -29.46 13.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.6 91.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.196 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.895 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . . . -99.2 122.12 41.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -139.95 154.55 47.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.095 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -98.87 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.067 0.46 . . . . 0.0 111.053 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.155 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' H3 ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD3' ' H3 ' ' A' ' 1' ' ' GLY . 21.2 Cg_endo -118.91 -179.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.052 3.168 . . . . 0.0 113.141 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.63 ' ND2' ' HB3' ' A' ' 7' ' ' TYR . 80.8 m-20 -74.5 129.97 38.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -63.91 -40.32 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.923 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HB3' ' ND2' ' A' ' 3' ' ' ASN . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.662 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.89 ' CD2' ' HA ' ' A' ' 58' ' ' VAL . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HD22 ' A' ' 23' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 18' ' ' TYR . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.002 ' HB2' HD22 ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.514 ' HG ' ' CB ' ' A' ' 22' ' ' GLN . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.784 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.935 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.809 HG11 ' HG ' ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.84 ' CB ' ' HB2' ' A' ' 41' ' ' PHE . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 74.7 m80 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HZ1' ' HB2' ' A' ' 3' ' ' ASN . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.799 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.848 ' CD1' HG21 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.996 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 1.078 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.787 ' O ' HG12 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.773 ' HD2' ' HB3' ' A' ' 81' ' ' GLU . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.02 HG22 HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.02 HD13 HG22 ' A' ' 50' ' ' ILE . 8.6 mp -60.22 -39.46 86.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.33 -40.03 16.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.794 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.454 ' HB2' ' HD3' ' A' ' 78' ' ' LYS . 53.7 m -100.37 -25.91 14.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.951 HD11 ' HG2' ' A' ' 51' ' ' PRO . 84.5 mt -69.54 -39.76 77.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.994 0.426 . . . . 0.0 110.88 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.61 -40.02 2.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . 160.04 -80.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.213 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.89 ' HA ' ' CD2' ' A' ' 12' ' ' LEU . 30.3 m -71.48 -20.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.163 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.823 HG12 HD12 ' A' ' 55' ' ' LEU . 20.4 mt 69.33 -17.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.39 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 ' H ' ' C ' ' A' ' 58' ' ' VAL . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.721 ' HG1' ' HA ' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.796 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.659 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.564 HG23 ' H ' ' A' ' 72' ' ' ASN . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HG1' ' A' ' 61' ' ' THR . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.547 ' ND2' HD13 ' A' ' 73' ' ' LEU . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 75' ' ' ASN . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.593 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.978 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HD2' ' A' ' 46' ' ' ASP . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.921 ' HA ' HG13 ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 1.038 HG11 HG13 ' A' ' 142' ' ' VAL . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.078 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.996 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.688 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.848 HG21 ' CD1' ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.742 ' O ' HG22 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.913 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.743 ' HD1' HD12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.53 92.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.913 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 57.5 Cg_endo -86.94 -104.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.015 1.81 . . . . 0.0 112.479 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.835 HG11 ' O ' ' A' ' 103' ' ' LYS . 23.6 t -132.3 136.18 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 122.15 -0.344 . . . . 0.0 111.112 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 1.024 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 96.0 m-20 -79.33 109.92 14.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.089 0.471 . . . . 0.0 110.345 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.78 -20.79 45.41 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.51 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.1 p -58.78 -41.28 86.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 0.0 111.621 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.605 ' HG1' ' HG2' ' A' ' 103' ' ' LYS . 1.4 p -124.9 17.66 8.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.022 0.439 . . . . 0.0 111.009 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 61.07 20.08 10.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.155 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 1.024 ' HB2' ' HB2' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -64.62 127.98 92.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.709 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -110.93 83.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.173 2.582 . . . . 0.0 110.438 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.743 HD12 ' HD1' ' A' ' 95' ' ' TYR . 1.3 pp -97.0 120.99 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.58 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.94 23.12 14.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -143.35 167.03 16.88 Favored Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.961 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -115.18 80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 122.74 2.294 . . . . 0.0 111.11 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 16.9 t-20 -86.27 0.71 53.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.084 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.953 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 98.4 m-70 70.12 9.69 7.13 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.446 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -61.95 -37.29 84.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.565 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.758 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.953 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.884 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.866 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.636 HD13 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.884 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.998 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.854 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.998 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 m120 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.441 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.859 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HD12 ' A' ' 141' ' ' ILE . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.859 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.675 ' O ' ' HE1' ' A' ' 110' ' ' HIS . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.854 ' CE2' HD13 ' A' ' 120' ' ' LEU . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.772 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 1.038 HG13 HG11 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.795 ' CE1' ' HA ' ' A' ' 147' ' ' GLU . 49.5 t-80 -82.51 71.89 9.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 85' ' ' VAL . . . -68.21 -40.08 82.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.068 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 144' ' ' HIS . . . -100.19 129.9 46.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.795 ' HA ' ' CE1' ' A' ' 144' ' ' HIS . 50.1 mt-10 -103.75 130.65 51.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.99 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.577 HE22 ' NE2' ' A' ' 144' ' ' HIS . 8.0 mp0 -89.84 120.32 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.56 0.695 . . . . 0.0 109.911 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.617 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.611 ' H3 ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.184 0 CA-C-O 120.158 -0.245 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.611 ' HD3' ' H3 ' ' A' ' 1' ' ' GLY . 60.2 Cg_endo -72.52 25.55 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.397 2.065 . . . . 0.0 112.278 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.8 m120 -72.91 133.66 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.21 -27.6 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.553 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.934 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 1.035 ' HB3' ' HD1' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.984 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.707 ' HG ' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' HA2' ' A' ' 57' ' ' GLY . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.746 ' CD2' HG11 ' A' ' 58' ' ' VAL . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.059 ' HB2' HD21 ' A' ' 23' ' ' LEU . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.807 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.059 HD21 ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.996 HG22 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.753 HD12 HG21 ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 1.091 HG12 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 1.035 ' HD1' ' HB3' ' A' ' 6' ' ' TYR . 82.8 t60 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.805 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.831 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.919 HG12 HG22 ' A' ' 89' ' ' ILE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.091 ' HG2' HG12 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.988 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.996 ' HA ' HG22 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.791 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 58' ' ' VAL . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.817 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.788 HG23 ' NH2' ' A' ' 79' ' ' ARG . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 50' ' ' ILE . 85.4 mt -60.62 -39.74 89.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.89 -36.7 12.62 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.902 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.1 t -61.04 -38.77 87.32 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.707 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.2 -40.08 96.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.592 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.16 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.607 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.617 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . -92.22 170.9 33.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.652 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.746 HG11 ' CD2' ' A' ' 15' ' ' LEU . 16.6 m -60.2 -49.79 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.016 0.408 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 58' ' ' VAL . 15.9 tt 167.18 29.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.357 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.723 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 1.002 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.002 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.769 ' SG ' HD13 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.626 HG12 ' CE2' ' A' ' 41' ' ' PHE . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.777 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.823 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.777 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.819 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.788 ' NH2' HG23 ' A' ' 50' ' ' ILE . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 144' ' ' HIS . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.735 HH21 ' HB1' ' A' ' 145' ' ' ALA . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.988 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.828 HH21 HG22 ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 39' ' ' ILE . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.584 HG23 ' CG1' ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.831 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.863 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -45.12 -48.89 31.77 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.863 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 24.3 Cg_exo -63.81 21.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.509 2.139 . . . . 0.0 113.429 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG23 ' C ' ' A' ' 96' ' ' PRO . 16.6 t -144.33 98.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.921 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.0 t0 -89.39 117.82 28.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.415 ' HZ2' ' NH1' ' A' ' 119' ' ' ARG . 64.5 pttt -62.19 -29.7 70.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 t -60.07 -53.95 51.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.621 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 5.8 p -126.38 16.57 7.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.918 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' ASP . 99.3 mtt180 60.49 36.42 20.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.428 0.632 . . . . 0.0 109.679 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.921 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 76.2 mttt -63.12 137.07 96.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 30.3 Cg_endo -112.58 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 123.53 2.82 . . . . 0.0 111.215 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 69.3 mt -91.61 104.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.811 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.54 68.29 2.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.701 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -149.76 166.26 15.63 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.922 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -109.33 76.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 124.307 3.338 . . . . 0.0 114.916 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.418 ' O ' HG21 ' A' ' 113' ' ' VAL . 97.1 m-20 -115.58 123.01 47.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.464 0.65 . . . . 0.0 112.537 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.892 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 99.4 m-70 -75.04 14.12 0.58 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' HD13 ' A' ' 112' ' ' LEU . 57.6 tt0 -57.66 -39.2 76.51 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.238 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.98 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.892 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.98 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.735 HD12 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.415 ' NH1' ' HZ2' ' A' ' 99' ' ' LYS . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 120' ' ' LEU . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.974 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.735 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.828 HG22 HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.974 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 85' ' ' VAL . 75.4 m80 -65.39 -40.14 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.735 ' HB1' HH21 ' A' ' 86' ' ' ARG . . . -60.83 -39.99 91.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.11 120.43 39.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.254 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -120.03 130.26 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.468 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.562 HE21 ' HE2' ' A' ' 127' ' ' LYS . 35.7 mt-30 -61.96 139.75 58.38 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 122.603 1.192 . . . . 0.0 110.372 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.3 -1.575 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.989 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.2 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.067 1.844 . . . . 0.0 112.254 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.649 ' HA ' ' CE1' ' A' ' 6' ' ' TYR . 40.0 p-10 -110.04 19.59 18.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.335 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.64 -39.56 77.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.215 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.44 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.649 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.815 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.716 HD13 HG11 ' A' ' 58' ' ' VAL . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.779 HG21 ' CG ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.722 HD11 ' CE2' ' A' ' 18' ' ' TYR . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' TYR . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.976 ' HB2' HD22 ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.753 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.976 HD22 ' HB2' ' A' ' 18' ' ' TYR . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.085 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.783 ' CE1' HD21 ' A' ' 42' ' ' LEU . 57.6 m170 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 29' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.757 HG22 ' CG ' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' HA ' HD12 ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 73.6 m80 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 1.006 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.94 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.828 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 89' ' ' ILE . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.757 ' CG ' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 1.092 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD21 ' CE1' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.815 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 1.085 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.64 ' CG1' HD13 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.733 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.708 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.029 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt -66.63 -39.27 88.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 1.035 HG22 ' HB ' ' A' ' 59' ' ' ILE . 18.6 p -49.9 -31.84 13.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.601 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.7 p -68.4 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.55 -40.54 91.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.518 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.44 -77.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.819 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.39 -39.43 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.716 HG11 HD13 ' A' ' 12' ' ' LEU . 61.9 t -125.12 129.81 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.035 ' HB ' HG22 ' A' ' 53' ' ' THR . 0.0 OUTLIER -53.24 -7.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 1.006 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.701 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.701 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.95 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.723 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.95 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.723 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.858 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.858 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.708 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.64 HD13 ' CG1' ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.662 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG22 ' HE2' ' A' ' 70' ' ' TYR . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.815 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 1.092 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.848 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 39' ' ' ILE . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.828 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.94 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.949 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -69.9 90.96 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.949 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 66.1 Cg_endo -88.96 57.91 2.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.461 2.107 . . . . 0.0 112.946 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.867 ' HA ' HG21 ' A' ' 105' ' ' ILE . 11.3 p 49.75 166.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.468 0.707 . . . . 0.0 112.565 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.04 109.84 20.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.399 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.09 -27.9 64.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.121 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.7 p -59.83 -40.57 88.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.8 p -121.16 -0.29 9.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.576 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.2 mtt-85 60.25 22.24 11.64 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.695 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.87 93.46 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.129 0.893 . . . . 0.0 112.429 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 5.0 Cg_endo -46.8 109.38 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.45 2.1 . . . . 0.0 112.117 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.867 HG21 ' HA ' ' A' ' 97' ' ' VAL . 19.9 tt -97.16 105.6 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.337 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -111.1 20.43 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -145.0 166.78 16.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -114.84 83.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.627 2.885 . . . . 0.0 112.69 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.65 2.02 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.973 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.942 ' HA ' HG22 ' A' ' 113' ' ' VAL . 87.8 m-70 60.03 30.83 20.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.779 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -61.09 -40.08 92.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.636 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.942 HG22 ' HA ' ' A' ' 110' ' ' HIS . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.58 ' O ' HG21 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 114' ' ' LYS . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.553 ' N ' HG21 ' A' ' 117' ' ' ILE . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.815 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.815 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.784 ' HB2' HG23 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.65 ' HB2' ' CE1' ' A' ' 110' ' ' HIS . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.848 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.784 HG23 ' HB2' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.807 ' ND2' ' HB2' ' A' ' 146' ' ' ALA . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -75.04 -36.32 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.53 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.87 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.807 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . . . -83.27 115.86 22.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.0 111.171 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.48 140.05 51.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.975 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.75 119.77 30.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.55 0.69 . . . . 0.0 110.076 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.008 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.43 31.97 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.698 2.265 . . . . 0.0 112.567 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -74.54 129.66 38.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 -92.95 103.41 15.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.973 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.948 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.521 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.061 HD23 HG21 ' A' ' 58' ' ' VAL . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' TYR . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.971 ' HB2' HD23 ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.547 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.965 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.742 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.742 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.76 HG22 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.973 ' CE1' ' HB2' ' A' ' 5' ' ' ASN . 74.2 t60 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.843 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 1.068 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.426 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.821 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.947 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.97 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.965 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.726 ' HB3' HG22 ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.888 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.775 ' CG1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.888 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.059 ' HA ' HD23 ' A' ' 55' ' ' LEU . 2.3 pp -60.18 -39.48 86.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 p -49.9 -34.37 20.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.485 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -60.28 -49.53 77.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.059 HD23 ' HA ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -69.59 -40.05 76.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.885 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.26 -10.01 75.63 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.949 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.821 ' N ' HD11 ' A' ' 55' ' ' LEU . . . -98.27 5.95 61.24 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.749 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 1.061 HG21 HD23 ' A' ' 12' ' ' LEU . 16.4 t 58.38 19.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.957 0.408 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.782 ' H ' HD12 ' A' ' 55' ' ' LEU . 20.6 mt 57.72 9.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.512 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.952 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.791 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.068 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.67 ' HB3' ' NE2' ' A' ' 110' ' ' HIS . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 89' ' ' ILE . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.721 HD11 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.863 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.633 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.863 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.823 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.823 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.693 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.592 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.493 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.799 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.97 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 21.3 m120 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.677 ' HA ' HD13 ' A' ' 105' ' ' ILE . 2.3 m-85 49.07 60.04 16.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 97' ' ' VAL . 60.3 Cg_endo -104.09 33.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.057 2.505 . . . . 0.0 114.052 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.978 ' HB ' ' CB ' ' A' ' 104' ' ' PRO . 22.5 t -146.35 -29.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.782 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.734 ' N ' ' HB3' ' A' ' 104' ' ' PRO . 12.2 p-10 -66.78 132.21 47.57 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.764 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 14.1 ttmm 72.24 -28.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.912 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 98' ' ' ASP . 52.4 m -71.76 -50.08 33.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.8 p -124.61 -6.66 7.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.147 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 84.1 mtm180 55.85 71.67 0.54 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.82 0.819 . . . . 0.0 111.194 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' O ' HG11 ' A' ' 97' ' ' VAL . 3.9 mmtt 159.93 70.74 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.978 ' CB ' ' HB ' ' A' ' 97' ' ' VAL 0.257 25.6 Cg_endo -118.95 -179.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.293 2.662 . . . . 0.0 114.897 -174.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.042 HG22 ' HA ' ' A' ' 111' ' ' GLN . 1.1 mp 45.04 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.99 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.08 31.27 0.26 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.246 0.546 . . . . 0.0 110.053 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.552 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 5.1 m-20 -142.91 177.08 1.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.894 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.552 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 91.7 Cg_endo -114.27 -179.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.722 0 C-N-CA 123.874 3.049 . . . . 0.0 111.837 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 60.57 13.24 4.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.315 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.67 ' NE2' ' HB3' ' A' ' 65' ' ' LYS . 75.3 m80 -160.67 -6.81 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 1.042 ' HA ' HG22 ' A' ' 105' ' ' ILE . 57.0 tt0 -60.51 -40.24 90.68 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 1.081 HD21 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 1.081 ' HG3' HD21 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 114' ' ' LYS . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.663 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HE2' ' CD1' ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.893 ' CB ' HG13 ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.672 ' O ' HG11 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.547 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 132' ' ' ASP . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.652 ' CE1' HD12 ' A' ' 117' ' ' ILE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.893 HG13 ' CB ' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.961 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' OE2' ' A' ' 129' ' ' GLU . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 -99.75 -13.06 19.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.799 ' CB ' HH21 ' A' ' 86' ' ' ARG . . . -60.06 -39.72 86.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.389 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.81 160.12 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.413 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 60.49 45.82 10.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.681 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 145' ' ' ALA . 70.7 mm-40 -80.39 -0.1 35.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.942 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 CA-C-O 120.115 -0.269 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -118.91 -179.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.007 3.138 . . . . 0.0 113.296 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -87.28 116.81 25.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.62 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 -99.01 109.28 22.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 1.118 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CB ' ' CD2' ' A' ' 33' ' ' HIS . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 10' ' ' PRO . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.834 ' O ' HD23 ' A' ' 29' ' ' LEU . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.733 ' O ' HG22 ' A' ' 8' ' ' ILE . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 ' CG ' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.543 ' O ' HD21 ' A' ' 23' ' ' LEU . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.05 ' HB2' HD21 ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.631 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 69.9 tp60 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.05 HD21 ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.889 HG22 ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' A' ' 22' ' ' GLN . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.661 ' HD1' ' CB ' ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 9' ' ' SER . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 6' ' ' TYR . 77.4 m80 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 1.118 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.62 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.967 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' HIS . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.849 HG22 HG22 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.892 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.661 ' CB ' ' HD1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.731 ' HE2' HD11 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.889 ' HA ' HG22 ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 83' ' ' ILE . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.582 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 47' ' ' LEU . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.885 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.885 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.73 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 88.8 mt -65.63 -39.72 91.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.97 HG21 HG13 ' A' ' 59' ' ' ILE . 6.8 p -47.73 -49.05 29.28 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.24 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -66.49 -39.8 88.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 51' ' ' PRO . 83.7 mt -60.36 -39.36 86.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.627 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.83 -170.8 43.65 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.407 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.07 19.04 8.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.722 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.6 t -60.82 -40.0 83.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.651 -0.323 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.97 HG13 HG21 ' A' ' 53' ' ' THR . 48.4 mm -70.49 -40.56 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.695 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.967 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.826 ' SG ' HD11 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.498 HG21 ' CA ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 1.068 ' HA ' HD12 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.498 ' CA ' HG21 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.695 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.911 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 78' ' ' LYS . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.637 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 1.03 ' HZ2' ' HA3' ' A' ' 82' ' ' GLY . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.62 ' HB3' ' HG3' ' A' ' 148' ' ' GLN . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.612 ' HA2' ' OE1' ' A' ' 148' ' ' GLN . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.849 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 1.03 ' HA3' ' HZ2' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 69' ' ' ILE . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.998 HG13 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.892 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.075 ' HG3' ' HE2' ' A' ' 129' ' ' GLU . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.849 HG22 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.618 ' HG1' HG21 ' A' ' 139' ' ' VAL . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.506 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.914 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.788 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -67.85 92.01 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.914 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.3 Cg_endo -90.67 49.93 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.893 2.395 . . . . 0.0 113.142 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 96' ' ' PRO . 9.8 p 51.47 168.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.619 0.574 . . . . 0.0 112.148 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.766 ' HD2' HD22 ' A' ' 112' ' ' LEU . 96.1 m-20 -100.22 115.73 30.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.08 -39.23 75.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.985 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.9 p -58.64 -30.64 67.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.069 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.8 p -120.51 -7.96 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.905 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 32.2 mmt180 60.4 21.68 11.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.341 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.677 ' O ' HG13 ' A' ' 105' ' ' ILE . 5.1 tptt -72.05 94.26 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 124.264 0.978 . . . . 0.0 112.316 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.905 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 74.8 Cg_exo -48.12 104.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.803 1.669 . . . . 0.0 112.426 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 103' ' ' LYS . 84.3 mt -99.71 113.15 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.278 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.6 37.33 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 110.754 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 38.1 m-20 -143.49 175.64 2.74 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.891 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 33.0 Cg_endo -114.32 81.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.048 2.499 . . . . 0.0 111.554 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 111' ' ' GLN . 51.4 t30 -116.65 119.36 35.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.684 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.803 ' HA ' HG21 ' A' ' 113' ' ' VAL . 55.3 p-80 -68.29 25.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.69 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.577 ' H ' ' C ' ' A' ' 109' ' ' ASN . 72.1 tp60 -60.93 -39.58 90.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.359 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.803 HG21 ' HA ' ' A' ' 110' ' ' HIS . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.577 ' HD1' HH21 ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.891 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.75 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.891 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.847 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.452 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.847 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.542 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.842 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 1.075 ' HE2' ' HG3' ' A' ' 88' ' ' ARG . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.783 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.884 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.783 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 1.005 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.998 ' HB ' HG13 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.831 HD21 ' HG2' ' A' ' 127' ' ' LYS . 82.1 m-20 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.507 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 64.08 49.99 2.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -59.63 -23.2 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 145' ' ' ALA . . . 77.94 95.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.217 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' HE2' ' ND2' ' A' ' 84' ' ' ASN . 19.1 pt-20 -139.77 159.76 41.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.925 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.62 ' HG3' ' HB3' ' A' ' 79' ' ' ARG . 97.0 mt-30 -80.33 -0.03 34.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.305 0.574 . . . . 0.0 111.897 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.863 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' H2 ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 120.129 -0.262 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' CD ' ' H2 ' ' A' ' 1' ' ' GLY . 20.9 Cg_endo -118.93 -179.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.86 3.04 . . . . 0.0 113.264 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -100.17 18.37 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.49 -39.98 89.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.834 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.673 ' CB ' HG22 ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.07 HD11 ' HA ' ' A' ' 53' ' ' THR . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.961 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.51 ' OG ' HD22 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.961 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.584 ' OG ' ' HG2' ' A' ' 22' ' ' GLN . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.875 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' C ' HD21 ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.584 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.806 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 15' ' ' LEU . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.866 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.809 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 1.016 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.806 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.751 ' HA ' HG13 ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.875 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.838 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.838 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.907 HD22 HG13 ' A' ' 59' ' ' ILE . 84.7 mt -60.2 -40.0 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 1.07 ' HA ' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -47.37 -49.63 24.09 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.661 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -61.3 -40.49 94.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.701 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 58' ' ' VAL . 85.5 mt -69.08 -39.39 79.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.69 8.0 11.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.841 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 49.58 3.33 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.743 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 55' ' ' LEU . 62.8 t -60.78 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.907 HG13 HD22 ' A' ' 52' ' ' LEU . 70.0 mt -63.7 -39.72 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 1.095 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.768 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.825 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.866 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HZ2' ' HB3' ' A' ' 96' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.825 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 1.095 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.599 HD13 ' CE2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CE2' HD13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.954 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.681 ' C ' HD11 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.708 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.708 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.676 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 98.5 m-20 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.793 ' CG2' ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.89 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.819 ' CD ' ' HE2' ' A' ' 129' ' ' GLU . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.809 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.72 ' O ' HG21 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.785 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.744 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HH ' ' H ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -63.25 98.55 0.15 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.9 Cg_endo -92.36 36.28 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.758 2.306 . . . . 0.0 112.595 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER 55.25 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.0 0.429 . . . . 0.0 111.028 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 1.054 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.2 t0 -92.09 106.02 18.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -69.85 -39.31 76.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -58.15 -34.93 70.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.736 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.55 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 11.5 p -123.05 6.54 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 102' ' ' ARG . 57.1 ttt85 59.97 25.58 14.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.457 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 1.054 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 7.8 mmpt? -60.95 133.49 92.43 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 38.7 Cg_endo -111.31 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.348 2.699 . . . . 0.0 111.134 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.567 HD11 ' OE1' ' A' ' 111' ' ' GLN . 59.2 mt -82.15 101.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.893 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -119.95 32.66 5.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.006 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' ASN . 12.5 m-20 -140.12 165.33 31.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.53 34.55 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.782 2.321 . . . . 0.0 112.869 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' ASP . 51.8 t30 -100.0 109.9 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.027 0.442 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 1.084 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 45.4 p-80 -80.04 69.46 6.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.567 ' OE1' HD11 ' A' ' 105' ' ' ILE . 64.0 tt0 -60.59 -40.64 92.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.65 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.766 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 1.084 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.884 ' HE3' ' NE2' ' A' ' 110' ' ' HIS . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.75 ' CD2' HD12 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.689 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.482 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.75 HD12 ' CD2' ' A' ' 116' ' ' HIS . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.9 HD22 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.597 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.9 ' HG2' HD22 ' A' ' 123' ' ' ASN . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.808 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.819 ' HE2' ' CD ' ' A' ' 88' ' ' ARG . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.818 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HE1' ' CD2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.889 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 85' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.89 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.793 ' H ' ' CG2' ' A' ' 85' ' ' VAL . 86.2 t60 -60.47 -40.31 90.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.627 ' CB ' ' HE ' ' A' ' 86' ' ' ARG . . . -60.23 -40.04 88.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.612 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.93 120.12 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.874 0.368 . . . . 0.0 111.233 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -120.04 140.0 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.688 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.34 -0.11 35.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.376 0.608 . . . . 0.0 111.899 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.915 179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -116.56 179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.973 3.115 . . . . 0.0 113.002 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 1.065 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 80.8 m-20 -100.02 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -61.28 -39.37 90.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.237 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.864 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 1.065 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' HH ' ' HE3' ' A' ' 38' ' ' LYS . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.851 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.708 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.851 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.487 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.005 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.687 HG21 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.93 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.93 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.7 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG12 ' CD2' ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.879 ' CD2' HG12 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.708 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 39' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.985 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.784 ' H ' ' HD1' ' A' ' 33' ' ' HIS . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.923 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.933 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.875 HG22 ' CE2' ' A' ' 41' ' ' PHE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.999 ' HE1' HD12 ' A' ' 69' ' ' ILE . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.876 ' HE2' HH21 ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.7 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 45' ' ' VAL . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.834 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.834 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' HG ' ' HA3' ' A' ' 57' ' ' GLY . 60.1 tp -61.82 -39.99 93.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.95 ' HB ' HD12 ' A' ' 60' ' ' ILE . 12.7 p -47.47 -49.38 25.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.609 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 1.005 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 46.9 t -64.03 -39.9 95.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.345 0.593 . . . . 0.0 109.548 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 51' ' ' PRO . 85.4 mt -60.94 -39.87 91.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.521 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.02 49.98 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' ' HG ' ' A' ' 52' ' ' LEU . . . -89.61 -168.39 43.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.205 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' TYR . 18.0 t -79.81 -14.42 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.52 -43.72 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.95 HD12 ' HB ' ' A' ' 53' ' ' THR . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.923 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.888 ' HG3' HD12 ' A' ' 68' ' ' ILE . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.841 ' SG ' HD11 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.888 HD12 ' HG3' ' A' ' 63' ' ' GLU . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.999 HD12 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.481 ' O ' HG12 ' A' ' 58' ' ' VAL . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 1.119 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.822 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 1.119 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.568 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.565 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.977 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.727 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.876 HH21 ' HE2' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.999 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.916 ' HA ' HG21 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.841 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.512 ' O ' ' HD1' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -49.41 -48.73 74.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.622 ' O ' HG21 ' A' ' 97' ' ' VAL . 67.3 Cg_endo -94.47 34.07 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.354 2.036 . . . . 0.0 113.211 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 96' ' ' PRO . 16.9 t -152.17 93.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.839 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.9 t0 -80.0 118.87 22.12 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.688 ' HZ1' ' HD2' ' A' ' 119' ' ' ARG . 65.4 pttt -68.02 -28.92 67.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -60.26 -47.35 86.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 p -126.45 14.08 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.835 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 60.25 35.57 20.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.571 0.7 . . . . 0.0 109.638 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -63.32 131.0 94.65 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.515 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -111.04 82.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.687 HD13 ' CG ' ' A' ' 103' ' ' LYS . 32.7 mm -74.21 125.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.174 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -110.05 22.45 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.564 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -145.03 159.09 50.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.266 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -92.79 50.05 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.933 2.422 . . . . 0.0 112.606 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.505 ' HB3' HE21 ' A' ' 111' ' ' GLN . 98.6 m-20 -80.87 -7.41 59.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.361 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.855 ' HB3' HG12 ' A' ' 113' ' ' VAL . 78.6 m80 59.42 34.0 22.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.505 HE21 ' HB3' ' A' ' 109' ' ' ASN . 97.7 mm-40 -60.61 -40.17 90.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.491 HD23 HG13 ' A' ' 105' ' ' ILE . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 110' ' ' HIS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.41 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.456 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.863 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.749 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.688 ' HD2' ' HZ1' ' A' ' 99' ' ' LYS . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.959 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.535 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.798 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HE3' HE22 ' A' ' 148' ' ' GLN . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.817 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.771 ' O ' HG11 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.863 ' CG ' HD13 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.959 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.817 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.916 HG21 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 86' ' ' ARG . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.42 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 -60.9 -40.3 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.4 88.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.669 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 59.82 78.1 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.978 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.21 -40.31 89.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.004 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.503 HE22 ' HE3' ' A' ' 127' ' ' LYS . 64.0 mt-30 -60.79 139.92 57.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.28 1.038 . . . . 0.0 110.659 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.966 179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 120.165 -0.242 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.34 29.37 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.466 2.111 . . . . 0.0 112.423 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -77.18 136.26 38.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.039 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.78 -39.88 94.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.648 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HA ' HD13 ' A' ' 8' ' ' ILE . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.1 HD13 HD12 ' A' ' 55' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 29' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.974 ' HB2' HD23 ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD21 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.754 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HD2' HD21 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.029 HG22 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HD2' HG21 ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.029 HD11 HG22 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.693 HG21 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.2 m80 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 1.022 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.799 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.693 ' HG2' HG21 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.853 ' HZ ' HD12 ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.781 ' HB2' HG13 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.643 ' C ' HG22 ' A' ' 83' ' ' ILE . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.786 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.686 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.786 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.981 HD13 ' HA ' ' A' ' 12' ' ' LEU . 89.5 mt -59.39 -11.53 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.771 ' CG2' ' HG2' ' A' ' 51' ' ' PRO . 5.3 t -47.63 -34.25 7.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.033 0.444 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.76 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 22.5 t -127.94 78.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.712 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.1 HD12 HD13 ' A' ' 12' ' ' LEU . 85.3 mt -60.22 -40.31 89.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.855 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.57 124.45 7.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.29 -88.42 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.438 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.76 ' CG2' ' HB3' ' A' ' 54' ' ' SER . 28.6 m -61.28 -40.16 85.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.05 HG21 HG12 ' A' ' 60' ' ' ILE . 48.5 mm -89.83 -80.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.981 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG21 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.898 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.978 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.617 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' CD2' ' A' ' 47' ' ' LEU . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 42' ' ' LEU . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.935 ' H ' HD21 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.762 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.785 ' CE2' HD11 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.01 93.42 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.762 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 28.2 Cg_endo -114.29 -179.03 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.728 2.952 . . . . 0.0 113.091 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 60.2 t -59.21 140.09 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.972 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' HD2' ' HB2' ' A' ' 100' ' ' SER . 57.3 t0 -77.9 110.04 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.262 0.553 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.02 -27.11 64.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.492 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.626 ' HB2' ' HD2' ' A' ' 98' ' ' ASP . 58.7 m -59.99 -39.68 86.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 103' ' ' LYS . 14.4 p -124.46 8.44 8.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.713 0.292 . . . . 0.0 111.516 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 71.85 -21.37 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.609 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 8.4 tmtm? -60.12 140.14 90.96 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.917 178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 97' ' ' VAL . 40.8 Cg_endo -112.92 178.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.69 2.26 . . . . 0.0 112.576 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.785 HD11 ' CE2' ' A' ' 95' ' ' TYR . 41.8 mt -119.56 119.87 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.59 19.65 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.608 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -147.01 160.03 41.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.585 0.231 . . . . 0.0 111.462 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.23 54.1 4.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.646 2.23 . . . . 0.0 112.102 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -120.06 129.44 54.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.248 0.546 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.975 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 48.3 p-80 -69.31 69.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.83 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.2 -40.06 88.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.368 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.975 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.577 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.826 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.79 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.79 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.79 HD13 ' OH ' ' A' ' 138' ' ' TYR . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.797 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.797 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' OH ' ' A' ' 138' ' ' TYR . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.852 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.462 ' HB2' ' HE2' ' A' ' 129' ' ' GLU . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.646 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.79 ' OH ' HD13 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 129' ' ' GLU . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.831 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 86.3 t60 -60.11 -40.46 89.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.0 93.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.45 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.19 92.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 59.52 39.95 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.26 120.02 31.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.645 0.736 . . . . 0.0 110.087 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.899 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.2 Cg_endo -118.8 -179.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.952 3.101 . . . . 0.0 113.312 -176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.77 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 98.5 m-20 -79.84 139.55 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -79.89 -12.05 59.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.366 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.77 ' CE1' ' HB2' ' A' ' 3' ' ' ASN . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 53' ' ' THR . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.61 ' O ' HD22 ' A' ' 23' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 1.01 ' HB2' HD22 ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 48' ' ' ALA . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.823 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.0 tp60 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.01 HD22 ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.914 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.969 ' HB ' HD21 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.914 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.969 HD21 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 1.081 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 1.081 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.593 HD12 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 39' ' ' ILE . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 42' ' ' LEU . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.669 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 1.095 ' HG2' HD12 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.816 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 1.054 HD21 HG21 ' A' ' 53' ' ' THR . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 20' ' ' LEU . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.921 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.834 ' HB ' HD21 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.921 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.834 HD21 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp -59.91 -40.67 89.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 1.054 HG21 HD21 ' A' ' 47' ' ' LEU . 81.6 p -52.99 -33.67 52.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.882 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.7 m -80.61 -8.2 59.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD11 ' HA ' ' A' ' 52' ' ' LEU . 85.7 mt -60.52 -40.72 92.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.47 -21.91 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.123 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.86 18.03 6.17 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.697 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.12 -40.02 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.709 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.792 HD13 ' OE2' ' A' ' 81' ' ' GLU . 20.2 tt -59.79 -40.2 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.486 ' N ' HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.939 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.055 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.925 ' HG3' ' ND2' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 39' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.733 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.792 ' OE2' HD13 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 1.095 HD12 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.593 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 1.063 HG22 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.677 ' CZ ' ' HA ' ' A' ' 148' ' ' GLN . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.566 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.624 ' O ' HG21 ' A' ' 89' ' ' ILE . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.984 ' HG1' HG11 ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CZ ' ' O ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.925 ' ND2' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t30 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.818 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.661 ' HH ' ' H ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -70.91 93.06 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.818 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 36.4 Cg_endo -114.58 -178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.591 2.194 . . . . 0.0 112.865 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 103' ' ' LYS . 42.4 t -93.28 139.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.169 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.977 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 56.1 t0 -81.68 99.93 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.555 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.08 -38.79 79.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.725 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -57.99 -32.54 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.37 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.893 ' HG1' ' CG ' ' A' ' 103' ' ' LYS . 12.4 p -122.14 7.93 9.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 0.0 111.661 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 60.68 20.05 10.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.177 0.513 . . . . 0.0 110.536 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.977 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 31.5 mmtt -65.79 120.63 70.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.036 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -110.74 81.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.727 2.951 . . . . 0.0 111.233 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.22 119.84 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.679 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 88.0 tttt -119.52 19.87 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.275 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -146.73 159.84 42.73 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.619 ' HA ' ' CE2' ' A' ' 95' ' ' TYR . 68.8 Cg_endo -91.42 69.04 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.869 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.661 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 37.5 t30 -99.76 3.42 44.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.295 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.862 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 97.0 m-70 60.22 40.47 17.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.824 0.345 . . . . 0.0 110.95 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 109' ' ' ASN . 97.6 mm-40 -60.48 -40.4 91.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.862 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 1.005 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.914 HD21 ' CE2' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 1.005 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.876 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.876 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.739 ' CB ' HG21 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.82 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' OH ' HG11 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.914 ' CE2' HD21 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.984 HG11 ' HG1' ' A' ' 90' ' ' THR . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.873 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.731 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.739 HG21 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.593 ' CD2' ' HB3' ' A' ' 84' ' ' ASN . 87.8 m-70 -69.86 -40.82 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.56 91.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.366 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.411 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . . . 60.44 20.26 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.85 140.47 50.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.659 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.677 ' HA ' ' CZ ' ' A' ' 86' ' ' ARG . 7.2 pt20 -80.99 0.09 37.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.623 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.84 27.98 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.321 2.014 . . . . 0.0 112.338 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.3 m120 -74.97 139.15 42.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.24 -39.08 78.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.855 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HE1' ' CG1' ' A' ' 30' ' ' VAL . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.836 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.709 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.475 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.803 HG22 ' CG ' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.556 ' HA ' HD11 ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.857 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.705 ' HG ' ' CB ' ' A' ' 22' ' ' GLN . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 23' ' ' LEU . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 1.099 HH21 ' HB3' ' A' ' 48' ' ' ALA . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.729 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.938 HG13 ' HB2' ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.3 t60 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.938 ' HB2' HG13 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.623 ' HB ' ' HE1' ' A' ' 41' ' ' PHE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.855 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 8.1 t60 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.795 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 ' CB ' ' A' ' 89' ' ' ILE . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.906 ' HG2' HG23 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.867 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 27' ' ' PRO . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.959 ' HE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.829 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 1.012 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB3' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.75 ' H ' HD12 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 16' ' ' SER . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HG ' HD11 ' A' ' 47' ' ' LEU . 85.8 mt -64.23 -38.76 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 p -46.66 -48.99 19.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.527 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -65.95 -39.73 90.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 51' ' ' PRO . 85.7 mt -60.85 -40.14 91.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.793 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.12 -75.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.12 -19.61 4.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.527 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.4 p -69.84 -30.01 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 59' ' ' ILE . 9.7 tp 45.7 40.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.0 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.831 HG22 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.444 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.789 ' CG ' HD13 ' A' ' 68' ' ' ILE . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.85 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.709 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.52 ' SG ' HG23 ' A' ' 89' ' ' ILE . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.921 HD12 HG13 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.858 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 75' ' ' ASN . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.858 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.624 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.923 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 1.022 ' HB2' ' HH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.734 ' HA ' HG13 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.921 HG13 HD12 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.959 ' HB2' ' HE2' ' A' ' 43' ' ' GLU . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.926 ' HG2' HG12 ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.771 ' CB ' HG21 ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.685 ' H ' HG23 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.717 ' O ' HG22 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.654 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.728 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HH ' ' C ' ' A' ' 109' ' ' ASN . 5.1 t80 -48.74 -45.86 71.84 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.875 ' O ' ' HA ' ' A' ' 104' ' ' PRO . 65.4 Cg_endo -93.28 32.48 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.559 2.173 . . . . 0.0 113.858 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 94' ' ' CYS . 10.6 p -137.52 72.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.479 0.657 . . . . 0.0 112.063 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.967 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 56.8 t0 -71.89 120.03 16.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.63 -28.52 69.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -60.0 -55.73 30.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 4.3 p -126.84 18.01 7.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.749 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.6 mtm105 60.33 37.27 20.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 109.715 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.967 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 69.3 mttt -61.62 137.08 94.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.25 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.875 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 28.7 Cg_endo -112.78 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.526 2.818 . . . . 0.0 111.509 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.716 ' H ' ' HA ' ' A' ' 96' ' ' PRO . 26.0 mt -84.82 109.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.243 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -106.59 69.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.91 151.8 42.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -94.04 64.98 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 112.35 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.721 ' C ' ' HH ' ' A' ' 95' ' ' TYR . 98.6 m-20 -109.96 169.9 8.42 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.736 0.779 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.844 ' HA ' HG23 ' A' ' 113' ' ' VAL . 95.8 m-70 -109.84 24.47 13.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.59 -39.79 85.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD13 ' HE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.936 HG11 ' HH ' ' A' ' 131' ' ' TYR . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.427 ' NH1' ' HE2' ' A' ' 118' ' ' GLU . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.936 ' HE2' HD13 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.822 HD13 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HE2' ' NH1' ' A' ' 115' ' ' ARG . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.852 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.918 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.532 ' N ' HD11 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.852 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.691 ' CD1' HD12 ' A' ' 120' ' ' LEU . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.826 ' OE1' HG12 ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.936 ' HH ' HG11 ' A' ' 113' ' ' VAL . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 110' ' ' HIS . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.746 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.826 HG12 ' OE1' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.918 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.926 HG12 ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 144' ' ' HIS . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.592 ' OD1' ' HB2' ' A' ' 145' ' ' ALA . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.641 ' H ' ' CG2' ' A' ' 85' ' ' VAL . 73.6 m80 -102.43 7.95 40.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.592 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . . . -60.76 -40.61 93.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.679 0.276 . . . . 0.0 111.424 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 148' ' ' GLN . . . -107.54 -23.65 12.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.409 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 46.9 tp10 59.78 39.08 21.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.481 ' HG3' ' HB2' ' A' ' 146' ' ' ALA . 54.8 mt-30 -60.83 139.92 57.8 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.251 1.024 . . . . 0.0 110.756 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 C--N 1.297 -1.679 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.864 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.747 0.308 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.902 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.866 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.902 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.692 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.979 ' CD2' ' HG3' ' A' ' 22' ' ' GLN . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.914 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.979 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 13.0 tp-100 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.704 HD23 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.914 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 ' CD2' HG11 ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 8' ' ' ILE . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.94 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.94 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.895 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.728 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.909 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 83' ' ' ILE . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.603 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.899 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.987 ' H ' HD23 ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.963 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 50' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.724 HG13 ' CB ' ' A' ' 52' ' ' LEU . 11.4 tt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.533 ' CD1' HG11 ' A' ' 31' ' ' VAL . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CE1' HD11 ' A' ' 39' ' ' ILE . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.581 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.733 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.724 ' SG ' HD13 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.609 ' CG1' ' HG3' ' A' ' 63' ' ' GLU . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.635 HD11 ' CA ' ' A' ' 72' ' ' ASN . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 45' ' ' VAL . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.63 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 26.2 m120 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.646 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.909 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.724 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.575 ' OH ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG23 ' OH ' ' A' ' 95' ' ' TYR . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.832 ' O ' HG22 ' A' ' 117' ' ' ILE . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' HD12 ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.773 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.648 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.429 ' CG2' HG23 ' A' ' 90' ' ' THR . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.775 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.648 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.629 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' O ' HD13 ' A' ' 8' ' ' ILE . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.973 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.805 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.966 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.48 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 8' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.836 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.839 HD11 ' CE1' ' A' ' 62' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.862 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.968 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG12 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.897 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.84 HD12 HG11 ' A' ' 31' ' ' VAL . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.889 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.774 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.889 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.905 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.905 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.74 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.657 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.687 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.634 HG12 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.899 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.968 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.089 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.836 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.651 ' O ' HG23 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.562 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.566 ' OD1' ' HA3' ' A' ' 136' ' ' GLY . 35.8 t30 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.619 ' OH ' HG23 ' A' ' 113' ' ' VAL . 6.4 t80 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.722 0.296 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.619 HG23 ' OH ' ' A' ' 95' ' ' TYR . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.687 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.886 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.789 HD13 ' CE1' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.886 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA3' ' OD1' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.789 ' CE1' HD13 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.766 HG12 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 1.089 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 85' ' ' VAL . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.899 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.903 HG23 HG22 ' A' ' 31' ' ' VAL . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 1.002 ' HG2' HG22 ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' CG2' ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.002 HG22 ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.757 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 8.5 tp-100 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.111 ' HB ' HD21 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.111 HD21 ' HB ' ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.51 ' ND1' ' HB3' ' A' ' 6' ' ' TYR . 88.3 m-70 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.784 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.861 ' CD1' HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.818 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.871 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.933 HG12 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.933 ' HG ' HG12 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.647 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.062 ' HB2' HD12 ' A' ' 59' ' ' ILE . 84.6 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.672 HD11 HG11 ' A' ' 31' ' ' VAL . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.74 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.872 ' SG ' HD12 ' A' ' 89' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.033 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 1.078 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.935 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.078 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.744 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.028 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.863 ' OE1' HD23 ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.028 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.749 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.741 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.872 HD12 ' SG ' ' A' ' 67' ' ' CYS . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.784 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.799 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.559 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.74 ' OH ' ' HB3' ' A' ' 111' ' ' GLN . 65.6 t80 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.74 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 111' ' ' GLN . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 114' ' ' LYS . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 113' ' ' VAL . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.833 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.676 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.823 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.491 ' OE1' HG11 ' A' ' 139' ' ' VAL . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.676 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.491 HG11 ' OE1' ' A' ' 129' ' ' GLU . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.709 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.1 p80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.824 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.891 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.891 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.869 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.059 HD22 ' HD2' ' A' ' 41' ' ' PHE . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.797 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 38' ' ' LYS . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.984 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.981 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.832 ' O ' ' HB ' ' A' ' 90' ' ' THR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.853 HD13 ' SG ' ' A' ' 67' ' ' CYS . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.797 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 1.059 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.829 ' HG3' ' N ' ' A' ' 86' ' ' ARG . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 47' ' ' LEU . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.016 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.869 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.869 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.974 HD12 HD13 ' A' ' 50' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' A' ' 52' ' ' LEU . 16.6 tt . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.981 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.856 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.853 ' SG ' HD13 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 87' ' ' ALA . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 68' ' ' ILE . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.767 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.767 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.806 ' CB ' HG22 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.829 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.034 HH21 HG11 ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.847 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' ILE . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.558 ' HB3' ' HZ ' ' A' ' 62' ' ' PHE . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.775 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.541 HG22 ' CE1' ' A' ' 95' ' ' TYR . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.75 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.904 HD13 ' CD1' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.794 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.794 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.904 ' CD1' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.928 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 1.034 HG11 HH21 ' A' ' 88' ' ' ARG . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.669 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.751 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.7 ' HB3' ' NE2' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.734 ' OH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 31' ' ' VAL . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.717 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.801 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 6.6 tp-100 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.801 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.7 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 45' ' ' VAL . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 41' ' ' PHE . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.717 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 8' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.84 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 37.0 t-80 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.988 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.988 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.979 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.866 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.871 ' CD1' HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.887 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.861 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB3' HD22 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.941 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.941 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.926 HD23 HG12 ' A' ' 59' ' ' ILE . 60.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.926 HG12 HD23 ' A' ' 52' ' ' LEU . 86.1 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.558 ' N ' HD13 ' A' ' 60' ' ' ILE . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.979 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.859 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB2' HG21 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 71' ' ' ALA . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.939 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.752 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.936 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.939 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.99 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' CD1' ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.861 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.887 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.904 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 ' CD1' ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.866 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.687 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.529 HG22 ' CZ ' ' A' ' 95' ' ' TYR . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.952 HD11 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.952 ' CE2' HD11 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.467 ' OE2' HG12 ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.695 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.904 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.811 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.576 ' CE1' HG12 ' A' ' 142' ' ' VAL . 56.1 m80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.728 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' HD13 ' A' ' 8' ' ' ILE . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.647 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 47' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.856 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.792 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.922 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.927 HG11 HD21 ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.922 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.927 HD21 HG11 ' A' ' 26' ' ' VAL . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.814 ' HB2' ' O ' ' A' ' 36' ' ' TYR . 63.3 m-70 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.814 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.021 HG12 HG23 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.87 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 1.09 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.746 ' CG1' ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 15' ' ' LEU . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.879 ' CG2' HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.879 HD13 ' CG2' ' A' ' 50' ' ' ILE . 8.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 60' ' ' ILE . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.745 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.785 HG22 ' H ' ' A' ' 71' ' ' ALA . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 76' ' ' ARG . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' HD11 ' A' ' 73' ' ' LEU . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.012 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.533 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.746 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 142' ' ' VAL . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.09 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.87 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.021 HG23 HG12 ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.788 ' O ' HG23 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.618 ' OH ' ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.635 HG13 ' OH ' ' A' ' 131' ' ' TYR . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.887 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.88 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.887 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 1.007 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.897 HD12 HD12 ' A' ' 117' ' ' ILE . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.951 ' CE1' HD11 ' A' ' 117' ' ' ILE . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' OE2' ' HE3' ' A' ' 127' ' ' LYS . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.882 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.772 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.789 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.86 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.927 0.394 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.637 ' HB3' ' NE2' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.026 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.784 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.712 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.816 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.799 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.103 HG13 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 8' ' ' ILE . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 1.026 ' HD2' ' HB3' ' A' ' 6' ' ' TYR . 29.6 t-80 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.866 ' HB2' ' HD1' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.103 ' HG2' HG13 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 1.006 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.911 ' HA ' HG23 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.811 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' HD21 ' A' ' 15' ' ' LEU . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 52' ' ' LEU . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 50' ' ' ILE . 85.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.595 HD12 ' CD1' ' A' ' 52' ' ' LEU . 15.9 tt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.666 0.27 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.847 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 1.004 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.931 ' HB3' HG21 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 71' ' ' ALA . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.953 HD12 HG13 ' A' ' 85' ' ' VAL . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.773 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.839 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.773 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.807 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.807 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLU . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.811 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.794 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 HD12 ' A' ' 69' ' ' ILE . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.006 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.79 HH21 ' CG2' ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.931 HG21 ' HB3' ' A' ' 67' ' ' CYS . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.681 ' OG1' HG12 ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.848 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CE2' HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.477 ' CB ' HD12 ' A' ' 112' ' ' LEU . 57.6 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 95' ' ' TYR . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.966 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.947 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.452 ' O ' HG22 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.79 ' CG2' HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.855 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.947 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.755 ' CE1' HG21 ' A' ' 85' ' ' VAL . 75.4 m80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HD1' ' OD1' ' A' ' 5' ' ' ASN . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' O ' HD13 ' A' ' 8' ' ' ILE . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.928 HD22 ' CG2' ' A' ' 59' ' ' ILE . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 29' ' ' LEU . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.863 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.758 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.002 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.729 ' CG ' ' HG ' ' A' ' 42' ' ' LEU . 6.2 m-70 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 15' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.095 HG22 ' HG3' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.677 HG13 ' CD1' ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.4 m-70 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.015 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.952 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.872 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.871 HG21 ' SG ' ' A' ' 67' ' ' CYS . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.095 ' HG3' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.801 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.729 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.834 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 1.002 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.008 HD11 HD22 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.748 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.012 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.012 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.015 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 71' ' ' ALA . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.959 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.705 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.959 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.857 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.857 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.748 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG11 ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.681 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.834 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.835 HD13 ' HB2' ' A' ' 67' ' ' CYS . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.872 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.952 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.438 ' O ' HD23 ' A' ' 112' ' ' LEU . 78.4 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 115' ' ' ARG . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.763 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.708 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.811 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.81 ' CB ' HG22 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.942 ' CE2' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.708 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.869 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.81 HG22 ' CB ' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.045 0.45 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.794 ' HB2' ' NE2' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.97 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HE2' HG11 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.944 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.544 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.82 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.781 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.82 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.976 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.759 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.757 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.944 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.97 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.7 t-80 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.632 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.075 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.053 HG23 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.875 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.906 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 1.029 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.976 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD13 ' CG2' ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 59' ' ' ILE . 20.6 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG13 HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.973 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.075 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.862 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.88 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.88 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.826 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.826 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.72 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.512 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.029 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.906 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.053 HG22 HG23 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 83.8 m-20 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.055 HD23 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 1.055 ' HG3' HD23 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 120' ' ' LEU . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.797 HD12 HD12 ' A' ' 117' ' ' ILE . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.771 ' HE2' HD11 ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.507 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.85 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.942 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.573 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 1.134 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 31' ' ' VAL . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 8' ' ' ILE . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.646 ' CD ' HD22 ' A' ' 29' ' ' LEU . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD12 ' CE2' ' A' ' 18' ' ' TYR . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.878 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 12.7 tp-100 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.878 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.842 ' CG2' ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 26' ' ' VAL . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.622 ' CE1' HD23 ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD ' ' A' ' 10' ' ' PRO . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 1.134 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.63 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.959 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.123 HG22 HG23 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.793 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.622 HD23 ' CE1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.791 ' OE2' HG23 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.842 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 26' ' ' VAL . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.585 ' N ' HG22 ' A' ' 45' ' ' VAL . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 50' ' ' ILE . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.863 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 47' ' ' LEU . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.863 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB2' HD11 ' A' ' 59' ' ' ILE . 88.8 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' ' 52' ' ' LEU . 48.4 mm . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.549 0.214 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.959 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.843 ' HB3' HD13 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.773 HD12 ' CG2' ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HA ' HD13 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.707 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.022 HD13 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 77' ' ' PRO . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.923 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.71 ' HA3' ' HZ3' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.791 HG23 ' OE2' ' A' ' 43' ' ' GLU . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.796 HG12 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 141' ' ' ILE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.035 ' HE ' HG11 ' A' ' 139' ' ' VAL . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.123 HG23 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.793 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.793 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.441 ' CG1' ' CE1' ' A' ' 131' ' ' TYR . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.909 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.788 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.909 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.871 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.622 ' HG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.859 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.837 ' OE2' HG13 ' A' ' 141' ' ' ILE . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.776 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 1.035 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.776 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 1.023 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.796 ' HB ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' A' ' 127' ' ' LYS . 27.9 m120 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.518 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.861 0.362 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.653 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.977 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.798 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.977 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.768 ' O ' HD12 ' A' ' 23' ' ' LEU . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 ' HB1' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.601 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD21 ' OG ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.837 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD22 HG11 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.849 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 31' ' ' VAL . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.798 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.938 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.763 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG12 ' HG ' ' A' ' 47' ' ' LEU . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.819 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.837 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.859 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 52' ' ' LEU . 70.0 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.075 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.79 ' HE1' ' HB3' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.858 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.844 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.858 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.075 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.956 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.948 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.432 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.948 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.742 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.742 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.718 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 9.5 m120 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.851 HG23 ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.9 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.938 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.627 ' CG ' HD13 ' A' ' 141' ' ' ILE . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.805 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.433 ' HG ' ' HE1' ' A' ' 138' ' ' TYR . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.544 ' HE1' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.841 0.353 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.544 HD21 ' HE1' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 117' ' ' ILE . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.688 ' NE2' HD11 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.896 HD22 ' CZ ' ' A' ' 140' ' ' PHE . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.877 HD21 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.899 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.809 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.825 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.825 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.896 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 142' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.9 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.851 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.88 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.993 ' HD1' ' HB2' ' A' ' 33' ' ' HIS . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.622 ' O ' HD13 ' A' ' 8' ' ' ILE . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.969 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 12' ' ' LEU . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.934 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.707 HD11 ' NH2' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 23' ' ' LEU . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.707 ' NH2' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.69 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.789 HG23 ' CD1' ' A' ' 8' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.993 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.88 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.929 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.552 ' NZ ' ' HB2' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.946 HG23 HG12 ' A' ' 89' ' ' ILE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.855 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 69' ' ' ILE . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.793 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.69 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 83' ' ' ILE . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.86 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.834 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 59' ' ' ILE . 60.1 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' LEU . 86.4 mt . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.596 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.929 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 66' ' ' THR . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' OD1' ' A' ' 72' ' ' ASN . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 1.135 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.631 ' CD1' ' H ' ' A' ' 76' ' ' ARG . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 1.135 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.616 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.631 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.744 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.793 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.935 ' HA ' HG22 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.946 HG12 HG23 ' A' ' 39' ' ' ILE . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.602 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' O ' ' HD1' ' A' ' 95' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.815 0.34 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 114' ' ' LYS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.54 ' N ' HG13 ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.865 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.965 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.555 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.786 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.865 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.965 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.734 ' OD1' HD12 ' A' ' 141' ' ' ILE . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.825 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.912 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.912 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.055 HD22 ' HB3' ' A' ' 52' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.694 ' HB ' ' HG2' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.97 HD23 HD11 ' A' ' 52' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.917 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.917 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HD2' HD22 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 1.061 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 66.6 m-70 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.061 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.729 HD11 ' HD2' ' A' ' 62' ' ' PHE . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.554 ' HZ ' ' CD1' ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.923 HD22 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.724 ' CG ' HG11 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.728 ' HB ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.778 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.778 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.055 ' HB3' HD22 ' A' ' 12' ' ' LEU . 89.5 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.05 HG22 HG12 ' A' ' 60' ' ' ILE . 48.5 mm . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG22 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.918 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.987 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.78 ' HB3' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.879 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.879 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.849 ' H ' HD23 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.533 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.877 ' HD2' HD21 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.849 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 44' ' ' PRO . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.923 ' H ' HD22 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.764 0.316 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.852 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.4 HG22 ' HE1' ' A' ' 95' ' ' TYR . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.585 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.852 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.812 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.642 HD11 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.812 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 142' ' ' VAL . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.653 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.653 ' CD2' ' HD2' ' A' ' 131' ' ' TYR . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.568 ' N ' ' HD1' ' A' ' 138' ' ' TYR . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.85 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 126' ' ' SER . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.849 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 44.0 t-80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 15' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.89 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.841 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 12.7 tp-100 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.89 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.62 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.911 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.911 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.478 ' C ' HD12 ' A' ' 29' ' ' LEU . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.599 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.667 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 1.059 ' HG2' HD13 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.83 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' VAL . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.936 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.873 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.873 HD23 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 HG13 ' A' ' 60' ' ' ILE . 20.2 tt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.6 0.238 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.811 HG13 HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.949 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.065 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.79 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 89' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' HD22 ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.884 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.059 HD13 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.404 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.049 HG21 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.802 ' H ' HG12 ' A' ' 85' ' ' VAL . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG3' HD11 ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.802 HD11 ' SG ' ' A' ' 67' ' ' CYS . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.603 HG23 ' CG1' ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.79 ' OD1' ' HG3' ' A' ' 65' ' ' LYS . 18.3 t-20 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.476 0.179 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG13 ' OH ' ' A' ' 131' ' ' TYR . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.979 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.979 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.896 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.896 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.836 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.581 ' OH ' HG13 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.872 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.836 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.552 ' HD2' ' OH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 84' ' ' ASN . 74.8 m80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.816 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 8' ' ' ILE . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.727 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.859 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HD23 ' A' ' 23' ' ' LEU . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.595 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.845 ' CB ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.917 HG11 HD22 ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.917 HD22 HG11 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.97 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.879 HG13 HD12 ' A' ' 8' ' ' ILE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.816 ' HE2' ' HB3' ' A' ' 5' ' ' ASN . 63.0 t-80 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.587 ' HB2' ' ND1' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 90' ' ' THR . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HG2' HG22 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.875 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.855 ' OE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.845 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.019 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.732 ' CB ' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.684 ' H ' HD13 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 59' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 59' ' ' ILE . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.832 HG23 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 66' ' ' THR . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.872 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.718 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.832 ' HB ' HG23 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.076 HG21 HG12 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.826 ' OH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.872 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 76' ' ' ARG . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.83 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.826 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.758 ' HA ' HG12 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.702 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.076 HG12 HG21 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.875 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.909 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.92 ' H ' HG22 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.865 ' O ' HG23 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.518 ' SG ' ' HD3' ' A' ' 65' ' ' LYS . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.667 0.27 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.761 HD12 ' NE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.687 HG13 ' OH ' ' A' ' 131' ' ' TYR . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.761 ' NE2' HD12 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.802 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.841 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.737 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.506 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.668 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.74 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.802 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.758 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.909 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.447 HG22 ' OG ' ' A' ' 126' ' ' SER . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.766 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.5 m-70 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.8 ' O ' ' HD2' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.027 -0.318 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.871 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -67.93 26.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.541 2.161 . . . . 0.0 112.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 1' ' ' GLY . 14.8 t-20 -70.05 129.23 38.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.942 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.6 -39.37 93.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.902 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.866 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.902 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.692 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.979 ' CD2' ' HG3' ' A' ' 22' ' ' GLN . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.914 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.979 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 13.0 tp-100 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.704 HD23 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.914 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 ' CD2' HG11 ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 8' ' ' ILE . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.94 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' A' ' 2' ' ' PRO . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.94 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.895 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.728 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.909 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 83' ' ' ILE . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.603 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.899 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.987 ' H ' HD23 ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.963 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 50' ' ' ILE . 3.2 mm? -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.38 -40.66 18.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.669 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.7 p -61.51 -41.26 97.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.951 0.405 . . . . 0.0 110.574 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -39.76 82.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.88 -104.46 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.403 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.93 -52.61 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.468 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 59' ' ' ILE . 29.3 m -70.31 -21.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.969 -0.136 . . . . 0.0 111.348 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 58' ' ' VAL . 11.4 tt 62.07 -25.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.859 0.864 . . . . 0.0 112.84 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.536 ' H ' ' C ' ' A' ' 58' ' ' VAL . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.694 ' CG2' HG21 ' A' ' 58' ' ' VAL . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CE1' HD11 ' A' ' 39' ' ' ILE . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.581 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.733 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.724 ' SG ' HD13 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.609 ' CG1' ' HG3' ' A' ' 63' ' ' GLU . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.635 HD11 ' CA ' ' A' ' 72' ' ' ASN . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 45' ' ' VAL . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.63 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.9 m-20 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.646 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.909 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.724 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.92 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.977 ' CE1' HD12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -69.06 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 79.2 Cg_endo -85.78 36.38 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.232 1.955 . . . . 0.0 112.784 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.67 ' HA ' ' CG1' ' A' ' 105' ' ' ILE . 9.8 p 51.05 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 123.841 0.713 . . . . 0.0 112.329 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.552 ' N ' HG22 ' A' ' 97' ' ' VAL . 57.6 t0 -98.49 111.96 24.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.318 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.58 -27.5 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.756 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -41.28 92.5 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.8 p -119.69 -1.7 10.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.7 0.286 . . . . 0.0 111.682 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.1 mtt85 60.01 24.0 13.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.83 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 97' ' ' VAL . 12.3 tttp -69.54 93.45 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 112.491 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.674 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 11.0 Cg_endo -52.47 92.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 111.966 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.977 HD12 ' CE1' ' A' ' 95' ' ' TYR . 3.5 pt -95.82 120.33 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.551 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 56.6 tptt -140.58 44.04 1.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 109' ' ' ASN . 21.5 m-20 -145.36 161.08 43.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 55.4 Cg_endo -69.0 34.33 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.451 2.1 . . . . 0.0 112.523 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 107' ' ' ASP . 98.8 m-20 -61.6 -40.24 94.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.955 ' HA ' HG23 ' A' ' 113' ' ' VAL . 76.0 m80 58.27 39.0 26.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -60.71 -40.76 93.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 110' ' ' HIS . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.832 ' O ' HG22 ' A' ' 117' ' ' ILE . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' HD12 ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.773 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.648 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.751 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.429 ' CG2' HG23 ' A' ' 90' ' ' THR . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.775 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.648 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 -111.33 17.99 19.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' OD1' ' A' ' 84' ' ' ASN . . . -60.3 -40.3 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.249 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.75 130.01 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -120.03 139.9 51.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.58 0.24 34.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.397 0.618 . . . . 0.0 111.858 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.844 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.51 31.36 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.623 2.215 . . . . 0.0 112.595 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -79.59 122.68 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.928 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.91 104.08 16.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.629 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' O ' HD13 ' A' ' 8' ' ' ILE . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.973 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.805 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.971 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.966 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.48 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 8' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.839 HD11 ' CE1' ' A' ' 62' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.862 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.968 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG12 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.897 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 59' ' ' ILE . 84.7 mt -69.67 -27.98 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -47.87 -40.13 20.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.545 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.1 p -61.15 -40.02 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.21 0.529 . . . . 0.0 109.928 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 52' ' ' LEU . 51.5 mt -63.11 -40.2 96.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.072 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.75 -96.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.477 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' A' ' 12' ' ' LEU . . . -172.94 -54.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.484 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.971 HG23 ' HG ' ' A' ' 12' ' ' LEU . 61.0 t -129.85 129.86 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt -71.24 41.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 58' ' ' VAL . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.889 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.774 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.889 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.905 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.905 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.74 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.657 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.687 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.634 HG12 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.899 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.968 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.089 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.836 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.651 ' O ' HG23 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.566 ' OD1' ' HA3' ' A' ' 136' ' ' GLY . 35.8 t30 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.619 ' OH ' HG23 ' A' ' 113' ' ' VAL . 6.4 t80 -42.71 -47.93 13.23 Favored Pre-proline 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 23.6 Cg_exo -64.28 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.153 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 95' ' ' TYR . 14.9 t -148.02 117.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.68 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.7 t0 -96.72 120.62 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.643 ' NZ ' ' HB2' ' A' ' 99' ' ' LYS . 10.0 mtmp? -69.36 -39.08 78.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -38.03 81.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.332 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -125.51 5.83 7.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 98' ' ' ASP . 41.2 mmt180 60.2 20.09 9.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.237 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.699 ' HG2' HG13 ' A' ' 105' ' ' ILE . 44.5 tttt -62.79 134.08 95.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.655 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.602 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 40.6 Cg_endo -111.28 82.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.3 2.667 . . . . 0.0 110.81 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 54.1 mt -93.94 111.52 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.435 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 104' ' ' PRO . 13.3 mptt -109.69 66.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -147.32 150.95 39.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -96.74 45.87 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.159 2.573 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.11 -0.31 57.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.92 ' HA ' HG23 ' A' ' 113' ' ' VAL . 88.3 m-70 57.21 41.05 27.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.982 0.42 . . . . 0.0 110.951 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.19 -40.6 86.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.786 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 110' ' ' HIS . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.687 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.886 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.789 HD13 ' CE1' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.886 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.733 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA3' ' OD1' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.789 ' CE1' HD13 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.766 HG12 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.089 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 85' ' ' VAL . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.899 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -119.27 -3.32 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.56 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . . . -60.37 -39.92 88.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 111.343 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.67 121.19 40.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.75 140.36 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.12 119.93 30.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.405 0.621 . . . . 0.0 109.953 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.565 HG23 ' OXT' ' A' ' 149' ' ' THR . 7.4 t . . . . . 0 C--O 1.25 1.094 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.009 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.859 ' HA3' ' CE1' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.195 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.624 ' HG2' ' HG3' ' A' ' 4' ' ' GLU . 56.7 Cg_endo -70.42 38.76 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.251 1.967 . . . . 0.0 112.289 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.5 m-20 60.26 36.4 20.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.969 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' A' ' 2' ' ' PRO . 99.1 mt-10 -59.68 -39.97 86.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.701 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.903 HG23 HG22 ' A' ' 31' ' ' VAL . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 1.002 ' HG2' HG22 ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' CG2' ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.002 HG22 ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.757 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 8.5 tp-100 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.111 ' HB ' HD21 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.111 HD21 ' HB ' ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 76.0 m80 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.859 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.784 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.861 ' CD1' HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.818 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.871 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.933 HG12 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.933 ' HG ' HG12 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.647 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.062 ' HB2' HD12 ' A' ' 59' ' ' ILE . 84.6 mt -71.0 -32.17 68.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 t -47.82 -37.06 12.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.749 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -60.89 -39.54 89.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -38.96 77.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.85 -110.02 0.94 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.169 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.96 -59.75 0.08 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 60' ' ' ILE . 59.2 t -60.37 -39.8 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.744 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt 47.02 19.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.672 HD11 HG11 ' A' ' 31' ' ' VAL . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.74 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.872 ' SG ' HD12 ' A' ' 89' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.033 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 1.078 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.935 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.078 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.744 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.028 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.863 ' OE1' HD23 ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.028 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.749 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.741 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.872 HD12 ' SG ' ' A' ' 67' ' ' CYS . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.784 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.799 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.559 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 65.6 t80 -45.45 -36.12 4.08 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.896 ' HA ' ' N ' ' A' ' 105' ' ' ILE . 42.7 Cg_endo -111.77 82.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.717 1.611 . . . . 0.0 114.491 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.807 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 47.8 t -160.53 68.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.592 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.896 ' HA ' ' HD3' ' A' ' 106' ' ' LYS . 51.6 t0 -64.64 129.19 38.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.215 0.531 . . . . 0.0 110.527 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.866 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.7 pttp -70.33 -25.56 63.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.6 p -68.96 -56.7 7.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.576 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -128.09 19.81 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.842 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 27.9 mtm105 62.58 25.12 14.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.838 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 105' ' ' ILE . 13.7 mmtt -70.93 93.78 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 124.587 1.155 . . . . 0.0 111.446 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.842 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 38.9 Cg_exo -32.98 88.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.557 2.838 . . . . 0.0 115.166 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.896 ' N ' ' HA ' ' A' ' 96' ' ' PRO . 1.2 pp 173.32 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.917 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.896 ' HD3' ' HA ' ' A' ' 98' ' ' ASP . 9.3 pttp 59.72 43.68 15.15 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.138 0.575 . . . . 0.0 111.623 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.954 ' HB2' ' HA ' ' A' ' 95' ' ' TYR . 1.2 m-20 -140.75 159.34 62.93 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.652 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 1.021 ' HB3' ' HB2' ' A' ' 116' ' ' HIS . 47.8 Cg_endo -97.5 33.1 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.01 2.473 . . . . 0.0 114.563 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.81 ' HB3' ' CD1' ' A' ' 95' ' ' TYR . 35.3 t30 -60.57 -39.67 88.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 110.969 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.529 ' CD2' ' H ' ' A' ' 111' ' ' GLN . 25.8 p-80 -159.77 -62.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.74 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 -58.75 -40.37 83.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.234 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.724 ' HA ' ' CB ' ' A' ' 108' ' ' PRO . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 113' ' ' VAL . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 1.021 ' HB2' ' HB3' ' A' ' 108' ' ' PRO . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.833 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.676 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.823 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' OE1' HG11 ' A' ' 139' ' ' VAL . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.609 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.676 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.491 HG11 ' OE1' ' A' ' 129' ' ' GLU . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.709 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -123.86 17.63 9.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.493 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.32 119.97 38.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.174 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.93 -39.49 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -100.68 110.92 23.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.32 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.697 -179.799 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.42 28.39 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.334 2.023 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.1 m120 -80.09 139.91 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 -96.83 109.64 22.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.824 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.891 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.891 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.869 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.059 HD22 ' HD2' ' A' ' 41' ' ' PHE . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.797 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 38' ' ' LYS . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.984 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.981 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.832 ' O ' ' HB ' ' A' ' 90' ' ' THR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.853 HD13 ' SG ' ' A' ' 67' ' ' CYS . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.797 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 1.059 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.829 ' HG3' ' N ' ' A' ' 86' ' ' ARG . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 47' ' ' LEU . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.016 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.869 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.869 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.974 HD12 HD13 ' A' ' 50' ' ' ILE . 84.7 mt -62.95 -25.29 68.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -47.94 -39.15 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.443 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.0 m -108.93 -34.22 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.884 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.781 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 86.8 mt -69.03 -40.69 78.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.98 1.51 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.508 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.18 -110.62 0.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.697 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 60' ' ' ILE . 31.3 m -78.48 -7.05 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' A' ' 52' ' ' LEU . 16.6 tt 48.72 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.006 0.522 . . . . 0.0 112.073 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 58' ' ' VAL . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.981 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.856 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.853 ' SG ' HD13 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 87' ' ' ALA . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 68' ' ' ILE . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.767 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.767 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.806 ' CB ' HG22 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' OE1' ' A' ' 147' ' ' GLU . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 146' ' ' ALA . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.829 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.034 HH21 HG11 ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.847 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' ILE . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.558 ' HB3' ' HZ ' ' A' ' 62' ' ' PHE . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.775 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.587 ' CD2' HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -130.32 70.1 82.19 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG3' ' HZ2' ' A' ' 65' ' ' LYS . 67.9 Cg_endo -94.3 -83.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.697 2.265 . . . . 0.0 112.78 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 103' ' ' LYS . 12.9 p -130.26 139.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.75 0.309 . . . . 0.0 111.524 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.4 t0 -81.08 119.0 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 0.0 110.121 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.53 -40.49 91.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -58.55 -46.51 86.7 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.703 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 10.2 p -124.47 11.69 8.64 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 60.82 35.53 19.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 109.769 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.936 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 32.4 mmtt -63.06 136.03 96.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.286 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 40.4 Cg_endo -111.7 83.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.353 2.702 . . . . 0.0 110.401 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.587 HG21 ' CD2' ' A' ' 95' ' ' TYR . 20.1 mt -79.96 118.81 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.512 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -109.95 24.94 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.491 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 42.7 m-20 -144.81 173.03 4.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.419 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.465 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 35.2 Cg_endo -113.49 82.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.752 2.968 . . . . 0.0 112.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.704 ' CG ' ' HG3' ' A' ' 111' ' ' GLN . 59.8 t-20 -120.4 127.5 52.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.01 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.945 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 99.1 m-70 -67.09 28.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.704 ' HG3' ' CG ' ' A' ' 109' ' ' ASN . 31.6 mt-30 -58.57 -40.16 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.945 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.75 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.904 HD13 ' CD1' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.794 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.794 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.904 ' CD1' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.928 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 1.034 HG11 HH21 ' A' ' 88' ' ' ARG . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.669 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.751 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 145' ' ' ALA . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 144' ' ' HIS . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.563 ' ND1' ' HG2' ' A' ' 148' ' ' GLN . 67.8 m-70 60.01 40.39 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -60.0 -41.02 91.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.477 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . . . -124.07 -49.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.812 0.339 . . . . 0.0 111.545 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.626 ' OE1' HD11 ' A' ' 83' ' ' ILE . 50.2 mt-10 -125.72 146.32 49.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.564 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.563 ' HG2' ' ND1' ' A' ' 144' ' ' HIS . 80.0 mt-30 -87.32 119.21 27.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.236 0.541 . . . . 0.0 111.026 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.954 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 27.99 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.315 2.01 . . . . 0.0 112.451 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.6 m-20 -79.69 139.93 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.15 104.21 16.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.772 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.7 ' HB3' ' NE2' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.734 ' OH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 31' ' ' VAL . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.717 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD11 ' CA ' ' A' ' 56' ' ' GLY . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.801 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 6.6 tp-100 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.801 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.7 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 45' ' ' VAL . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 41' ' ' PHE . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.717 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 8' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.84 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 37.0 t-80 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.988 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.988 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.979 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.866 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.871 ' CD1' HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.887 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.861 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB3' HD22 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.941 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.941 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.016 HD12 HD12 ' A' ' 55' ' ' LEU . 60.4 tp -61.3 -39.85 92.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.736 ' CG2' HD13 ' A' ' 47' ' ' LEU . 1.5 t -49.55 -29.92 7.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.6 p -60.46 -36.5 78.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.747 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 HD12 ' A' ' 52' ' ' LEU . 86.7 mt -61.13 -40.6 94.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.31 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' CA ' HD11 ' A' ' 12' ' ' LEU . . . 81.86 131.42 1.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.083 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.42 -20.24 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.831 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.893 HG11 HD11 ' A' ' 52' ' ' LEU . 57.3 t -66.2 -48.14 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.926 HG12 HD23 ' A' ' 52' ' ' LEU . 86.1 mt -70.18 -40.12 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.558 ' N ' HD13 ' A' ' 60' ' ' ILE . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.979 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.859 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB2' HG21 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 71' ' ' ALA . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.939 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.752 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.936 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.939 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.99 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' CD1' ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.861 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.887 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.904 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 ' CD1' ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.866 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.687 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -63.39 99.13 0.17 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 25.5 Cg_endo -115.16 82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.661 2.907 . . . . 0.0 113.047 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.804 HG23 ' HB3' ' A' ' 104' ' ' PRO . 14.8 p 49.8 154.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 56.8 t0 -89.46 109.59 20.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.458 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -69.42 -20.56 63.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.0 m -60.08 -41.5 92.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.625 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' LYS . 12.2 p -125.92 8.58 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.682 0.277 . . . . 0.0 111.424 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 101' ' ' THR . 99.2 mtt180 73.0 -24.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.01 0.434 . . . . 0.0 110.235 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 52.1 mttt -60.98 139.99 93.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.639 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.804 ' HB3' HG23 ' A' ' 97' ' ' VAL . 48.1 Cg_endo -113.34 178.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.589 2.193 . . . . 0.0 112.852 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 112' ' ' LEU . 85.0 mt -119.98 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.384 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.07 28.7 8.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.805 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -145.08 159.94 47.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.28 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.59 47.97 2.71 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.481 2.121 . . . . 0.0 112.272 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -109.76 115.26 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.533 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.894 ' ND1' HG21 ' A' ' 113' ' ' VAL . 93.2 m-70 -74.54 55.31 0.64 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.429 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.47 -39.99 89.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.142 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.894 HG21 ' ND1' ' A' ' 110' ' ' HIS . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.952 HD11 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.952 ' CE2' HD11 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' OE2' HG12 ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.695 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.904 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.811 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.8 ' ND2' ' HB3' ' A' ' 146' ' ' ALA . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.576 ' CE1' HG12 ' A' ' 142' ' ' VAL . 56.1 m80 -96.84 -29.46 13.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.6 91.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.196 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.8 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . . . -99.2 122.12 41.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -139.95 154.55 47.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.095 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -98.87 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.067 0.46 . . . . 0.0 111.053 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.155 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -118.91 -179.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.052 3.168 . . . . 0.0 113.141 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 7' ' ' TYR . 28.3 m120 -74.5 129.97 38.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -63.91 -40.32 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.728 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' HB3' ' OD1' ' A' ' 3' ' ' ASN . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.647 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' VAL . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 47' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.856 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.792 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.922 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.927 HG11 HD21 ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.922 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.927 HD21 HG11 ' A' ' 26' ' ' VAL . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.814 ' HB2' ' O ' ' A' ' 36' ' ' TYR . 63.3 m-70 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.814 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.021 HG12 HG23 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.87 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 1.09 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.746 ' CG1' ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 15' ' ' LEU . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.879 ' CG2' HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.879 HD13 ' CG2' ' A' ' 50' ' ' ILE . 8.6 mp -60.22 -39.46 86.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.33 -40.03 16.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.794 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.495 ' HB2' ' HD3' ' A' ' 78' ' ' LYS . 53.7 m -100.37 -25.91 14.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.931 HD11 ' HG2' ' A' ' 51' ' ' PRO . 84.5 mt -69.54 -39.76 77.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.994 0.426 . . . . 0.0 110.88 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.61 -40.02 2.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . 160.04 -80.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.213 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.91 ' HA ' HD21 ' A' ' 12' ' ' LEU . 30.3 m -71.48 -20.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.163 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 55' ' ' LEU . 20.4 mt 69.33 -17.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.39 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 58' ' ' VAL . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.745 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.785 HG22 ' H ' ' A' ' 71' ' ' ALA . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 76' ' ' ARG . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' HD11 ' A' ' 73' ' ' LEU . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.012 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.746 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.898 HG12 ' HB2' ' A' ' 145' ' ' ALA . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.09 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.87 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.021 HG23 HG12 ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.788 ' O ' HG23 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.914 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.698 ' HD1' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.53 92.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.914 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 57.5 Cg_endo -86.94 -104.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.015 1.81 . . . . 0.0 112.479 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.848 HG13 ' HA ' ' A' ' 104' ' ' PRO . 23.6 t -132.3 136.18 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 122.15 -0.344 . . . . 0.0 111.112 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 1.074 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 96.0 m-20 -79.33 109.92 14.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.089 0.471 . . . . 0.0 110.345 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.78 -20.79 45.41 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.51 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.1 p -58.78 -41.28 86.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 0.0 111.621 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 1.4 p -124.9 17.66 8.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.022 0.439 . . . . 0.0 111.009 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 61.07 20.08 10.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.155 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -64.62 127.98 92.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.709 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.848 ' HA ' HG13 ' A' ' 97' ' ' VAL . 42.6 Cg_endo -110.93 83.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.173 2.582 . . . . 0.0 110.438 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.698 HD13 ' HD1' ' A' ' 95' ' ' TYR . 1.3 pp -97.0 120.99 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.58 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.94 23.12 14.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -143.35 167.03 16.88 Favored Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.961 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -115.18 80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 122.74 2.294 . . . . 0.0 111.11 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 16.9 t-20 -86.27 0.71 53.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.084 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.999 ' HA ' HG23 ' A' ' 113' ' ' VAL . 52.2 m80 70.12 9.69 7.13 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.446 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -61.95 -37.29 84.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.565 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 110' ' ' HIS . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.887 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.88 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.887 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 1.007 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.897 HD12 HD12 ' A' ' 117' ' ' ILE . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.951 ' CE1' HD11 ' A' ' 117' ' ' ILE . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' OE2' ' HE3' ' A' ' 127' ' ' LYS . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.882 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.772 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.789 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.86 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.8 ' CE1' ' HA ' ' A' ' 147' ' ' GLU . 49.5 t-80 -82.51 71.89 9.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.898 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -68.21 -40.08 82.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.068 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 144' ' ' HIS . . . -100.19 129.9 46.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.8 ' HA ' ' CE1' ' A' ' 144' ' ' HIS . 50.1 mt-10 -103.75 130.65 51.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.99 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -89.84 120.32 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.56 0.695 . . . . 0.0 109.911 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.617 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.184 0 CA-C-O 120.158 -0.245 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.52 25.55 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.397 2.065 . . . . 0.0 112.278 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.8 m120 -72.91 133.66 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.21 -27.6 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.553 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.637 ' HB3' ' NE2' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.026 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.784 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.661 HD21 ' HA2' ' A' ' 57' ' ' GLY . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.712 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.816 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.552 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.799 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.103 HG13 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 8' ' ' ILE . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 1.026 ' HD2' ' HB3' ' A' ' 6' ' ' TYR . 29.6 t-80 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.866 ' HB2' ' HD1' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.103 ' HG2' HG13 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 1.006 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.911 ' HA ' HG23 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.811 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' HD21 ' A' ' 15' ' ' LEU . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 52' ' ' LEU . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 50' ' ' ILE . 85.4 mt -60.62 -39.74 89.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.89 -36.7 12.62 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.902 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.1 t -61.04 -38.77 87.32 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.707 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.2 -40.08 96.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.592 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.16 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.607 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.661 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . -92.22 170.9 33.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.652 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.583 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 16.6 m -60.2 -49.79 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.016 0.408 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.595 HD12 ' CD1' ' A' ' 52' ' ' LEU . 15.9 tt 167.18 29.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.357 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.847 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 1.004 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.931 ' HB3' HG21 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 71' ' ' ALA . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.953 HD12 HG13 ' A' ' 85' ' ' VAL . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.773 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.839 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.773 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.807 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.807 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLU . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.811 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.794 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 HD12 ' A' ' 69' ' ' ILE . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.758 HH21 ' HB1' ' A' ' 145' ' ' ALA . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.006 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.79 HH21 ' CG2' ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.931 HG21 ' HB3' ' A' ' 67' ' ' CYS . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.681 ' OG1' HG12 ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.848 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.873 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -45.12 -48.89 31.77 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.873 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 24.3 Cg_exo -63.81 21.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.509 2.139 . . . . 0.0 113.429 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 95' ' ' TYR . 16.6 t -144.33 98.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.0 t0 -89.39 117.82 28.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.19 -29.7 70.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 t -60.07 -53.95 51.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.644 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 5.8 p -126.38 16.57 7.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.918 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' ASP . 99.3 mtt180 60.49 36.42 20.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.428 0.632 . . . . 0.0 109.679 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.926 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 76.2 mttt -63.12 137.07 96.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 30.3 Cg_endo -112.58 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 123.53 2.82 . . . . 0.0 111.215 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 69.3 mt -91.61 104.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.811 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.54 68.29 2.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.701 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -149.76 166.26 15.63 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.922 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -109.33 76.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 124.307 3.338 . . . . 0.0 114.916 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.1 m-20 -115.58 123.01 47.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.464 0.65 . . . . 0.0 112.537 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.901 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 64.2 m80 -75.04 14.12 0.58 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.477 ' CB ' HD12 ' A' ' 112' ' ' LEU . 57.6 tt0 -57.66 -39.2 76.51 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.238 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.901 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.966 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.947 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.452 ' O ' HG22 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.79 ' CG2' HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.855 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.947 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.755 ' CE1' HG21 ' A' ' 85' ' ' VAL . 75.4 m80 -65.39 -40.14 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' HH21 ' A' ' 86' ' ' ARG . . . -60.83 -39.99 91.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.11 120.43 39.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.254 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -120.03 130.26 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.468 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -61.96 139.75 58.38 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 122.603 1.192 . . . . 0.0 110.372 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.3 -1.575 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.989 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.2 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.067 1.844 . . . . 0.0 112.254 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.662 ' HA ' ' CE1' ' A' ' 6' ' ' TYR . 40.0 p-10 -110.04 19.59 18.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.335 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.64 -39.56 77.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.215 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.572 ' O ' HD13 ' A' ' 8' ' ' ILE . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.928 HD22 ' CG2' ' A' ' 59' ' ' ILE . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 29' ' ' LEU . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.863 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.758 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.002 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.729 ' CG ' ' HG ' ' A' ' 42' ' ' LEU . 6.2 m-70 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 15' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.095 HG22 ' HG3' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.677 HG13 ' CD1' ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.4 m-70 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.015 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.952 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.872 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.871 HG21 ' SG ' ' A' ' 67' ' ' CYS . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.095 ' HG3' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.801 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.729 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.834 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 1.002 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.008 HD11 HD22 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.748 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.012 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt -66.63 -39.27 88.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.908 HG22 ' H ' ' A' ' 59' ' ' ILE . 18.6 p -49.9 -31.84 13.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.601 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.7 p -68.4 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 HH21 ' A' ' 79' ' ' ARG . 86.1 mt -60.55 -40.54 91.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.518 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.44 -77.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.819 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.39 -39.43 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 12' ' ' LEU . 61.9 t -125.12 129.81 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.012 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -53.24 -7.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.015 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 71' ' ' ALA . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.959 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.705 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.959 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.857 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.857 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.748 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG11 ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.681 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.834 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.835 HD13 ' HB2' ' A' ' 67' ' ' CYS . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.872 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.952 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.944 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -69.9 90.96 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.944 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 66.1 Cg_endo -88.96 57.91 2.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.461 2.107 . . . . 0.0 112.946 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.953 ' HA ' HG22 ' A' ' 105' ' ' ILE . 11.3 p 49.75 166.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.468 0.707 . . . . 0.0 112.565 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.565 ' N ' HG22 ' A' ' 97' ' ' VAL . 96.1 m-20 -90.04 109.84 20.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.09 -27.9 64.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.121 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.7 p -59.83 -40.57 88.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.8 p -121.16 -0.29 9.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.2 mtt-85 60.25 22.24 11.64 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.695 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -70.87 93.46 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.129 0.893 . . . . 0.0 112.429 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 5.0 Cg_endo -46.8 109.38 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.45 2.1 . . . . 0.0 112.117 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.953 HG22 ' HA ' ' A' ' 97' ' ' VAL . 19.9 tt -97.16 105.6 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.337 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -111.1 20.43 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -145.0 166.78 16.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -114.84 83.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.627 2.885 . . . . 0.0 112.69 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.65 2.02 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.973 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.946 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 35.6 m80 60.03 30.83 20.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.779 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' O ' HD23 ' A' ' 112' ' ' LEU . 31.4 mt-30 -61.09 -40.08 92.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 115' ' ' ARG . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.946 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.763 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.708 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.811 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.81 ' CB ' HG22 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.942 ' CE2' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.632 ' HB1' ' NE2' ' A' ' 110' ' ' HIS . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.708 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.869 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.81 HG22 ' CB ' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 146' ' ' ALA . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -75.04 -36.32 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.53 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.87 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . . . -83.27 115.86 22.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.0 111.171 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.48 140.05 51.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.975 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.75 119.77 30.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.55 0.69 . . . . 0.0 110.076 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.008 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.43 31.97 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.698 2.265 . . . . 0.0 112.567 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -74.54 129.66 38.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 -92.95 103.41 15.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.794 ' HB2' ' NE2' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.97 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HE2' HG11 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.944 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.544 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.828 HD21 ' CG2' ' A' ' 58' ' ' VAL . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.82 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.781 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.82 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.976 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.759 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.757 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.944 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.97 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.7 t-80 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.632 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.075 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.053 HG23 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.875 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.906 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 1.029 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.976 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD13 ' CG2' ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp -60.18 -39.48 86.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 p -49.9 -34.37 20.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.485 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -60.28 -49.53 77.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.065 HD11 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -69.59 -40.05 76.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.885 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.26 -10.01 75.63 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.949 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.991 ' H ' HD12 ' A' ' 55' ' ' LEU . . . -98.27 5.95 61.24 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.749 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.828 ' CG2' HD21 ' A' ' 12' ' ' LEU . 16.4 t 58.38 19.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.957 0.408 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.065 ' H ' HD11 ' A' ' 55' ' ' LEU . 20.6 mt 57.72 9.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.512 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG13 HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.973 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.075 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB3' ' NE2' ' A' ' 110' ' ' HIS . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.862 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.88 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.88 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.826 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.826 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.72 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.512 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.029 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.906 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.053 HG22 HG23 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 83.8 m-20 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.832 ' HA ' HD11 ' A' ' 105' ' ' ILE . 2.3 m-85 49.07 60.04 16.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 95' ' ' TYR . 60.3 Cg_endo -104.09 33.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.057 2.505 . . . . 0.0 114.052 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.987 ' HB ' ' CB ' ' A' ' 104' ' ' PRO . 22.5 t -146.35 -29.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.782 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.762 ' N ' ' HB3' ' A' ' 104' ' ' PRO . 12.2 p-10 -66.78 132.21 47.57 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.764 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 14.1 ttmm 72.24 -28.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.912 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 98' ' ' ASP . 52.4 m -71.76 -50.08 33.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.8 p -124.61 -6.66 7.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.147 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 84.1 mtm180 55.85 71.67 0.54 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.82 0.819 . . . . 0.0 111.194 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' HG11 ' A' ' 97' ' ' VAL . 3.9 mmtt 159.93 70.74 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.987 ' CB ' ' HB ' ' A' ' 97' ' ' VAL 0.257 25.6 Cg_endo -118.95 -179.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.293 2.662 . . . . 0.0 114.897 -174.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.832 HD11 ' HA ' ' A' ' 95' ' ' TYR . 1.1 mp 45.04 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.99 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.08 31.27 0.26 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.246 0.546 . . . . 0.0 110.053 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 5.1 m-20 -142.91 177.08 1.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.894 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.556 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 91.7 Cg_endo -114.27 -179.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.722 0 C-N-CA 123.874 3.049 . . . . 0.0 111.837 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 60.57 13.24 4.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.315 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.687 ' NE2' ' HB3' ' A' ' 65' ' ' LYS . 75.3 m80 -160.67 -6.81 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.806 ' HA ' HG21 ' A' ' 105' ' ' ILE . 57.0 tt0 -60.51 -40.24 90.68 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.055 HD23 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 1.055 ' HG3' HD23 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 120' ' ' LEU . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.797 HD12 HD12 ' A' ' 117' ' ' ILE . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.771 ' HE2' HD11 ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.507 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.85 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.942 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.573 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 -99.75 -13.06 19.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.821 ' CB ' HH21 ' A' ' 86' ' ' ARG . . . -60.06 -39.72 86.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.389 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.81 160.12 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.413 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 60.49 45.82 10.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.681 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.681 ' HG2' ' O ' ' A' ' 145' ' ' ALA . 70.7 mm-40 -80.39 -0.1 35.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.942 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 CA-C-O 120.115 -0.269 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -118.91 -179.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.007 3.138 . . . . 0.0 113.296 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -87.28 116.81 25.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 -99.01 109.28 22.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 1.134 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 31' ' ' VAL . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 8' ' ' ILE . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.646 ' CD ' HD22 ' A' ' 29' ' ' LEU . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 53' ' ' THR . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD12 ' CE2' ' A' ' 18' ' ' TYR . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.878 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 12.7 tp-100 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.878 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.842 ' CG2' ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 26' ' ' VAL . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.622 ' CE1' HD23 ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD ' ' A' ' 10' ' ' PRO . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 1.134 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.63 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.959 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.123 HG22 HG23 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.793 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.622 HD23 ' CE1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' OE2' HG23 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.842 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 26' ' ' VAL . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.585 ' N ' HG22 ' A' ' 45' ' ' VAL . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 50' ' ' ILE . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.863 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 47' ' ' LEU . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.863 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB2' HD11 ' A' ' 59' ' ' ILE . 88.8 mt -65.63 -39.72 91.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 HG21 ' A' ' 59' ' ' ILE . 6.8 p -47.73 -49.05 29.28 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.24 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -66.49 -39.8 88.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 52' ' ' LEU . 83.7 mt -60.36 -39.36 86.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.627 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.83 -170.8 43.65 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.407 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.07 19.04 8.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.722 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.6 t -60.82 -40.0 83.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.651 -0.323 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' ' 52' ' ' LEU . 48.4 mm -70.49 -40.56 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.959 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.843 ' HB3' HD13 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.773 HD12 ' CG2' ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HA ' HD13 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.707 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.022 HD13 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 77' ' ' PRO . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.923 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.638 ' HB3' ' HG3' ' A' ' 148' ' ' GLN . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA2' ' OE1' ' A' ' 148' ' ' GLN . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.71 ' HA3' ' HZ3' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.791 HG23 ' OE2' ' A' ' 43' ' ' GLU . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.796 HG12 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 141' ' ' ILE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.035 ' HE ' HG11 ' A' ' 139' ' ' VAL . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.123 HG23 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.919 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.793 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -67.85 92.01 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.919 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.3 Cg_endo -90.67 49.93 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.893 2.395 . . . . 0.0 113.142 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 96' ' ' PRO . 9.8 p 51.47 168.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.619 0.574 . . . . 0.0 112.148 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.588 ' H ' HG22 ' A' ' 97' ' ' VAL . 96.1 m-20 -100.22 115.73 30.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.08 -39.23 75.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.985 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.9 p -58.64 -30.64 67.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.069 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.8 p -120.51 -7.96 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.903 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 32.2 mmt180 60.4 21.68 11.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.341 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.692 ' O ' HG13 ' A' ' 105' ' ' ILE . 5.1 tptt -72.05 94.26 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 124.264 0.978 . . . . 0.0 112.316 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 74.8 Cg_exo -48.12 104.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.803 1.669 . . . . 0.0 112.426 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 103' ' ' LYS . 84.3 mt -99.71 113.15 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.278 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.6 37.33 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 110.754 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 38.1 m-20 -143.49 175.64 2.74 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.891 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 33.0 Cg_endo -114.32 81.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.048 2.499 . . . . 0.0 111.554 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 111' ' ' GLN . 51.4 t30 -116.65 119.36 35.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.684 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.808 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 55.3 p-80 -68.29 25.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.69 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' H ' ' C ' ' A' ' 109' ' ' ASN . 72.1 tp60 -60.93 -39.58 90.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.359 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.793 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.808 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.909 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.788 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.909 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.871 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.622 ' HG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.859 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.837 ' OE2' HG13 ' A' ' 141' ' ' ILE . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.776 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 1.035 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.776 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.023 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.796 ' HB ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.552 ' OD1' ' HG2' ' A' ' 127' ' ' LYS . 27.9 m120 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.518 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 64.08 49.99 2.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -59.63 -23.2 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 77.94 95.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.217 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -139.77 159.76 41.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.925 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 79' ' ' ARG . 97.0 mt-30 -80.33 -0.03 34.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.305 0.574 . . . . 0.0 111.897 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.863 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 120.129 -0.262 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -118.93 -179.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.86 3.04 . . . . 0.0 113.264 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -100.17 18.37 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.49 -39.98 89.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.653 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.122 HD13 ' HA ' ' A' ' 53' ' ' THR . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.977 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.798 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.977 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.768 ' O ' HD12 ' A' ' 23' ' ' LEU . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 ' HB1' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.601 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD21 ' OG ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.837 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 26' ' ' VAL . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD22 HG11 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.849 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 31' ' ' VAL . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.798 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.938 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.763 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG12 ' HG ' ' A' ' 47' ' ' LEU . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.819 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.837 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.859 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 59' ' ' ILE . 84.7 mt -60.2 -40.0 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.122 ' HA ' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -47.37 -49.63 24.09 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.661 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -61.3 -40.49 94.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.701 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' HB3' HG23 ' A' ' 58' ' ' VAL . 85.5 mt -69.08 -39.39 79.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.69 8.0 11.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.841 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 49.58 3.33 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.743 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 55' ' ' LEU . 62.8 t -60.78 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 52' ' ' LEU . 70.0 mt -63.7 -39.72 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.075 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.79 ' HE1' ' HB3' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.858 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.844 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.858 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.075 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.956 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.948 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.432 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.948 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.742 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.742 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.718 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 9.5 m120 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG23 ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.9 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.938 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.627 ' CG ' HD13 ' A' ' 141' ' ' ILE . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.805 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.735 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.544 ' HE1' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -63.25 98.55 0.15 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.9 Cg_endo -92.36 36.28 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.758 2.306 . . . . 0.0 112.595 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER 55.25 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.0 0.429 . . . . 0.0 111.028 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.2 t0 -92.09 106.02 18.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -69.85 -39.31 76.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -58.15 -34.93 70.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.736 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 11.5 p -123.05 6.54 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 102' ' ' ARG . 57.1 ttt85 59.97 25.58 14.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.457 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 7.8 mmpt? -60.95 133.49 92.43 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.624 ' HA ' HG22 ' A' ' 97' ' ' VAL . 38.7 Cg_endo -111.31 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.348 2.699 . . . . 0.0 111.134 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.594 HD11 ' OE1' ' A' ' 111' ' ' GLN . 59.2 mt -82.15 101.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.893 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -119.95 32.66 5.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.006 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 109' ' ' ASN . 12.5 m-20 -140.12 165.33 31.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.53 34.55 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.782 2.321 . . . . 0.0 112.869 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 107' ' ' ASP . 51.8 t30 -100.0 109.9 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.027 0.442 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 1.119 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 45.4 p-80 -80.04 69.46 6.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.594 ' OE1' HD11 ' A' ' 105' ' ' ILE . 64.0 tt0 -60.59 -40.64 92.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.65 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.544 HD21 ' HE1' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.119 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.899 ' HE3' ' NE2' ' A' ' 110' ' ' HIS . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.688 ' NE2' HD11 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.896 HD22 ' CZ ' ' A' ' 140' ' ' PHE . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.877 HD21 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.899 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.809 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.825 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.825 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.896 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 142' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.9 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.851 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 -60.47 -40.31 90.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HE ' ' A' ' 86' ' ' ARG . . . -60.23 -40.04 88.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.612 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.93 120.12 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.874 0.368 . . . . 0.0 111.233 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -120.04 140.0 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.688 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.34 -0.11 35.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.376 0.608 . . . . 0.0 111.899 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.915 179.913 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -116.56 179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.973 3.115 . . . . 0.0 113.002 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 1.106 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 80.8 m-20 -100.02 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -61.28 -39.37 90.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.237 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.88 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.106 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.622 ' O ' HD13 ' A' ' 8' ' ' ILE . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.969 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.001 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.934 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.707 HD11 ' NH2' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 23' ' ' LEU . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.707 ' NH2' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.69 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.789 HG23 ' CD1' ' A' ' 8' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.993 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.88 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.929 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' NZ ' ' HB2' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.946 HG23 HG12 ' A' ' 89' ' ' ILE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.855 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 69' ' ' ILE . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.793 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.69 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 83' ' ' ILE . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.86 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.834 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' ' HA3' ' A' ' 57' ' ' GLY . 60.1 tp -61.82 -39.99 93.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.029 ' HB ' HD12 ' A' ' 60' ' ' ILE . 12.7 p -47.47 -49.38 25.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.609 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.001 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 46.9 t -64.03 -39.9 95.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.345 0.593 . . . . 0.0 109.548 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 52' ' ' LEU . 85.4 mt -60.94 -39.87 91.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.521 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.02 49.98 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.543 ' HA3' ' HG ' ' A' ' 52' ' ' LEU . . . -89.61 -168.39 43.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.205 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.81 -14.42 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' LEU . 86.4 mt -59.52 -43.72 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.029 HD12 ' HB ' ' A' ' 53' ' ' THR . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.596 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.929 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 66' ' ' THR . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' OD1' ' A' ' 72' ' ' ASN . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 1.135 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.631 ' CD1' ' H ' ' A' ' 76' ' ' ARG . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 1.135 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.616 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.631 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.744 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.793 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.935 ' HA ' HG22 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.946 HG12 HG23 ' A' ' 39' ' ' ILE . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.602 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -49.41 -48.73 74.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 95' ' ' TYR . 67.3 Cg_endo -94.47 34.07 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.354 2.036 . . . . 0.0 113.211 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 16.9 t -152.17 93.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.9 t0 -80.0 118.87 22.12 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' NZ ' ' HD2' ' A' ' 119' ' ' ARG . 65.4 pttt -68.02 -28.92 67.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -60.26 -47.35 86.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 p -126.45 14.08 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.835 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 60.25 35.57 20.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.571 0.7 . . . . 0.0 109.638 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -63.32 131.0 94.65 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.515 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -111.04 82.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.792 HD11 ' HG2' ' A' ' 103' ' ' LYS . 32.7 mm -74.21 125.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.174 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -110.05 22.45 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.564 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 105' ' ' ILE . 57.9 m-20 -145.03 159.09 50.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.266 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -92.79 50.05 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.933 2.422 . . . . 0.0 112.606 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -80.87 -7.41 59.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.361 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.621 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 90.6 m-70 59.42 34.0 22.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -60.61 -40.17 90.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.621 ' CG1' ' HB3' ' A' ' 110' ' ' HIS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.54 ' N ' HG13 ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.865 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.577 ' HD2' ' NZ ' ' A' ' 99' ' ' LYS . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.965 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.555 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.786 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.865 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.965 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.734 ' OD1' HD12 ' A' ' 141' ' ' ILE . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 -60.9 -40.3 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.4 88.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.669 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 59.82 78.1 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.978 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.21 -40.31 89.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.004 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -60.79 139.92 57.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.28 1.038 . . . . 0.0 110.659 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.966 179.919 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 120.165 -0.242 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.34 29.37 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.466 2.111 . . . . 0.0 112.423 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -77.18 136.26 38.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.039 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.78 -39.88 94.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.912 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.912 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.094 HD11 HD11 ' A' ' 55' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.694 ' HB ' ' HG2' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.97 HD23 HD11 ' A' ' 52' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.917 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.917 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HD2' HD22 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 1.061 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 66.6 m-70 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.061 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.729 HD11 ' HD2' ' A' ' 62' ' ' PHE . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.554 ' HZ ' ' CD1' ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.923 HD22 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.724 ' CG ' HG11 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.728 ' HB ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.778 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.957 ' HG2' HG22 ' A' ' 53' ' ' THR . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.055 ' HB3' HD22 ' A' ' 12' ' ' LEU . 89.5 mt -59.39 -11.53 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.957 HG22 ' HG2' ' A' ' 51' ' ' PRO . 5.3 t -47.63 -34.25 7.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.033 0.444 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.76 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 22.5 t -127.94 78.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.712 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.094 HD11 HD11 ' A' ' 12' ' ' LEU . 85.3 mt -60.22 -40.31 89.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.855 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.57 124.45 7.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.29 -88.42 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.438 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.76 ' CG2' ' HB3' ' A' ' 54' ' ' SER . 28.6 m -61.28 -40.16 85.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.05 HG22 HG12 ' A' ' 60' ' ' ILE . 48.5 mm -89.83 -80.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.981 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG22 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.918 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.987 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.78 ' HB3' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.879 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.879 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.849 ' H ' HD23 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.877 ' HD2' HD21 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.849 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 44' ' ' PRO . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.923 ' H ' HD22 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.749 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.817 ' CE2' HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.01 93.42 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.749 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 28.2 Cg_endo -114.29 -179.03 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.728 2.952 . . . . 0.0 113.091 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 104' ' ' PRO . 60.2 t -59.21 140.09 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.972 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 57.3 t0 -77.9 110.04 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.262 0.553 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.02 -27.11 64.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.492 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 m -59.99 -39.68 86.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 103' ' ' LYS . 14.4 p -124.46 8.44 8.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.713 0.292 . . . . 0.0 111.516 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 71.85 -21.37 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 8.4 tmtm? -60.12 140.14 90.96 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.917 178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.707 ' HB3' HG13 ' A' ' 97' ' ' VAL . 40.8 Cg_endo -112.92 178.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.69 2.26 . . . . 0.0 112.576 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.817 HG21 ' CE2' ' A' ' 95' ' ' TYR . 41.8 mt -119.56 119.87 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.59 19.65 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.608 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -147.01 160.03 41.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.585 0.231 . . . . 0.0 111.462 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.23 54.1 4.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.646 2.23 . . . . 0.0 112.102 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -120.06 129.44 54.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.248 0.546 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.973 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 48.3 p-80 -69.31 69.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.83 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' NE2' HG23 ' A' ' 105' ' ' ILE . 78.3 mt-30 -60.2 -40.06 88.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.368 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.852 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.973 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.585 ' HB2' ' NZ ' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.852 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.812 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.642 HD11 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.812 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 142' ' ' VAL . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.653 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.653 ' CD2' ' HD2' ' A' ' 131' ' ' TYR . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.568 ' N ' ' HD1' ' A' ' 138' ' ' TYR . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.85 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 126' ' ' SER . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.849 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 44.0 t-80 -60.11 -40.46 89.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.0 93.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.45 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.19 92.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 59.52 39.95 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.26 120.02 31.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.645 0.736 . . . . 0.0 110.087 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.899 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.497 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.2 Cg_endo -118.8 -179.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.952 3.101 . . . . 0.0 113.312 -176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.781 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 98.5 m-20 -79.84 139.55 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -79.89 -12.05 59.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.366 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.781 ' CE1' ' HB2' ' A' ' 3' ' ' ASN . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 53' ' ' THR . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 15' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.89 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.841 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 12.7 tp-100 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.89 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.62 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.911 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.911 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.478 ' C ' HD12 ' A' ' 29' ' ' LEU . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.599 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.667 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 1.059 ' HG2' HD13 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.83 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' VAL . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.936 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.873 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.873 HD23 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp -59.91 -40.67 89.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 59' ' ' ILE . 81.6 p -52.99 -33.67 52.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.882 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.7 m -80.61 -8.2 59.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 85.7 mt -60.52 -40.72 92.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.47 -21.91 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.123 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.86 18.03 6.17 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.697 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.12 -40.02 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.709 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 53' ' ' THR . 20.2 tt -59.79 -40.2 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.811 HG13 HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.949 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.065 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.79 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 89' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' HD22 ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.884 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.059 HD13 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.404 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.049 HG21 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.802 ' H ' HG12 ' A' ' 85' ' ' VAL . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG3' HD11 ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.802 HD11 ' SG ' ' A' ' 67' ' ' CYS . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.603 HG23 ' CG1' ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.79 ' OD1' ' HG3' ' A' ' 65' ' ' LYS . 18.3 t-20 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.803 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -70.91 93.06 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.803 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 36.4 Cg_endo -114.58 -178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.591 2.194 . . . . 0.0 112.865 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 104' ' ' PRO . 42.4 t -93.28 139.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.169 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.958 ' CB ' ' HB2' ' A' ' 103' ' ' LYS . 56.1 t0 -81.68 99.93 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.555 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.08 -38.79 79.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.725 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -57.99 -32.54 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.37 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 12.4 p -122.14 7.93 9.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 0.0 111.661 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 60.68 20.05 10.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.177 0.513 . . . . 0.0 110.536 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HB2' ' CB ' ' A' ' 98' ' ' ASP . 31.5 mmtt -65.79 120.63 70.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.036 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.551 ' HA ' HG13 ' A' ' 97' ' ' VAL . 41.4 Cg_endo -110.74 81.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.727 2.951 . . . . 0.0 111.233 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.536 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mt -68.22 119.84 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.679 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 88.0 tttt -119.52 19.87 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.275 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -146.73 159.84 42.73 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 95' ' ' TYR . 68.8 Cg_endo -91.42 69.04 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.869 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -99.76 3.42 44.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.295 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.966 ' HA ' HG23 ' A' ' 113' ' ' VAL . 97.0 m-70 60.22 40.47 17.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.824 0.345 . . . . 0.0 110.95 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.433 ' HB2' HD13 ' A' ' 105' ' ' ILE . 29.8 mm100 -60.48 -40.4 91.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 110' ' ' HIS . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.979 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.979 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.896 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.896 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.836 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.581 ' OH ' HG13 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.872 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.836 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.552 ' HD2' ' OH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 84' ' ' ASN . 74.8 m80 -69.86 -40.82 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.56 91.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.366 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . . . 60.44 20.26 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.85 140.47 50.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.659 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.704 ' HA ' ' CZ ' ' A' ' 86' ' ' ARG . 7.2 pt20 -80.99 0.09 37.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.623 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.84 27.98 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.321 2.014 . . . . 0.0 112.338 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.3 m120 -74.97 139.15 42.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.24 -39.08 78.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.816 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 8' ' ' ILE . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.727 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.859 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HD23 ' A' ' 23' ' ' LEU . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.595 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.845 ' CB ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.917 HG11 HD22 ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.917 HD22 HG11 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.97 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.879 HG13 HD12 ' A' ' 8' ' ' ILE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.816 ' HE2' ' HB3' ' A' ' 5' ' ' ASN . 63.0 t-80 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.587 ' HB2' ' ND1' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 90' ' ' THR . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HG2' HG22 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.875 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.855 ' OE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.845 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.019 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.732 ' CB ' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.684 ' H ' HD13 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.828 HD23 HD12 ' A' ' 55' ' ' LEU . 85.8 mt -64.23 -38.76 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 p -46.66 -48.99 19.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.527 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -65.95 -39.73 90.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.828 HD12 HD23 ' A' ' 52' ' ' LEU . 85.7 mt -60.85 -40.14 91.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.793 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.12 -75.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.12 -19.61 4.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.527 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.4 p -69.84 -30.01 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 59' ' ' ILE . 9.7 tp 45.7 40.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.0 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 59' ' ' ILE . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.832 HG23 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 66' ' ' THR . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.872 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.718 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.832 ' HB ' HG23 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.076 HG21 HG12 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.826 ' OH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.872 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 76' ' ' ARG . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.83 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.826 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.758 ' HA ' HG12 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.702 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.076 HG12 HG21 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.875 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.909 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.92 ' H ' HG22 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.865 ' O ' HG23 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.817 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 109' ' ' ASN . 5.1 t80 -48.74 -45.86 71.84 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 104' ' ' PRO . 65.4 Cg_endo -93.28 32.48 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.559 2.173 . . . . 0.0 113.858 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 94' ' ' CYS . 10.6 p -137.52 72.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.479 0.657 . . . . 0.0 112.063 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.986 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 56.8 t0 -71.89 120.03 16.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.63 -28.52 69.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -60.0 -55.73 30.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 4.3 p -126.84 18.01 7.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.749 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 mtm105 60.33 37.27 20.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 109.715 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.986 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 69.3 mttt -61.62 137.08 94.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.25 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.858 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 28.7 Cg_endo -112.78 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.526 2.818 . . . . 0.0 111.509 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.788 ' H ' ' HA ' ' A' ' 96' ' ' PRO . 26.0 mt -84.82 109.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.243 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -106.59 69.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.91 151.8 42.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -94.04 64.98 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 112.35 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 98.6 m-20 -109.96 169.9 8.42 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.736 0.779 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.787 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 65.8 m80 -109.84 24.47 13.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.59 -39.79 85.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.761 HD12 ' NE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.787 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.761 ' NE2' HD12 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.802 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.841 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.737 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.506 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.668 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.74 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.802 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.517 ' HB1' ' NE2' ' A' ' 110' ' ' HIS . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.758 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.909 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.447 HG22 ' OG ' ' A' ' 126' ' ' SER . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.766 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.5 m-70 -102.43 7.95 40.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.61 93.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.679 0.276 . . . . 0.0 111.424 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -107.54 -23.65 12.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.409 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 46.9 tp10 59.78 39.08 21.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -60.83 139.92 57.8 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.251 1.024 . . . . 0.0 110.756 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 C--N 1.297 -1.679 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.864 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.747 0.308 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.902 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.866 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.902 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.692 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.979 ' CD2' ' HG3' ' A' ' 22' ' ' GLN . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.914 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.979 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.4 tp60 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.704 HD23 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.914 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 ' CD2' HG11 ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 8' ' ' ILE . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.94 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.94 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.895 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.728 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.909 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 83' ' ' ILE . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.603 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.899 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.987 ' H ' HD23 ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.963 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 50' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.724 HG13 ' CB ' ' A' ' 52' ' ' LEU . 11.4 tt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.533 ' CD1' HG11 ' A' ' 31' ' ' VAL . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CE1' HD11 ' A' ' 39' ' ' ILE . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.581 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.733 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.724 ' SG ' HD13 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.609 ' CG1' ' HG3' ' A' ' 63' ' ' GLU . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.635 HD11 ' CA ' ' A' ' 72' ' ' ASN . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 45' ' ' VAL . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.63 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 26.2 m120 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.646 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.909 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.724 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.575 ' OH ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG23 ' OH ' ' A' ' 95' ' ' TYR . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.832 ' O ' HG22 ' A' ' 117' ' ' ILE . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' HD12 ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.773 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.648 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.429 ' CG2' HG23 ' A' ' 90' ' ' THR . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.775 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.648 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.629 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' O ' HD13 ' A' ' 8' ' ' ILE . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.973 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.805 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.966 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.48 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 36.6 t-80 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 8' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.836 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.839 HD11 ' CE1' ' A' ' 62' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.862 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.968 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG12 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.897 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.84 HD12 HG11 ' A' ' 31' ' ' VAL . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.889 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.774 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.889 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.905 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.905 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.74 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.657 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.687 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.634 HG12 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.899 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.968 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.089 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.836 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.651 ' O ' HG23 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.562 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.719 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 21.8 t-20 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.619 ' OH ' HG23 ' A' ' 113' ' ' VAL . 6.4 t80 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.722 0.296 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.619 HG23 ' OH ' ' A' ' 95' ' ' TYR . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.687 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.886 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.789 HD13 ' CE1' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.6 m-80 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.886 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' ND2' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.789 ' CE1' HD13 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.766 HG12 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 1.089 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 85' ' ' VAL . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.899 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.701 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.903 HG23 HG22 ' A' ' 31' ' ' VAL . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 1.002 ' HG2' HG22 ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' CG2' ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.002 HG22 ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.757 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 52.3 tp60 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.111 ' HB ' HD21 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.513 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.5 t60 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.111 HD21 ' HB ' ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 76.0 m80 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.784 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.861 ' CD1' HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.818 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.871 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.933 HG12 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.933 ' HG ' HG12 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.647 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.062 ' HB2' HD12 ' A' ' 59' ' ' ILE . 84.6 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.672 HD11 HG11 ' A' ' 31' ' ' VAL . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.74 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.872 ' SG ' HD12 ' A' ' 89' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.033 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 1.078 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.935 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.078 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.744 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.028 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.863 ' OE1' HD23 ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.028 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.749 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.741 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.872 HD12 ' SG ' ' A' ' 67' ' ' CYS . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.784 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.799 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.559 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.74 ' OH ' ' HB3' ' A' ' 111' ' ' GLN . 65.6 t80 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.74 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 ' HG2' ' A' ' 111' ' ' GLN . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.55 HG13 ' N ' ' A' ' 114' ' ' LYS . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 113' ' ' VAL . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.833 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.676 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.823 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.904 ' HE3' HD21 ' A' ' 143' ' ' ASN . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.491 ' OE1' HG11 ' A' ' 139' ' ' VAL . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.676 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.491 HG11 ' OE1' ' A' ' 129' ' ' GLU . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.904 HD21 ' HE3' ' A' ' 127' ' ' LYS . 40.3 p-10 -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.1 p80 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.824 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.891 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.891 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.869 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.059 HD22 ' HD2' ' A' ' 41' ' ' PHE . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.797 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 38' ' ' LYS . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.984 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.981 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.832 ' O ' ' HB ' ' A' ' 90' ' ' THR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.853 HD13 ' SG ' ' A' ' 67' ' ' CYS . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.797 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 1.059 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.829 ' HG3' ' N ' ' A' ' 86' ' ' ARG . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 47' ' ' LEU . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.016 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.869 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.869 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.974 HD12 HD13 ' A' ' 50' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' A' ' 52' ' ' LEU . 16.6 tt . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.981 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.856 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.853 ' SG ' HD13 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 87' ' ' ALA . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 68' ' ' ILE . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.767 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.767 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.806 ' CB ' HG22 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.829 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.034 HH21 HG11 ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.847 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' ILE . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.558 ' HB3' ' HZ ' ' A' ' 62' ' ' PHE . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.775 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.541 HG22 ' CE1' ' A' ' 95' ' ' TYR . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.75 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.904 HD13 ' CD1' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.794 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.794 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.904 ' CD1' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.928 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 1.034 HG11 HH21 ' A' ' 88' ' ' ARG . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.669 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.751 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 1.014 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.734 ' OH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 31' ' ' VAL . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.717 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.801 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 39.4 tp60 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.801 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.7 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 45' ' ' VAL . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 41' ' ' PHE . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.717 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 8' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 1.014 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 74.1 t60 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.988 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.988 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.979 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.866 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.871 ' CD1' HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.887 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.861 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB3' HD22 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.941 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.941 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.926 HD23 HG12 ' A' ' 59' ' ' ILE . 60.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.926 HG12 HD23 ' A' ' 52' ' ' LEU . 86.1 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.558 ' N ' HD13 ' A' ' 60' ' ' ILE . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.979 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.859 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB2' HG21 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 71' ' ' ALA . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.939 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.752 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.936 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.939 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.99 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' CD1' ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.861 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.887 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.904 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 ' CD1' ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.866 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.687 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.529 HG22 ' CZ ' ' A' ' 95' ' ' TYR . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.952 HD11 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.952 ' CE2' HD11 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.467 ' OE2' HG12 ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.695 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.904 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.811 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.797 ' HD2' HG11 ' A' ' 85' ' ' VAL . 95.1 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' HD13 ' A' ' 8' ' ' ILE . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.647 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 47' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.856 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.792 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.922 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.927 HG11 HD21 ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.922 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.927 HD21 HG11 ' A' ' 26' ' ' VAL . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.928 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 74.7 m80 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.814 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.021 HG12 HG23 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.87 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 1.09 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.746 ' CG1' ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 15' ' ' LEU . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.879 ' CG2' HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.879 HD13 ' CG2' ' A' ' 50' ' ' ILE . 8.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 60' ' ' ILE . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.745 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.785 HG22 ' H ' ' A' ' 71' ' ' ALA . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 76' ' ' ARG . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' HD11 ' A' ' 73' ' ' LEU . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.012 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.533 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.746 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 142' ' ' VAL . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.09 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.87 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.021 HG23 HG12 ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.788 ' O ' HG23 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.618 ' OH ' ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.635 HG13 ' OH ' ' A' ' 131' ' ' TYR . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.887 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.88 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.887 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 1.007 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.897 HD12 HD12 ' A' ' 117' ' ' ILE . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 m120 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.951 ' CE1' HD11 ' A' ' 117' ' ' ILE . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' OE2' ' HE3' ' A' ' 127' ' ' LYS . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.882 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.772 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.789 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.86 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.927 0.394 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.96 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.784 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.712 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.816 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.799 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.103 HG13 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 8' ' ' ILE . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.96 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 82.8 t60 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.885 ' HB2' ' HD2' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.103 ' HG2' HG13 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 1.006 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.911 ' HA ' HG23 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.811 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' HD21 ' A' ' 15' ' ' LEU . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 52' ' ' LEU . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 50' ' ' ILE . 85.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.595 HD12 ' CD1' ' A' ' 52' ' ' LEU . 15.9 tt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.666 0.27 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.847 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 1.004 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.931 ' HB3' HG21 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 71' ' ' ALA . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.953 HD12 HG13 ' A' ' 85' ' ' VAL . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.773 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.839 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.773 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.807 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.807 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLU . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.811 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.794 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 HD12 ' A' ' 69' ' ' ILE . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.006 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.79 HH21 ' CG2' ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.931 HG21 ' HB3' ' A' ' 67' ' ' CYS . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.681 ' OG1' HG12 ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.848 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CE2' HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.477 ' CB ' HD12 ' A' ' 112' ' ' LEU . 57.6 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 95' ' ' TYR . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.966 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.947 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.452 ' O ' HG22 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.79 ' CG2' HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.855 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.947 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.755 ' CE1' HG21 ' A' ' 85' ' ' VAL . 75.4 m80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.022 0.439 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.491 ' CG ' ' CD2' ' A' ' 33' ' ' HIS . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' O ' HD13 ' A' ' 8' ' ' ILE . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.928 HD22 ' CG2' ' A' ' 59' ' ' ILE . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 29' ' ' LEU . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.863 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.758 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.002 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.768 ' CE1' HD23 ' A' ' 42' ' ' LEU . 57.6 m170 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 15' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.095 HG22 ' HG3' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.677 HG13 ' CD1' ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 73.6 m80 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.015 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.952 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.872 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.871 HG21 ' SG ' ' A' ' 67' ' ' CYS . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.095 ' HG3' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.801 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD23 ' CE1' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.834 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 1.002 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.008 HD11 HD22 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.748 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.012 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.012 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.015 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 71' ' ' ALA . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.959 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.705 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.959 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.857 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.857 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.748 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG11 ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.681 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.834 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.835 HD13 ' HB2' ' A' ' 67' ' ' CYS . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.872 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.952 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.438 ' O ' HD23 ' A' ' 112' ' ' LEU . 78.4 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 115' ' ' ARG . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.763 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.708 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.811 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.81 ' CB ' HG22 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.942 ' CE2' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.708 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.869 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.81 HG22 ' CB ' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 121.045 0.45 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.99 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.97 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HE2' HG11 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.944 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.544 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.82 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.781 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.82 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.976 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.759 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.757 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.944 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.99 ' CE1' ' HB2' ' A' ' 5' ' ' ASN . 74.2 t60 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.853 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.075 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.053 HG23 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.875 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.906 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 1.029 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.976 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD13 ' CG2' ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 59' ' ' ILE . 20.6 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG13 HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.973 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.075 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.862 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.88 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.88 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.826 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.826 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.72 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.512 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.029 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.906 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.053 HG22 HG23 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 21.3 m120 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.055 HD23 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 1.055 ' HG3' HD23 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 120' ' ' LEU . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.797 HD12 HD12 ' A' ' 117' ' ' ILE . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.771 ' HE2' HD11 ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.507 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.85 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.942 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.573 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 1.134 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CB ' ' CD2' ' A' ' 33' ' ' HIS . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 31' ' ' VAL . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 8' ' ' ILE . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.646 ' CD ' HD22 ' A' ' 29' ' ' LEU . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD12 ' CE2' ' A' ' 18' ' ' TYR . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.878 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 69.9 tp60 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.878 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.842 ' CG2' ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD3' ' NE2' ' A' ' 22' ' ' GLN . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.622 ' CE1' HD23 ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD ' ' A' ' 10' ' ' PRO . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 6' ' ' TYR . 77.4 m80 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 1.134 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.63 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.959 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.123 HG22 HG23 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.793 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.622 HD23 ' CE1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.791 ' OE2' HG23 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.842 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 26' ' ' VAL . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.585 ' N ' HG22 ' A' ' 45' ' ' VAL . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 50' ' ' ILE . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.863 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 47' ' ' LEU . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.863 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB2' HD11 ' A' ' 59' ' ' ILE . 88.8 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' ' 52' ' ' LEU . 48.4 mm . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.549 0.214 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.959 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.843 ' HB3' HD13 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.773 HD12 ' CG2' ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HA ' HD13 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.707 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.022 HD13 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 77' ' ' PRO . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.923 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.71 ' HA3' ' HZ3' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.791 HG23 ' OE2' ' A' ' 43' ' ' GLU . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.796 HG12 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 141' ' ' ILE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.035 ' HE ' HG11 ' A' ' 139' ' ' VAL . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.123 HG23 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.793 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.793 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.441 ' CG1' ' CE1' ' A' ' 131' ' ' TYR . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.909 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.788 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.909 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.871 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.622 ' HG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.88 ' HG2' HD22 ' A' ' 143' ' ' ASN . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.837 ' OE2' HG13 ' A' ' 141' ' ' ILE . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.776 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 1.035 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.776 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 1.023 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.796 ' HB ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.88 HD22 ' HG2' ' A' ' 127' ' ' LYS . 82.1 m-20 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.518 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.861 0.362 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.653 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.977 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.798 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.977 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.768 ' O ' HD12 ' A' ' 23' ' ' LEU . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 ' HB1' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.601 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD21 ' OG ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.837 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD22 HG11 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.849 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 31' ' ' VAL . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.798 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.938 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.763 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG12 ' HG ' ' A' ' 47' ' ' LEU . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.819 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.837 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.859 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 59' ' ' ILE . 84.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 52' ' ' LEU . 70.0 mt . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.075 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.79 ' HE1' ' HB3' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.858 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.844 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.858 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.075 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.956 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.948 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.432 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.948 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.742 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.742 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.718 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 98.5 m-20 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.851 HG23 ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.9 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.938 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.627 ' CG ' HD13 ' A' ' 141' ' ' ILE . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.805 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.433 ' HG ' ' HE1' ' A' ' 138' ' ' TYR . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.544 ' HE1' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.841 0.353 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.544 HD21 ' HE1' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 117' ' ' ILE . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.688 ' NE2' HD11 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.896 HD22 ' CZ ' ' A' ' 140' ' ' PHE . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.877 HD21 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.899 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.809 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.825 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.825 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.896 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 142' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.9 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.851 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.88 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.993 ' HD1' ' HB2' ' A' ' 33' ' ' HIS . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.622 ' O ' HD13 ' A' ' 8' ' ' ILE . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.969 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 12' ' ' LEU . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.934 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.707 HD11 ' NH2' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 23' ' ' LEU . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.707 ' NH2' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.69 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.789 HG23 ' CD1' ' A' ' 8' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.993 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.88 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.929 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.552 ' NZ ' ' HB2' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.946 HG23 HG12 ' A' ' 89' ' ' ILE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.855 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 69' ' ' ILE . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.793 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.69 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 83' ' ' ILE . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.86 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.834 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 59' ' ' ILE . 60.1 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' LEU . 86.4 mt . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.596 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.929 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 66' ' ' THR . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' OD1' ' A' ' 72' ' ' ASN . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 1.135 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.631 ' CD1' ' H ' ' A' ' 76' ' ' ARG . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 1.135 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.616 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.631 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.744 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.793 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.935 ' HA ' HG22 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.946 HG12 HG23 ' A' ' 39' ' ' ILE . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.602 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' O ' ' HD1' ' A' ' 95' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.815 0.34 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 114' ' ' LYS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.54 ' N ' HG13 ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.865 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.965 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.555 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.786 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.865 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.965 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.734 ' OD1' HD12 ' A' ' 141' ' ' ILE . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.825 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.912 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.912 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.055 HD22 ' HB3' ' A' ' 52' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.694 ' HB ' ' HG2' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.97 HD23 HD11 ' A' ' 52' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.917 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.917 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HD2' HD22 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 1.061 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.2 m80 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.061 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.729 HD11 ' HD2' ' A' ' 62' ' ' PHE . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.554 ' HZ ' ' CD1' ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.923 HD22 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.724 ' CG ' HG11 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.728 ' HB ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.778 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.778 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.055 ' HB3' HD22 ' A' ' 12' ' ' LEU . 89.5 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.05 HG22 HG12 ' A' ' 60' ' ' ILE . 48.5 mm . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG22 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.918 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.987 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.78 ' HB3' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.879 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.879 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.849 ' H ' HD23 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.533 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.877 ' HD2' HD21 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.849 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 44' ' ' PRO . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.923 ' H ' HD22 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.764 0.316 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.852 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.4 HG22 ' HE1' ' A' ' 95' ' ' TYR . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.585 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.852 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.812 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.642 HD11 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.812 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 142' ' ' VAL . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.653 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.653 ' CD2' ' HD2' ' A' ' 131' ' ' TYR . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.568 ' N ' ' HD1' ' A' ' 138' ' ' TYR . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.85 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 126' ' ' SER . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.849 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 86.3 t60 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 15' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.89 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.841 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.0 tp60 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.89 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.62 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.911 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.911 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.478 ' C ' HD12 ' A' ' 29' ' ' LEU . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.599 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.667 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 1.059 ' HG2' HD13 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.83 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' VAL . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.936 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.873 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.873 HD23 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 HG13 ' A' ' 60' ' ' ILE . 20.2 tt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.6 0.238 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.811 HG13 HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.949 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.065 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.94 ' HG3' ' ND2' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 89' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' HD22 ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.884 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.059 HD13 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.049 HG21 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.802 ' H ' HG12 ' A' ' 85' ' ' VAL . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG3' HD11 ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.802 HD11 ' SG ' ' A' ' 67' ' ' CYS . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.603 HG23 ' CG1' ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.94 ' ND2' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t30 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.476 0.179 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG13 ' OH ' ' A' ' 131' ' ' TYR . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.979 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.979 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.896 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.896 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.836 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.581 ' OH ' HG13 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.872 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.836 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.552 ' HD2' ' OH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.601 ' CD2' ' HB3' ' A' ' 84' ' ' ASN . 87.8 m-70 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.857 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 8' ' ' ILE . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.727 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.859 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HD23 ' A' ' 23' ' ' LEU . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.595 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.845 ' CB ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.917 HG11 HD22 ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.3 t60 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.917 HD22 HG11 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.97 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.879 HG13 HD12 ' A' ' 8' ' ' ILE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.857 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 8.1 t60 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.787 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 90' ' ' THR . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HG2' HG22 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.875 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.855 ' OE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.845 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.019 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.732 ' CB ' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.684 ' H ' HD13 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 59' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 59' ' ' ILE . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.832 HG23 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 66' ' ' THR . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.872 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.718 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.832 ' HB ' HG23 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.076 HG21 HG12 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.826 ' OH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.872 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 76' ' ' ARG . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.83 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.826 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.758 ' HA ' HG12 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.702 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.076 HG12 HG21 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.875 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.909 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.92 ' H ' HG22 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.865 ' O ' HG23 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.518 ' SG ' ' HD3' ' A' ' 65' ' ' LYS . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.667 0.27 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.761 HD12 ' NE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.687 HG13 ' OH ' ' A' ' 131' ' ' TYR . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.761 ' NE2' HD12 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.802 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.841 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.737 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.506 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.668 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.74 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.802 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.758 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.909 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 144' ' ' HIS . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.766 ' H ' HG23 ' A' ' 85' ' ' VAL . 73.6 m80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.8 ' O ' ' HD2' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.027 -0.318 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.871 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 16.6 Cg_exo -67.93 26.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.541 2.161 . . . . 0.0 112.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 1' ' ' GLY . 14.8 t-20 -70.05 129.23 38.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.942 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.6 -39.37 93.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 6' ' ' TYR . 62.3 t30 -91.85 -161.04 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.052 0.454 . . . . 0.0 110.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 6.4 p90 -118.49 147.31 43.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.161 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -112.78 158.3 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.784 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -130.07 173.17 14.66 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.9 m -82.82 68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.902 ' HG2' ' CG2' ' A' ' 14' ' ' THR . 91.9 Cg_endo -114.68 34.34 1.09 Allowed 'Cis proline' 0 N--CA 1.448 -1.155 0 CA-C-N 122.825 2.044 . . . . 0.0 113.785 5.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.866 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER 131.16 161.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.012 1.325 . . . . 0.0 109.915 179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 8' ' ' ILE . 82.0 mt -61.15 -47.91 84.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 110.09 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.72 -43.38 59.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.823 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.902 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 1.6 m -58.33 -38.48 77.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.692 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -61.29 -40.49 94.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.805 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -58.46 -37.7 76.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 m -65.66 -1.04 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.893 0.378 . . . . 0.0 111.185 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.979 ' CD2' ' HG3' ' A' ' 22' ' ' GLN . 2.5 m-30 -68.33 153.85 42.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 52.4 m -70.43 177.67 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 3.4 mm? -59.36 -49.39 77.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.633 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.914 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 14.5 mt -71.83 -39.6 69.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 0.0 111.288 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.979 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.4 tp60 -61.33 -40.52 94.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.115 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.704 HD23 ' HB2' ' A' ' 18' ' ' TYR . 5.8 mt -66.9 -41.27 87.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.78 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.914 ' HE ' ' HA ' ' A' ' 21' ' ' LEU . 33.2 ptt180 -86.96 -9.52 55.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.776 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 63.2 tttp -127.97 71.38 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.293 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 29' ' ' LEU . 15.7 t -70.95 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 123.86 0.864 . . . . 0.0 112.526 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.4 Cg_endo -46.3 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.642 2.228 . . . . 0.0 113.053 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -96.71 127.1 42.37 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 ' CD2' HG11 ' A' ' 26' ' ' VAL . 84.2 mt -100.05 119.85 38.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.426 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.16 120.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.801 0.334 . . . . 0.0 111.444 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 8' ' ' ILE . 25.2 t -137.44 121.58 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.13 151.05 21.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.746 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.94 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 1.8 t60 -115.77 21.49 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' A' ' 2' ' ' PRO . 63.0 tttp 59.93 -84.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' CE1' ' A' ' 92' ' ' PHE . 43.0 t -60.16 -40.24 89.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.76 0.314 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.94 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 73.9 m-85 -68.93 -35.97 77.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.07 5.58 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mttm -97.53 120.13 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.89 0.376 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.895 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.7 mt -120.36 130.04 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.728 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.0 mt-10 -125.4 130.06 51.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.952 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.909 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 90.2 m-85 -108.88 132.36 54.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.06 8.63 44.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.6 mm-40 -91.03 179.53 1.42 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.291 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 28.6 Cg_endo -115.33 178.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.488 2.792 . . . . 0.0 112.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 83' ' ' ILE . 1.4 t -146.92 96.51 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.303 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 24' ' ' ARG . 54.8 t0 -104.81 101.32 10.92 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.279 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.3 -20.93 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.476 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.603 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 57.9 40.33 25.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.502 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.899 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 153.11 -8.99 0.52 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.288 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.987 ' H ' HD23 ' A' ' 47' ' ' LEU . 29.9 mm 58.85 72.35 0.84 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.828 0.314 . . . . 0.0 111.212 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.963 ' HD3' ' HB2' ' A' ' 47' ' ' LEU . 84.2 Cg_endo -94.24 32.02 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.429 2.086 . . . . 0.0 112.204 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD23 HG23 ' A' ' 50' ' ' ILE . 3.2 mm? -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.106 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.38 -40.66 18.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.669 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.7 p -61.51 -41.26 97.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.951 0.405 . . . . 0.0 110.574 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -39.76 82.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.88 -104.46 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.403 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.93 -52.61 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.468 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 59' ' ' ILE . 29.3 m -70.31 -21.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.969 -0.136 . . . . 0.0 111.348 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 58' ' ' VAL . 11.4 tt 62.07 -25.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.859 0.864 . . . . 0.0 112.84 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.536 ' H ' ' C ' ' A' ' 58' ' ' VAL . 15.9 tt -165.03 126.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 111.468 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.694 ' CG2' HG21 ' A' ' 58' ' ' VAL . 75.4 p -129.18 140.44 51.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CE1' HD11 ' A' ' 39' ' ' ILE . 41.6 t80 -138.63 111.04 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 111.267 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 66' ' ' THR . 19.5 mt-10 -75.23 139.19 72.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 57.4 Cg_endo -71.34 55.02 1.91 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.849 1.699 . . . . 0.0 112.336 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.581 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 4.3 ttmp? 171.6 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.373 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.733 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 29.2 m -141.24 149.87 41.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.024 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.724 ' SG ' HD13 ' A' ' 89' ' ' ILE . 28.3 p -91.17 139.37 30.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.558 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.609 ' CG1' ' HG3' ' A' ' 63' ' ' GLU . 48.5 mm -119.94 120.3 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.536 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.635 HD11 ' CA ' ' A' ' 72' ' ' ASN . 45.7 pt -80.88 -160.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.911 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 96.8 m-85 -60.51 -42.49 96.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.222 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 160.57 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.286 0.634 . . . . 0.0 110.285 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.859 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.7 m120 59.24 30.52 20.28 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.314 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 28.8 tp -69.51 92.72 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 124.202 1.001 . . . . 0.0 112.123 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 7.4 Cg_exo -70.22 39.07 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.171 1.914 . . . . 0.0 111.993 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 16.3 t-20 59.8 37.75 21.77 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.291 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 94.16 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.584 0.753 . . . . 0.0 112.646 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 91.8 Cg_endo -94.8 67.98 0.27 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.522 2.148 . . . . 0.0 113.105 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 98.5 mttt -60.01 -38.82 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 82.9 mtt85 -157.9 114.45 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.86 -161.21 13.13 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.617 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 46' ' ' ASP . 45.7 mt-10 -108.98 146.06 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.45 158.78 22.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.597 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 45' ' ' VAL . 45.6 pt -100.83 134.49 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.897 0.379 . . . . 0.0 111.574 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.683 ' ND2' ' HB1' ' A' ' 145' ' ' ALA . 26.2 m120 -79.58 159.85 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.363 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 144' ' ' HIS . 28.7 m -103.36 32.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.48 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.646 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 39.8 ttm180 -80.33 66.58 5.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.053 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.909 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -138.87 170.56 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.609 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 48.8 mtm180 -100.0 132.32 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.724 HD13 ' SG ' ' A' ' 67' ' ' CYS . 85.2 mt -110.08 129.57 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.686 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.3 m -119.2 129.74 55.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.297 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.92 140.03 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 9.5 p90 -92.43 169.69 10.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.887 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 59.66 46.61 11.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.92 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 89.2 m -60.76 -39.33 88.37 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.07 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.977 ' CE1' HD12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -69.06 92.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 124.314 1.045 . . . . 0.0 112.274 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 79.2 Cg_endo -85.78 36.38 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.232 1.955 . . . . 0.0 112.784 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.67 ' HA ' ' CG1' ' A' ' 105' ' ' ILE . 9.8 p 51.05 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 123.841 0.713 . . . . 0.0 112.329 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.552 ' N ' HG22 ' A' ' 97' ' ' VAL . 57.6 t0 -98.49 111.96 24.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.318 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.58 -27.5 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.756 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -41.28 92.5 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.8 p -119.69 -1.7 10.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.7 0.286 . . . . 0.0 111.682 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.1 mtt85 60.01 24.0 13.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.83 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 97' ' ' VAL . 12.3 tttp -69.54 93.45 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 112.491 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.674 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 11.0 Cg_endo -52.47 92.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 111.966 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.977 HD12 ' CE1' ' A' ' 95' ' ' TYR . 3.5 pt -95.82 120.33 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.551 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 56.6 tptt -140.58 44.04 1.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 109' ' ' ASN . 21.5 m-20 -145.36 161.08 43.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 55.4 Cg_endo -69.0 34.33 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.451 2.1 . . . . 0.0 112.523 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 107' ' ' ASP . 98.8 m-20 -61.6 -40.24 94.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.955 ' HA ' HG23 ' A' ' 113' ' ' VAL . 76.0 m80 58.27 39.0 26.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -60.71 -40.76 93.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 116' ' ' HIS . 1.3 pp -132.27 14.75 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.671 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 110' ' ' HIS . 65.4 t -61.65 -39.81 84.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.832 ' O ' HG22 ' A' ' 117' ' ' ILE . 22.0 pttp -59.9 -38.08 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.549 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.74 -40.71 96.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 0.0 111.122 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' HD12 ' A' ' 112' ' ' LEU . 89.7 m-70 -63.48 -40.78 98.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.64 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -65.17 -38.62 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.128 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -62.04 -39.32 91.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.583 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -62.46 -38.38 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.369 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 84.7 mt -60.72 -40.06 90.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.796 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 117' ' ' ILE . 98.6 mttt -62.24 -40.79 97.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mttt -62.88 -40.31 97.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.416 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.13 99.39 0.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.354 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.773 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 67.6 Cg_endo -91.02 33.23 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.292 1.995 . . . . 0.0 112.599 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -108.96 -19.81 13.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.379 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.648 ' CB ' HG22 ' A' ' 142' ' ' VAL . 54.3 m -130.07 149.78 51.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -98.46 120.96 39.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.42 126.74 30.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.629 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 52.2 tp10 -90.12 -79.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 m -159.91 136.05 8.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -112.02 129.95 56.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.844 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.28 118.15 35.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.719 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.751 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.63 -39.74 76.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.609 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.02 -41.27 91.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.8 p -99.27 -11.1 21.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.688 0.28 . . . . 0.0 111.649 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.57 9.77 14.42 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.68 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.429 ' CG2' HG23 ' A' ' 90' ' ' THR . 21.5 m -79.09 139.37 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.849 0.356 . . . . 0.0 111.116 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.1 t80 -115.68 120.45 39.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 130' ' ' SER . 28.6 m -120.95 129.84 75.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.898 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 38.2 p90 -144.17 160.11 41.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.775 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.9 mt -119.24 126.94 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.649 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.648 HG22 ' CB ' ' A' ' 126' ' ' SER . 21.7 t -127.52 81.08 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t30 -86.46 109.43 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.049 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 85' ' ' VAL . 46.5 p-80 -111.33 17.99 19.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.263 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.683 ' HB1' ' ND2' ' A' ' 84' ' ' ASN . . . -60.3 -40.3 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.249 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.75 130.01 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -120.03 139.9 51.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.804 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.58 0.24 34.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.397 0.618 . . . . 0.0 111.858 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.844 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.51 31.36 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.623 2.215 . . . . 0.0 112.595 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -79.59 122.68 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.928 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.91 104.08 16.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.629 ' HB3' ' HE2' ' A' ' 33' ' ' HIS . 58.5 t-20 -66.26 -38.56 88.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.879 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 53.6 p90 -108.04 149.52 28.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' O ' HD13 ' A' ' 8' ' ' ILE . 52.6 p90 -133.14 159.29 40.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.179 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mm -126.93 176.66 6.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.181 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.3 m -89.51 64.12 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.973 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 69.8 Cg_endo -116.48 33.32 0.73 Allowed 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 122.191 1.818 . . . . 0.0 112.919 5.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.805 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 23.2 t 139.13 166.13 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.663 1.185 . . . . 0.0 109.499 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.971 ' HG ' HG23 ' A' ' 58' ' ' VAL . 7.1 mp -61.1 -46.19 91.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.951 0.405 . . . . 0.0 110.426 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.31 -46.16 23.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.966 ' CG2' ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -59.05 -36.17 74.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.9 -40.38 88.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.5 p -59.98 -20.25 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.163 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.1 m -70.51 -5.25 27.44 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.011 0.434 . . . . 0.0 110.802 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 1.9 m-30 -59.97 144.74 48.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.332 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.48 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 54.6 m -70.43 -175.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 86.6 mt -59.58 -45.52 91.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.554 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.1 tt -70.08 -40.09 75.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 97.7 mm-40 -61.29 -45.4 94.62 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.911 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 81.5 mt -69.36 -40.21 77.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.126 0.489 . . . . 0.0 111.046 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 20' ' ' LEU . 99.3 mtt180 -63.63 -39.76 95.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.433 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.2 tttt -142.29 94.02 2.61 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.143 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 29' ' ' LEU . 11.8 t -70.91 92.15 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.897 0.879 . . . . 0.0 112.122 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 3.7 Cg_endo -43.61 -85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.708 2.272 . . . . 0.0 113.355 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 36.6 t-80 -96.21 108.36 20.82 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.338 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 26' ' ' VAL . 14.2 mt -101.45 124.06 46.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 24.2 t -120.11 112.74 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 111.039 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 8' ' ' ILE . 42.7 t -135.21 130.0 50.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.393 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 166.54 32.63 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.231 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 58.6 t-80 -140.15 150.65 44.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.42 -40.23 90.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.997 0.427 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -68.3 -40.25 81.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.334 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 89.9 m-85 -89.43 -73.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.631 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.32 -177.79 39.16 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.67 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.1 tttp -94.98 125.16 39.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.944 0.402 . . . . 0.0 111.106 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.839 HD11 ' CE1' ' A' ' 62' ' ' PHE . 77.0 mt -126.89 140.01 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.862 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -130.49 160.0 35.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.261 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.968 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 93.2 m-85 -154.57 116.68 4.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 86.3 mt -99.87 15.33 27.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.242 0.544 . . . . 0.0 110.892 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 84' ' ' ASN . 16.5 pt-20 -69.06 162.58 64.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.858 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.857 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 32.2 Cg_endo -113.04 82.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.636 2.891 . . . . 0.0 111.322 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG12 ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -67.99 91.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.907 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.1 p-10 -79.64 81.92 5.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.903 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.07 ' HB3' HG12 ' A' ' 50' ' ' ILE . 80.6 mt -86.66 -68.79 0.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.649 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 49.29 77.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.61 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.897 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 104.34 11.09 32.3 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.839 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.07 HG12 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -70.33 91.39 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.195 0.998 . . . . 0.0 112.948 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 16.7 Cg_exo -65.8 24.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.465 2.11 . . . . 0.0 112.903 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 59' ' ' ILE . 84.7 mt -69.67 -27.98 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -47.87 -40.13 20.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.545 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.1 p -61.15 -40.02 92.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.21 0.529 . . . . 0.0 109.928 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 52' ' ' LEU . 51.5 mt -63.11 -40.2 96.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.072 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.75 -96.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.477 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' A' ' 12' ' ' LEU . . . -172.94 -54.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.484 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.971 HG23 ' HG ' ' A' ' 12' ' ' LEU . 61.0 t -129.85 129.86 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 52' ' ' LEU . 20.4 mt -71.24 41.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.25 0.547 . . . . 0.0 110.256 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.866 HG23 HG12 ' A' ' 58' ' ' VAL . 43.1 pt -114.05 128.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.66 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 68' ' ' ILE . 93.7 m -120.51 129.97 54.06 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.8 t80 -135.0 109.41 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.889 ' HG3' HD12 ' A' ' 68' ' ' ILE . 1.8 mm-40 -79.72 141.18 55.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.044 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.774 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 57.6 Cg_endo -71.25 54.37 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.895 1.73 . . . . 0.0 112.104 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 28.5 mmtt 177.51 -30.05 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.0 m -149.94 159.95 43.98 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.253 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 92.6 m -100.81 125.4 47.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.462 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.889 HD12 ' HG3' ' A' ' 63' ' ' GLU . 85.2 mt -119.81 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.5 pt -137.73 -24.35 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.219 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.3 m-85 -94.31 -0.57 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.953 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -54.35 131.46 42.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 111.799 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.905 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 53.3 t30 64.86 -1.67 0.8 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.79 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 75' ' ' ASN . 0.6 OUTLIER -69.92 92.9 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 C-N-CA 123.812 0.845 . . . . 0.0 112.472 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.905 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 80.6 Cg_endo -93.28 31.94 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.569 2.18 . . . . 0.0 112.787 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.74 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.91 33.6 23.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.657 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 11.1 mtt180 -50.26 -50.43 70.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.63 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.839 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 68.5 Cg_endo -100.7 33.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.509 2.806 . . . . 0.0 112.635 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 39.7 ttpt -59.63 -40.53 87.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 111.167 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -79.18 120.1 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.67 -10.07 74.9 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.097 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.839 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 70.2 mm-40 -119.58 154.49 33.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.84 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.98 112.84 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.042 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.09 119.84 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.687 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 34.1 m120 -92.2 139.88 30.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.758 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.634 HG12 HG23 ' A' ' 142' ' ' VAL . 16.7 t -103.15 32.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.899 ' HG2' ' OD1' ' A' ' 143' ' ' ASN . 86.8 mtm180 -76.77 63.19 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.57 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.968 ' HB2' ' HA ' ' A' ' 41' ' ' PHE . . . -142.95 160.02 41.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.265 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.089 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 80.5 mtp180 -111.72 138.21 48.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.17 129.75 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.836 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.1 m -119.88 129.89 54.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.015 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.651 ' O ' HG23 ' A' ' 137' ' ' THR . 82.1 m -116.98 151.15 37.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.901 0.381 . . . . 0.0 111.219 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' HD2' ' O ' ' A' ' 36' ' ' TYR . 53.8 p90 -69.99 167.57 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.838 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.719 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 21.8 t-20 -73.14 100.62 3.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 110.983 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.729 ' HB2' ' NZ ' ' A' ' 65' ' ' LYS . 30.7 p -100.45 7.31 44.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.887 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.619 ' OH ' HG23 ' A' ' 113' ' ' VAL . 6.4 t80 -42.71 -47.93 13.23 Favored Pre-proline 0 N--CA 1.466 0.327 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 23.6 Cg_exo -64.28 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.153 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 95' ' ' TYR . 14.9 t -148.02 117.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.68 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.7 t0 -96.72 120.62 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.643 ' NZ ' ' HB2' ' A' ' 99' ' ' LYS . 10.0 mtmp? -69.36 -39.08 78.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -38.03 81.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.332 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -125.51 5.83 7.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 98' ' ' ASP . 41.2 mmt180 60.2 20.09 9.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.237 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.699 ' HG2' HG13 ' A' ' 105' ' ' ILE . 44.5 tttt -62.79 134.08 95.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.655 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.602 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 40.6 Cg_endo -111.28 82.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.3 2.667 . . . . 0.0 110.81 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 54.1 mt -93.94 111.52 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.435 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.602 ' NZ ' ' HB2' ' A' ' 104' ' ' PRO . 13.3 mptt -109.69 66.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -147.32 150.95 39.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -96.74 45.87 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.159 2.573 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.11 -0.31 57.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.92 ' HA ' HG23 ' A' ' 113' ' ' VAL . 76.0 m80 57.21 41.05 27.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.982 0.42 . . . . 0.0 110.951 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.19 -40.6 86.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.786 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -131.62 18.41 4.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.758 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 110' ' ' HIS . 67.2 t -61.01 -49.9 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.632 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -60.78 -41.38 95.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 119' ' ' ARG . 62.7 mtp180 -61.79 -38.86 89.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.605 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.687 ' HE1' ' HB2' ' A' ' 138' ' ' TYR . 27.5 t-80 -62.0 -42.76 99.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.886 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.57 -40.59 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.538 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.95 -40.45 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 49.4 mtp85 -63.42 -40.03 96.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.959 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.789 HD13 ' CE1' ' A' ' 138' ' ' TYR . 86.2 mt -61.21 -40.59 94.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.72 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -40.37 94.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.118 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.82 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.1 mttt -64.67 -39.41 93.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.724 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 123' ' ' ASN . 1.6 m-80 -68.16 97.04 0.1 Allowed Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.341 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.82 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 68.1 Cg_endo -88.89 31.87 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.418 2.079 . . . . 0.0 112.742 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -107.65 -26.52 10.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.411 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 142' ' ' VAL . 59.4 m -124.29 150.06 45.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -97.05 121.08 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.001 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.56 119.99 15.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.608 ' OE1' HG22 ' A' ' 141' ' ' ILE . 70.3 mm-40 -90.63 -79.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.005 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -148.55 136.78 21.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.997 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.886 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -118.75 131.01 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.641 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -109.78 119.96 40.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.9 76.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.471 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.44 -39.94 89.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.899 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -99.84 -19.24 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.619 0.247 . . . . 0.0 111.457 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' ND2' ' A' ' 93' ' ' ASN . . . 70.06 1.67 34.88 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.804 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.0 m -74.82 139.98 43.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.398 . . . . 0.0 110.958 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.789 ' CE1' HD13 ' A' ' 120' ' ' LEU . 6.7 t80 -114.49 124.19 51.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.766 HG12 HH21 ' A' ' 88' ' ' ARG . 61.9 t -120.01 129.11 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 37.3 p90 -150.0 160.05 43.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.089 ' HB ' ' HG2' ' A' ' 88' ' ' ARG . 19.7 tt -124.8 136.75 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.634 HG23 HG12 ' A' ' 85' ' ' VAL . 17.2 m -110.5 33.74 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.177 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.899 ' OD1' ' HG2' ' A' ' 86' ' ' ARG . 57.8 t-20 -77.84 110.77 13.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -119.27 -3.32 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.378 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.56 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . . . -60.37 -39.92 88.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 111.343 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.67 121.19 40.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.75 140.36 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -90.12 119.93 30.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.405 0.621 . . . . 0.0 109.953 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.565 HG23 ' OXT' ' A' ' 149' ' ' THR . 7.4 t . . . . . 0 C--O 1.25 1.094 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.009 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.859 ' HA3' ' CE1' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.195 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.624 ' HG2' ' HG3' ' A' ' 4' ' ' GLU . 56.7 Cg_endo -70.42 38.76 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.251 1.967 . . . . 0.0 112.289 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.5 m-20 60.26 36.4 20.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.969 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' A' ' 2' ' ' PRO . 99.1 mt-10 -59.68 -39.97 86.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -150.49 106.57 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.701 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.5 p90 -138.43 150.7 46.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -139.78 158.01 44.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.972 0.415 . . . . 0.0 111.04 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.903 HG23 HG22 ' A' ' 31' ' ' VAL . 1.3 mt -132.84 169.81 21.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.045 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -82.42 69.3 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 1.002 ' HG2' HG22 ' A' ' 14' ' ' THR . 91.5 Cg_endo -114.34 32.75 1.26 Allowed 'Cis proline' 0 N--CA 1.441 -1.599 0 CA-C-N 122.347 1.874 . . . . 0.0 113.869 4.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 5.3 t 139.46 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.394 1.477 . . . . 0.0 109.622 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' CG2' ' A' ' 60' ' ' ILE . 88.2 mt -59.85 -47.37 86.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.408 0.623 . . . . 0.0 110.976 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.6 -40.86 20.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.433 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.002 HG22 ' HG2' ' A' ' 10' ' ' PRO . 2.0 m -59.19 -39.89 84.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.89 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 40.4 tp -60.69 -38.93 86.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.019 0.438 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -60.69 -38.38 84.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -64.48 -4.39 3.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.757 ' CE1' ' HD3' ' A' ' 10' ' ' PRO . 2.6 m-85 -61.02 159.91 10.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.739 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -65.95 165.49 13.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.764 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 59.3 tp -59.06 -49.69 76.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.917 0.389 . . . . 0.0 110.935 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.73 -39.7 73.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.306 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 52.3 tp60 -64.78 -40.66 95.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD21 ' CD1' ' A' ' 50' ' ' ILE . 57.0 tp -69.77 -41.0 75.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.647 ' HE ' ' HB2' ' A' ' 48' ' ' ALA . 99.3 mtt180 -63.62 -39.72 95.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 88.0 tttt -126.92 84.97 2.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.468 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.111 ' HB ' HD21 ' A' ' 29' ' ' LEU . 1.2 m -70.38 93.4 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.025 0.828 . . . . 0.0 112.266 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.36 -84.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.235 1.957 . . . . 0.0 113.109 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.513 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.5 t60 -95.89 109.55 21.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 111.384 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.111 HD21 ' HB ' ' A' ' 26' ' ' VAL . 90.5 mt -107.58 130.44 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 21.3 t -120.04 109.89 27.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.945 0.402 . . . . 0.0 110.807 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 8' ' ' ILE . 63.4 t -130.11 130.36 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.903 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.9 163.07 28.5 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.748 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 76.0 m80 -117.56 17.17 14.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.716 0.293 . . . . 0.0 111.563 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 68.5 mttm 66.8 -68.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.104 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.7 p -60.88 -39.31 88.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.859 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 87.2 m-85 -85.05 -10.07 57.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.58 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 62' ' ' PHE . . . 107.51 157.4 20.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.588 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.784 ' O ' ' HB ' ' A' ' 90' ' ' THR . 39.6 ttpt -100.19 129.89 46.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.861 ' CD1' HG13 ' A' ' 89' ' ' ILE . 84.8 mt -127.69 139.34 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.974 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.818 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 99.0 mt-10 -127.34 138.0 52.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.408 . . . . 0.0 111.724 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.871 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.8 m-85 -109.19 126.39 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.915 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 86.9 mt -109.78 15.34 22.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 111.301 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.837 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 2.2 mm-40 -78.77 168.26 28.53 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.784 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 63.2 Cg_endo -113.89 84.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.955 2.437 . . . . 0.0 107.887 -177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.933 HG12 ' HG ' ' A' ' 47' ' ' LEU . 30.7 t -76.2 78.56 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 24' ' ' ARG . 92.1 m-20 -63.56 92.54 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.933 ' HG ' HG12 ' A' ' 45' ' ' VAL . 92.3 mt -112.03 -42.61 3.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.647 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 56.11 40.32 30.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 111.426 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 50' ' ' ILE . . . 164.4 -55.24 0.27 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.925 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.8 ' CD1' HD21 ' A' ' 23' ' ' LEU . 3.7 mp 56.18 83.59 0.22 Allowed Pre-proline 0 N--CA 1.463 0.2 0 CA-C-O 120.491 0.186 . . . . 0.0 111.406 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -106.08 35.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.165 1.91 . . . . 0.0 111.182 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.062 ' HB2' HD12 ' A' ' 59' ' ' ILE . 84.6 mt -71.0 -32.17 68.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.649 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 t -47.82 -37.06 12.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.749 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -60.89 -39.54 89.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -38.96 77.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.85 -110.02 0.94 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.169 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.96 -59.75 0.08 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 60' ' ' ILE . 59.2 t -60.37 -39.8 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.744 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 52' ' ' LEU . 19.3 tt 47.02 19.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.672 HD11 HG11 ' A' ' 31' ' ' VAL . 9.5 tp -160.9 120.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.763 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -137.91 149.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.406 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 39' ' ' ILE . 6.2 t80 -139.88 110.49 6.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.053 0.454 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . 1.9 mm-40 -78.49 139.94 59.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.416 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.74 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 58.9 Cg_endo -71.76 55.54 2.21 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.833 1.689 . . . . 0.0 112.108 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 31.9 mmtt 179.1 -31.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.681 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.9 m -149.87 153.38 36.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.872 ' SG ' HD12 ' A' ' 89' ' ' ILE . 29.8 p -99.93 119.91 38.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.668 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 49.6 mm -119.74 120.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.033 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.4 -54.96 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 1.078 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . 49.4 m-85 -99.58 -1.35 38.41 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 67.91 84.95 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.911 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.935 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 30.4 m120 60.24 38.79 19.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.997 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.078 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -68.31 93.01 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.896 1.278 . . . . 0.0 111.991 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 77.8 Cg_endo -90.04 33.27 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.985 2.457 . . . . 0.0 111.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 73' ' ' LEU . 98.4 m-20 57.78 28.26 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.297 0.57 . . . . 0.0 111.605 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.744 ' HG3' ' HG2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -50.73 -50.85 70.91 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 76' ' ' ARG . 5.6 Cg_exo -77.03 -110.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 0.0 113.138 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.028 ' HE2' ' H ' ' A' ' 83' ' ' ILE . 86.8 mttt 50.87 57.38 6.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.105 0.478 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -64.3 -39.39 93.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.722 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.89 -30.37 0.43 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.407 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.863 ' OE1' HD23 ' A' ' 47' ' ' LEU . 14.2 pt-20 -119.25 140.19 50.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.701 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 78' ' ' LYS . . . -115.48 141.36 16.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.635 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.028 ' H ' ' HE2' ' A' ' 78' ' ' LYS . 22.7 mt -99.83 120.03 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.749 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 98.7 m-20 -100.38 126.64 46.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.74 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.88 31.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 111.384 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 76.8 mtp85 -70.33 67.11 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.701 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -121.76 171.1 9.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.477 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.741 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.3 mtt180 -99.81 131.65 45.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.872 HD12 ' SG ' ' A' ' 67' ' ' CYS . 19.8 tt -109.95 120.47 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.485 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.784 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.1 m -101.25 120.1 39.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.117 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.799 ' O ' HG23 ' A' ' 137' ' ' THR . 77.1 m -99.41 139.85 34.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.308 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 36' ' ' TYR . 29.1 p90 -86.74 -168.64 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -79.77 109.9 14.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.42 0.629 . . . . 0.0 110.324 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.559 ' SG ' ' HE2' ' A' ' 65' ' ' LYS . 25.6 p -131.05 20.1 4.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.291 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 65.6 t80 -45.45 -36.12 4.08 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.896 ' HA ' ' N ' ' A' ' 105' ' ' ILE . 42.7 Cg_endo -111.77 82.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.717 1.611 . . . . 0.0 114.491 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.807 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 47.8 t -160.53 68.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.592 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.896 ' HA ' ' HD3' ' A' ' 106' ' ' LYS . 51.6 t0 -64.64 129.19 38.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.215 0.531 . . . . 0.0 110.527 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.866 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.7 pttp -70.33 -25.56 63.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.6 p -68.96 -56.7 7.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.576 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -128.09 19.81 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.842 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 27.9 mtm105 62.58 25.12 14.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.838 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 105' ' ' ILE . 13.7 mmtt -70.93 93.78 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 124.587 1.155 . . . . 0.0 111.446 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.842 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 38.9 Cg_exo -32.98 88.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.557 2.838 . . . . 0.0 115.166 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.896 ' N ' ' HA ' ' A' ' 96' ' ' PRO . 1.2 pp 173.32 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.917 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.896 ' HD3' ' HA ' ' A' ' 98' ' ' ASP . 9.3 pttp 59.72 43.68 15.15 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.138 0.575 . . . . 0.0 111.623 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.954 ' HB2' ' HA ' ' A' ' 95' ' ' TYR . 1.2 m-20 -140.75 159.34 62.93 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.652 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 1.021 ' HB3' ' HB2' ' A' ' 116' ' ' HIS . 47.8 Cg_endo -97.5 33.1 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.01 2.473 . . . . 0.0 114.563 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.81 ' HB3' ' CD1' ' A' ' 95' ' ' TYR . 23.5 t-20 -60.57 -39.67 88.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.054 0.454 . . . . 0.0 110.969 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.684 ' HD2' ' OD1' ' A' ' 109' ' ' ASN . 8.7 p80 -159.77 -62.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.74 ' HB3' ' OH ' ' A' ' 95' ' ' TYR . 56.4 tt0 -58.75 -40.37 83.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.234 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.821 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 9.1 mp -119.06 32.29 6.2 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 111.1 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.724 ' HA ' ' CB ' ' A' ' 108' ' ' PRO . 14.9 p -70.33 -49.55 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.648 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 113' ' ' VAL . 62.9 pttt -69.38 -30.78 68.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -70.06 -52.05 27.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.562 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 1.021 ' HB2' ' HB3' ' A' ' 108' ' ' PRO . 59.2 m170 -71.36 -38.56 71.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.229 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.833 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 2.8 tp -61.31 -39.25 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 120.815 0.34 . . . . 0.0 111.555 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.6 -41.17 98.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.01 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -60.52 -39.88 89.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.238 0.542 . . . . 0.0 110.84 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.676 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 86.7 mt -61.49 -41.03 96.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.262 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.87 -39.88 90.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.969 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.823 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 13.5 mmtm -62.05 -38.89 90.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.41 97.46 0.13 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.201 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.823 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.8 Cg_endo -87.1 32.54 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.77 1.647 . . . . 0.0 112.981 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.28 -22.67 16.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.647 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.4 p -130.58 152.97 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.638 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.904 ' HE3' HD21 ' A' ' 143' ' ' ASN . 98.7 mttt -97.52 120.45 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 30.5 t80 -74.36 122.48 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' OE1' HG11 ' A' ' 139' ' ' VAL . 41.6 tt0 -91.73 -79.84 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.538 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -166.91 158.47 12.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.703 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 137' ' ' THR . 26.4 p90 -140.07 152.14 45.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.841 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 96.1 m-20 -105.41 120.12 40.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.286 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.03 87.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.535 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 132' ' ' ASP . 34.0 p-10 -60.71 -41.26 94.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 76.8 p -98.75 -7.82 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.759 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . 63.29 15.26 56.52 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.412 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 91' ' ' CYS . 22.1 m -79.34 138.95 37.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.013 0.435 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.676 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 4.2 t80 -118.43 126.33 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.283 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.491 HG11 ' OE1' ' A' ' 129' ' ' GLU . 47.8 t -119.89 127.3 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.5 p90 -151.79 159.96 43.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.253 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.4 mt -119.75 119.74 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.14 65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.075 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.904 HD21 ' HE3' ' A' ' 127' ' ' LYS . 40.3 p-10 -80.03 110.08 15.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 111.185 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -123.86 17.63 9.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.202 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.493 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.32 119.97 38.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.174 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.93 -39.49 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -100.68 110.92 23.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.32 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.697 -179.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.42 28.39 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.334 2.023 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.1 m120 -80.09 139.91 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 6' ' ' TYR . 86.5 tt0 -96.83 109.64 22.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.072 0.463 . . . . 0.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -80.29 -9.7 59.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.9 p90 -115.43 141.4 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.824 ' HE2' ' HE2' ' A' ' 38' ' ' LYS . 43.8 p90 -130.17 153.61 48.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.953 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 2.0 mp -131.95 139.65 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 111.839 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' LEU . 63.9 m -114.39 75.19 3.26 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.486 0.314 . . . . 0.0 110.359 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 39.5 Cg_endo -117.49 -179.83 0.3 Allowed 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 124.634 -0.986 . . . . 0.0 113.457 5.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 21.1 t -57.12 162.32 2.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.249 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.1 mp -60.45 -40.47 91.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.346 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 32.8 p-10 -64.9 -41.41 95.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -59.92 -41.56 92.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.268 0.556 . . . . 0.0 109.906 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 58.9 tp -61.72 -39.43 91.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.185 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.4 m -60.77 -38.08 84.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.155 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -69.46 -5.05 21.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.891 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.3 m-30 -74.93 159.9 31.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.173 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.0 p -71.4 170.96 12.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.471 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.4 mm? -60.61 -41.47 94.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.92 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.1 tm? -70.96 -40.69 71.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.891 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.4 tt0 -69.65 -40.19 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 49' ' ' GLY . 38.5 tp -68.33 -39.59 81.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.3 mtt180 -80.45 -10.33 59.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 34.5 tttm -136.82 87.45 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.869 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 16.7 t -69.58 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.942 0.897 . . . . 0.0 113.014 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 18.9 Cg_endo -56.97 -89.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.006 1.804 . . . . 0.0 111.95 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -96.47 101.19 12.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.666 0.269 . . . . 0.0 110.699 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.059 HD22 ' HD2' ' A' ' 41' ' ' PHE . 9.4 tt -117.5 122.69 44.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.118 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.797 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.6 t -119.83 119.72 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.6 p -138.82 139.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.299 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 38' ' ' LYS . . . 156.91 176.51 29.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.192 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.984 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 80.6 m80 -120.36 142.52 49.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.205 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -59.24 -41.14 88.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.477 . . . . 0.0 110.504 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HE1' ' A' ' 92' ' ' PHE . 46.8 t -65.75 -40.26 91.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.16 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.981 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 86.6 m-85 -89.79 -74.9 0.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.933 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.27 154.88 10.52 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.832 ' O ' ' HB ' ' A' ' 90' ' ' THR . 99.9 mttt -100.21 138.97 36.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.703 0.287 . . . . 0.0 111.549 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.853 HD13 ' SG ' ' A' ' 67' ' ' CYS . 47.1 pt -130.7 156.24 42.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.83 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.797 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.7 mt-10 -139.86 138.12 35.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.84 0.352 . . . . 0.0 111.124 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 1.059 ' HD2' HD22 ' A' ' 29' ' ' LEU . 90.8 m-85 -109.1 120.2 41.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt -102.7 9.19 39.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.283 0.563 . . . . 0.0 111.586 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.829 ' HG3' ' N ' ' A' ' 86' ' ' ARG . 18.0 mm-40 -92.14 -175.91 0.55 Allowed Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.952 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 43' ' ' GLU . 40.3 Cg_endo -111.64 77.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 124.162 3.241 . . . . 0.0 113.022 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 47' ' ' LEU . 6.7 t -60.66 85.26 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 36.6 p-10 -65.58 106.82 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.78 0.324 . . . . 0.0 111.543 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.016 ' HB3' HG23 ' A' ' 50' ' ' ILE . 77.7 mt -109.25 -34.86 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.545 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' ' HE ' ' A' ' 24' ' ' ARG . . . 51.4 33.55 10.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.012 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.869 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 99.83 67.27 0.85 Allowed Glycine 0 C--O 1.223 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.221 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 47' ' ' LEU . 1.4 pp -69.82 90.83 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 124.308 1.043 . . . . 0.0 113.408 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.869 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.7 Cg_endo -68.6 50.79 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.257 1.971 . . . . 0.0 112.168 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.974 HD12 HD13 ' A' ' 50' ' ' ILE . 84.7 mt -62.95 -25.29 68.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.939 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -47.94 -39.15 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.443 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.0 m -108.93 -34.22 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.884 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.781 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 86.8 mt -69.03 -40.69 78.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.98 1.51 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.508 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.18 -110.62 0.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.697 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 60' ' ' ILE . 31.3 m -78.48 -7.05 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' A' ' 52' ' ' LEU . 16.6 tt 48.72 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.006 0.522 . . . . 0.0 112.073 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 58' ' ' VAL . 51.4 mm -120.27 128.58 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.733 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -119.71 129.82 54.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.576 0.226 . . . . 0.0 110.423 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.981 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 34.6 t80 -136.1 110.19 8.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.015 0.436 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 66' ' ' THR . 2.1 mt-10 -76.5 142.5 70.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.979 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.856 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.9 Cg_exo -71.26 52.99 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.068 1.845 . . . . 0.0 111.881 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 16.7 mtpp 179.37 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.422 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.6 m -148.17 150.07 33.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.654 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.853 ' SG ' HD13 ' A' ' 39' ' ' ILE . 42.0 t -100.19 121.66 41.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 70' ' ' TYR . 38.6 mm -104.37 119.93 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 87' ' ' ALA . 45.5 pt -96.6 -33.02 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 68' ' ' ILE . 51.3 p90 -69.24 -26.55 64.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.253 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 59.33 -158.81 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.264 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.2 p-10 -63.53 1.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.67 0.272 . . . . 0.0 111.526 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 70' ' ' TYR . 62.2 mt -64.31 100.82 0.23 Allowed Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.257 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 36.0 Cg_endo -112.48 82.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 123.761 2.974 . . . . 0.0 112.306 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.767 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 70.53 14.0 7.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.892 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 2.5 tpp180 -69.07 98.93 0.2 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.123 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.767 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 41.2 Cg_endo -98.3 69.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.403 2.069 . . . . 0.0 112.548 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.27 -32.44 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 68.94 30.75 4.47 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.885 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.2 -90.11 1.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.494 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.806 ' CB ' HG22 ' A' ' 50' ' ' ILE . 13.6 pt-20 -120.77 140.15 52.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.83 64.55 0.72 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.616 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' OE1' ' A' ' 147' ' ' GLU . 8.6 tp -103.05 134.67 43.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.925 ' HB2' ' HB3' ' A' ' 146' ' ' ALA . 27.5 m120 -79.68 129.99 34.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.442 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 6.2 m -149.41 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.826 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.829 ' N ' ' HG3' ' A' ' 43' ' ' GLU . 99.4 mtt180 -66.98 93.51 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.121 0.486 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 41' ' ' PHE . . . -120.61 140.42 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.034 HH21 HG11 ' A' ' 139' ' ' VAL . 79.4 ttt180 -115.48 121.41 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.847 ' HA ' HG22 ' A' ' 39' ' ' ILE . 45.7 pt -109.0 130.26 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.791 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' ILE . 93.9 m -120.09 129.84 54.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.558 ' HB3' ' HZ ' ' A' ' 62' ' ' PHE . 27.6 p -144.74 159.68 42.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.013 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.775 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 0.1 OUTLIER -109.81 17.76 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.847 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 65' ' ' LYS . 81.0 m-20 -100.32 105.8 17.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.1 -11.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.587 ' CD2' HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -130.32 70.1 82.19 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 120.599 0.237 . . . . 0.0 111.31 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG3' ' HZ2' ' A' ' 65' ' ' LYS . 67.9 Cg_endo -94.3 -83.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.697 2.265 . . . . 0.0 112.78 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 103' ' ' LYS . 12.9 p -130.26 139.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.75 0.309 . . . . 0.0 111.524 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.4 t0 -81.08 119.0 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 0.0 110.121 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -60.53 -40.49 91.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -58.55 -46.51 86.7 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.703 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 10.2 p -124.47 11.69 8.64 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 60.82 35.53 19.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 109.769 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.936 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 32.4 mmtt -63.06 136.03 96.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.286 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 40.4 Cg_endo -111.7 83.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.353 2.702 . . . . 0.0 110.401 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.587 HG21 ' CD2' ' A' ' 95' ' ' TYR . 20.1 mt -79.96 118.81 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.512 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -109.95 24.94 12.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.491 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 42.7 m-20 -144.81 173.03 4.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.419 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.465 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 35.2 Cg_endo -113.49 82.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.752 2.968 . . . . 0.0 112.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.755 ' ND2' HE21 ' A' ' 111' ' ' GLN . 59.8 t-20 -120.4 127.5 52.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.01 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.945 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 99.1 m-70 -67.09 28.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.755 HE21 ' ND2' ' A' ' 109' ' ' ASN . 79.5 mt-30 -58.57 -40.16 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.076 0.465 . . . . 0.0 111.582 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.16 18.72 4.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.908 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.945 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 82.6 t -67.03 -38.51 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.451 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.32 -39.47 87.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.269 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.45 -42.12 86.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.936 0.398 . . . . 0.0 111.132 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.75 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 91.4 m-70 -61.01 -39.56 90.2 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.647 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 120' ' ' LEU . 48.4 mm -62.88 -39.57 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.952 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.07 -41.41 96.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.694 0.283 . . . . 0.0 110.289 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -67.0 -37.7 84.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 110.778 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.904 HD13 ' CD1' ' A' ' 128' ' ' PHE . 87.4 mt -63.22 -36.54 83.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.91 -40.24 92.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.67 -40.72 84.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.059 0.457 . . . . 0.0 110.715 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.794 ' OD1' ' HA ' ' A' ' 127' ' ' LYS . 1.1 t30 51.85 60.85 13.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.555 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 123' ' ' ASN . 61.0 Cg_endo -104.3 33.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.388 2.725 . . . . 0.0 112.145 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.64 -48.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 m -129.87 150.04 51.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.706 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.794 ' HA ' ' OD1' ' A' ' 123' ' ' ASN . 87.9 tttt -95.44 120.01 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.904 ' CD1' HD13 ' A' ' 120' ' ' LEU . 27.9 t80 -84.96 119.04 24.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.673 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 139' ' ' VAL . 86.4 tt0 -81.98 -69.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 139' ' ' VAL . 0.3 OUTLIER -167.27 151.64 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.949 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.928 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 65.4 t80 -119.91 137.49 54.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -109.95 112.08 23.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.334 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.77 76.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.974 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.37 -39.71 94.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.289 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 137' ' ' THR . 54.1 m -100.06 -10.78 21.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.546 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 -19.91 1.02 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.354 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 57.7 m -79.6 140.03 37.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 42.5 p90 -126.88 156.0 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 1.034 HG11 HH21 ' A' ' 88' ' ' ARG . 12.9 m -106.66 130.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.669 ' CE1' ' HD1' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -119.13 143.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.764 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.751 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 50.7 mm -120.03 121.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.537 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 145' ' ' ALA . 22.0 t -100.47 74.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.74 138.15 32.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.235 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.763 ' CD2' ' HG2' ' A' ' 148' ' ' GLN . 70.8 m80 60.01 40.39 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -60.0 -41.02 91.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.477 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . . . -124.07 -49.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.812 0.339 . . . . 0.0 111.545 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.626 ' OE1' HD11 ' A' ' 83' ' ' ILE . 50.2 mt-10 -125.72 146.32 49.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.564 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.763 ' HG2' ' CD2' ' A' ' 144' ' ' HIS . 80.0 mt-30 -87.32 119.21 27.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.236 0.541 . . . . 0.0 111.026 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.954 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 27.99 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.315 2.01 . . . . 0.0 112.451 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 1' ' ' GLY . 98.6 m-20 -79.69 139.93 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.15 104.21 16.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.772 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 1.014 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 22.2 m120 -61.78 -39.67 92.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.829 ' CE1' ' HB2' ' A' ' 33' ' ' HIS . 90.7 m-85 -105.51 140.02 39.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.734 ' OH ' ' HE2' ' A' ' 38' ' ' LYS . 42.9 p90 -114.6 152.9 31.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.732 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 31' ' ' VAL . 33.2 mm -130.1 159.78 41.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.717 ' CB ' ' HB ' ' A' ' 30' ' ' VAL . 39.9 t -119.91 73.97 19.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 39.8 Cg_endo -115.21 -179.16 0.39 Allowed 'Cis proline' 0 C--N 1.352 0.73 0 C-N-CA 124.885 -0.881 . . . . 0.0 113.017 5.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 83.4 p -49.8 168.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.756 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD11 ' CA ' ' A' ' 56' ' ' GLY . 86.2 mt -60.46 -40.72 92.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -63.89 -46.48 84.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.5 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 93.7 m -61.29 -40.24 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 57.3 tp -61.39 -40.89 96.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 47' ' ' LEU . 79.6 p -62.12 -24.73 67.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 m -69.95 -5.08 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.154 0.502 . . . . 0.0 110.061 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.801 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 2.6 m-85 -60.33 159.99 9.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.062 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 54.8 m -78.99 174.23 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.33 -49.25 78.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.509 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.02 -40.74 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.982 0.42 . . . . 0.0 110.95 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.775 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 39.4 tp60 -61.25 -41.66 97.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.713 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.801 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 66.7 mt -61.18 -39.02 88.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.398 0.618 . . . . 0.0 110.749 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 79.1 mtp180 -68.19 -22.57 64.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.029 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.7 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.3 tttt -140.58 93.31 2.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 45' ' ' VAL . 34.9 t -71.2 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 123.604 0.762 . . . . 0.0 111.365 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 11.4 Cg_endo -52.46 -87.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.217 1.945 . . . . 0.0 112.934 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 30' ' ' VAL . 54.6 t-80 -95.73 101.04 12.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 41' ' ' PHE . 58.8 tp -109.25 127.06 53.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.311 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.717 ' HB ' ' CB ' ' A' ' 9' ' ' SER . 45.1 t -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.46 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 8' ' ' ILE . 62.0 t -130.27 130.08 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.861 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.89 169.97 42.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.064 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 1.014 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 74.1 t60 -127.46 43.48 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.917 0.389 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.988 ' HG3' ' H ' ' A' ' 35' ' ' SER . 58.2 pttt 46.16 -86.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.877 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.988 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 58.0 m -59.46 -41.25 89.27 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.979 ' HB3' ' HE2' ' A' ' 62' ' ' PHE . 5.8 m-85 -62.7 -39.86 95.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 111.7 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' HZ ' ' A' ' 62' ' ' PHE . . . 139.71 146.19 4.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.018 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.866 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.7 mttt -100.06 127.97 46.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 0.0 111.765 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.871 ' CD1' HG12 ' A' ' 89' ' ' ILE . 20.0 tt -130.07 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -120.01 139.91 51.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.705 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 88.1 m-85 -117.38 129.72 56.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.5 mp -103.3 14.12 32.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.532 0.682 . . . . 0.0 110.607 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.887 ' HG2' ' O ' ' A' ' 84' ' ' ASN . 18.7 mt-10 -68.96 167.88 18.1 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.066 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.861 ' HD2' ' O ' ' A' ' 82' ' ' GLY . 64.8 Cg_endo -107.82 75.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.697 2.265 . . . . 0.0 111.004 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 26' ' ' VAL . 12.2 t -66.03 65.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.679 -1.146 . . . . 0.0 114.048 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 33.4 p-10 -51.92 118.09 3.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB3' HD22 ' A' ' 23' ' ' LEU . 38.2 tp -99.99 -0.39 39.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.222 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.15 90.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.905 0.383 . . . . 0.0 111.218 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.941 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -111.46 -67.34 0.54 Allowed Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.563 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 50' ' ' ILE . 41.2 pt -70.43 92.81 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.149 0.98 . . . . 0.0 112.778 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.941 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 84.0 Cg_endo -83.75 30.66 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.128 1.885 . . . . 0.0 112.321 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.016 HD12 HD12 ' A' ' 55' ' ' LEU . 60.4 tp -61.3 -39.85 92.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.216 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.736 ' CG2' HD13 ' A' ' 47' ' ' LEU . 1.5 t -49.55 -29.92 7.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.6 p -60.46 -36.5 78.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.747 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 HD12 ' A' ' 52' ' ' LEU . 86.7 mt -61.13 -40.6 94.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.31 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' CA ' HD11 ' A' ' 12' ' ' LEU . . . 81.86 131.42 1.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.083 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.42 -20.24 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.831 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.893 HG11 HD11 ' A' ' 52' ' ' LEU . 57.3 t -66.2 -48.14 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.926 HG12 HD23 ' A' ' 52' ' ' LEU . 86.1 mt -70.18 -40.12 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG13 ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -118.9 128.92 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.558 ' N ' HD13 ' A' ' 60' ' ' ILE . 93.2 m -120.03 130.06 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.127 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.979 ' HE2' ' HB3' ' A' ' 36' ' ' TYR . 62.2 t80 -123.86 104.25 8.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 111.235 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 66' ' ' THR . 51.3 mt-10 -80.3 139.03 52.0 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.122 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.859 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 59.1 Cg_endo -72.07 53.54 2.03 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.849 1.699 . . . . 0.0 112.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 170.8 -27.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 30.0 m -139.97 150.05 44.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.0 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB2' HG21 ' A' ' 89' ' ' ILE . 70.7 m -119.76 130.0 54.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.794 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 71' ' ' ALA . 42.3 mm -118.33 118.0 56.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 89' ' ' ILE . 84.5 mt -80.01 -49.68 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.939 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.7 p90 -60.73 -42.71 97.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.277 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.752 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 63.15 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.936 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 40.5 p-10 -79.67 -8.06 58.97 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.939 ' HB2' ' CD1' ' A' ' 70' ' ' TYR . 4.3 mm? -69.24 92.53 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.585 0.754 . . . . 0.0 112.707 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -94.81 34.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.753 2.302 . . . . 0.0 112.852 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.4 m120 -156.38 -90.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.119 0.262 . . . . 0.0 110.888 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.99 ' HB3' ' HD3' ' A' ' 77' ' ' PRO . 2.9 ttm180 179.11 -62.13 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.538 0.208 . . . . 0.0 111.018 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.99 ' HD3' ' HB3' ' A' ' 76' ' ' ARG . 75.2 Cg_endo -88.27 32.25 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.779 2.32 . . . . 0.0 112.563 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 73' ' ' LEU . 74.4 mmtt -104.8 32.97 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.77 139.95 57.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' CD1' ' A' ' 83' ' ' ILE . . . -108.59 -160.04 19.87 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.685 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -102.89 139.88 37.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.703 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.861 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . 94.25 -1.08 66.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.865 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.7 pt -104.5 112.03 36.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 111.291 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.887 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 54.1 t30 -109.87 115.12 29.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 142' ' ' VAL . 16.8 t -60.05 1.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 68.8 ttt180 -81.53 65.5 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.904 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -132.26 158.2 42.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HG2' ' HB ' ' A' ' 141' ' ' ILE . 84.0 mtm180 -108.32 135.81 49.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.871 HG12 ' CD1' ' A' ' 39' ' ' ILE . 84.7 mt -119.71 120.09 62.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.866 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 95.7 m -120.28 129.73 54.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.612 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.5 p -142.99 159.97 41.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.525 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.687 ' HE1' ' HA ' ' A' ' 36' ' ' TYR . 33.5 p90 -98.89 159.05 15.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.686 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.65 48.68 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.142 0.496 . . . . 0.0 111.153 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 138' ' ' TYR . 91.8 m -60.26 -38.83 84.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -63.39 99.13 0.17 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.696 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 25.5 Cg_endo -115.16 82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.661 2.907 . . . . 0.0 113.047 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.804 HG23 ' HB3' ' A' ' 104' ' ' PRO . 14.8 p 49.8 154.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 56.8 t0 -89.46 109.59 20.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.458 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -69.42 -20.56 63.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.0 m -60.08 -41.5 92.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.625 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' LYS . 12.2 p -125.92 8.58 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.682 0.277 . . . . 0.0 111.424 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 101' ' ' THR . 99.2 mtt180 73.0 -24.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.01 0.434 . . . . 0.0 110.235 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 52.1 mttt -60.98 139.99 93.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.639 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.804 ' HB3' HG23 ' A' ' 97' ' ' VAL . 48.1 Cg_endo -113.34 178.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.589 2.193 . . . . 0.0 112.852 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 112' ' ' LEU . 85.0 mt -119.98 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.384 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.07 28.7 8.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.805 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -145.08 159.94 47.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.28 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.59 47.97 2.71 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.481 2.121 . . . . 0.0 112.272 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -109.76 115.26 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.533 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.894 ' ND1' HG21 ' A' ' 113' ' ' VAL . 93.2 m-70 -74.54 55.31 0.64 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.429 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.47 -39.99 89.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.142 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.8 pp -131.78 15.98 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.894 HG21 ' ND1' ' A' ' 110' ' ' HIS . 88.3 t -61.29 -41.91 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.784 0.326 . . . . 0.0 111.054 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 117' ' ' ILE . 39.6 ttpt -60.34 -41.27 93.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.348 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -68.66 -41.03 79.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.73 -40.76 93.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.558 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.952 HD11 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tp -65.68 -39.95 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.12 -40.31 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.864 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.9 mmt180 -60.93 -40.09 91.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.492 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 85.9 mt -61.09 -40.38 93.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.702 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.86 -40.23 94.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.541 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.734 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 48.3 mttt -63.16 -40.0 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.265 0.555 . . . . 0.0 110.354 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -66.49 101.31 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.693 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 81.9 Cg_endo -88.99 32.83 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.859 1.706 . . . . 0.0 112.174 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -100.51 -24.11 14.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.1 m -128.43 149.7 50.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.108 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.6 mttt -98.51 120.37 38.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 111.271 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.952 ' CE2' HD11 ' A' ' 117' ' ' ILE . 62.5 t80 -78.42 129.73 35.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.541 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' OE2' HG12 ' A' ' 139' ' ' VAL . 99.0 mt-10 -99.04 -70.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.979 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.4 p -160.1 141.14 12.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.73 132.64 55.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.749 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.68 117.26 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.743 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.78 75.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.571 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.57 -40.18 93.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.557 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.0 m -99.94 -17.03 17.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.774 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.27 0.43 29.28 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.631 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.6 m -70.74 133.15 46.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.862 0.363 . . . . 0.0 111.294 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.695 ' HB3' ' SG ' ' A' ' 94' ' ' CYS . 6.8 t80 -116.98 119.95 36.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.369 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 90' ' ' THR . 47.4 t -119.98 121.55 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 39.7 p90 -140.09 153.97 46.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.861 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.904 HG13 ' O ' ' A' ' 87' ' ' ALA . 19.6 tt -120.5 121.83 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.142 0.496 . . . . 0.0 111.096 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.811 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -97.83 72.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.8 ' ND2' ' HB3' ' A' ' 146' ' ' ALA . 50.2 t30 -90.02 107.66 19.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.797 ' HD2' HG11 ' A' ' 85' ' ' VAL . 95.1 m-70 -96.84 -29.46 13.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.6 91.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.196 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.8 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . . . -99.2 122.12 41.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -139.95 154.55 47.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.095 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -98.87 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.067 0.46 . . . . 0.0 111.053 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.155 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -118.91 -179.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.052 3.168 . . . . 0.0 113.141 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.652 ' ND2' ' HB3' ' A' ' 7' ' ' TYR . 80.8 m-20 -74.5 129.97 38.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -63.91 -40.32 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 6' ' ' TYR . 23.7 p-10 -157.53 -31.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.791 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.928 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 54.7 p90 -129.95 155.72 45.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.851 0.357 . . . . 0.0 110.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.652 ' HB3' ' ND2' ' A' ' 3' ' ' ASN . 43.1 p90 -129.98 153.4 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.2 mm -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.463 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.647 ' HB3' ' HB ' ' A' ' 30' ' ' VAL . 56.9 p -119.05 72.95 12.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 35.2 Cg_endo -114.82 -179.25 0.42 Allowed 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 125.408 -0.663 . . . . 0.0 113.021 5.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 85.7 p -50.43 169.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.614 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' VAL . 7.1 mp -60.92 -40.84 94.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.67 -48.21 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 88.0 m -59.76 -41.36 90.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.253 0.549 . . . . 0.0 111.131 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.968 HD21 HD13 ' A' ' 47' ' ' LEU . 59.0 tp -60.88 -43.6 98.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -60.97 -39.18 88.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -61.66 -4.93 1.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.856 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -60.7 159.92 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.865 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -76.19 174.19 10.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.64 -46.67 88.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.323 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -69.61 -41.2 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.078 0.466 . . . . 0.0 111.214 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.792 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 53.7 tt0 -63.16 -41.05 99.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.234 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.9 mt -62.58 -39.6 94.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.301 0.572 . . . . 0.0 110.407 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 79.8 mtp85 -79.98 -10.36 59.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.775 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.922 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 88.7 tttt -129.36 84.58 2.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.417 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.927 HG11 HD21 ' A' ' 29' ' ' LEU . 8.4 t -71.06 91.48 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.03 . . . . 0.0 112.311 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.922 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.5 Cg_exo -60.47 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.857 1.705 . . . . 0.0 113.135 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -98.13 120.15 38.02 Favored 'General case' 0 N--CA 1.461 0.094 0 O-C-N 122.205 -0.309 . . . . 0.0 111.756 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.927 HD21 HG11 ' A' ' 26' ' ' VAL . 21.3 mt -108.36 119.46 39.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.523 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 41.9 t -130.65 109.64 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.154 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 8' ' ' ILE . 58.7 t -129.93 130.33 66.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 6' ' ' TYR . . . -179.64 168.31 38.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.952 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.928 ' CD2' ' HB3' ' A' ' 6' ' ' TYR . 74.7 m80 -120.09 132.63 55.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HZ3' HD22 ' A' ' 3' ' ' ASN . 60.0 mttp -60.48 -40.74 92.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 m -71.54 -40.26 70.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.206 0.527 . . . . 0.0 110.327 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.814 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 34.9 p90 -164.77 99.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.785 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA3' ' H ' ' A' ' 33' ' ' HIS . . . 154.12 110.03 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.442 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 90' ' ' THR . 63.5 tttm -139.91 86.3 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 110.307 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.021 HG12 HG23 ' A' ' 89' ' ' ILE . 85.0 mt -131.52 139.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 50.1 mt-10 -130.86 129.81 42.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.438 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.87 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.6 m-85 -104.18 124.57 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.437 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.13 10.6 41.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.273 0.559 . . . . 0.0 111.255 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 1.09 ' HG3' ' HB2' ' A' ' 86' ' ' ARG . 80.7 mm-40 -119.96 158.58 49.78 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 45' ' ' VAL . 30.7 Cg_endo -115.32 179.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.367 2.711 . . . . 0.0 112.676 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.746 ' CG1' ' HA ' ' A' ' 83' ' ' ILE . 3.3 m -162.9 -172.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 34.6 p-10 -106.16 109.96 22.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.968 HD13 HD21 ' A' ' 15' ' ' LEU . 86.9 mt -110.1 7.38 23.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.667 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -60.56 -39.0 86.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 111.027 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.73 -40.28 96.37 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.838 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.879 ' CG2' HD13 ' A' ' 52' ' ' LEU . 77.5 mt 55.08 60.05 9.99 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 120.657 0.265 . . . . 0.0 111.23 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.012 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 73.0 Cg_endo -75.82 46.53 1.72 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.412 2.075 . . . . 0.0 112.582 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.879 HD13 ' CG2' ' A' ' 50' ' ' ILE . 8.6 mp -60.22 -39.46 86.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.33 -40.03 16.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.794 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.495 ' HB2' ' HD3' ' A' ' 78' ' ' LYS . 53.7 m -100.37 -25.91 14.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.931 HD11 ' HG2' ' A' ' 51' ' ' PRO . 84.5 mt -69.54 -39.76 77.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.994 0.426 . . . . 0.0 110.88 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.61 -40.02 2.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . 160.04 -80.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.213 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.91 ' HA ' HD21 ' A' ' 12' ' ' LEU . 30.3 m -71.48 -20.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.163 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 55' ' ' LEU . 20.4 mt 69.33 -17.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.39 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 58' ' ' VAL . 45.6 pt -122.93 131.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.707 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 71' ' ' ALA . 28.3 p -129.95 140.15 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' A' ' 67' ' ' CYS . 64.4 t80 -129.66 112.27 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.493 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 66' ' ' THR . 32.4 tt0 -71.27 142.96 87.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.474 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.745 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.3 Cg_endo -70.75 55.87 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.546 1.497 . . . . 0.0 112.218 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm 174.57 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.536 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 30.0 m -149.35 149.69 31.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.864 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 t -100.16 119.98 39.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.785 HG22 ' H ' ' A' ' 71' ' ' ALA . 84.9 mt -120.05 120.44 63.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.101 0.476 . . . . 0.0 111.283 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.6 -40.72 79.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.751 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 87.5 m-85 -66.06 -29.94 70.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.709 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 74.37 56.02 0.09 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.106 0.479 . . . . 0.0 110.943 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.8 m-20 61.11 24.61 14.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -67.09 92.69 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 123.924 0.89 . . . . 0.0 112.598 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 64.6 Cg_endo -93.27 38.33 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.732 2.288 . . . . 0.0 113.943 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 76' ' ' ARG . 2.8 p30 -149.2 -79.51 0.13 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.592 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' HD11 ' A' ' 73' ' ' LEU . 44.4 ttt180 178.43 134.46 0.23 Allowed Pre-proline 0 N--CA 1.456 -0.167 0 CA-C-O 120.748 0.309 . . . . 0.0 111.659 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.8 Cg_endo -107.9 77.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.479 3.453 . . . . 0.0 115.236 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.012 ' HE3' ' HB2' ' A' ' 51' ' ' PRO . 25.3 pttm 47.78 -170.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.257 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -61.66 -39.92 93.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.052 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' H ' ' HG3' ' A' ' 78' ' ' LYS . . . 81.6 170.22 43.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.846 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.11 147.46 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.65 0.262 . . . . 0.0 110.751 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.39 78.16 0.12 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.397 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.746 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 45.7 pt -100.89 127.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.809 0.337 . . . . 0.0 111.589 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -86.99 139.87 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.57 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.898 HG12 ' HB2' ' A' ' 145' ' ' ALA . 14.5 p -104.91 33.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 111.311 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.09 ' HB2' ' HG3' ' A' ' 43' ' ' GLU . 84.7 mtm180 -78.35 64.02 3.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.624 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.87 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -133.92 167.41 20.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.223 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 28.2 mtm105 -99.98 120.34 39.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.021 HG23 HG12 ' A' ' 39' ' ' ILE . 84.5 mt -109.89 129.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.819 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.3 m -114.85 120.82 41.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.788 ' O ' HG23 ' A' ' 137' ' ' THR . 83.2 m -121.85 140.07 52.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 111.428 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 15.1 p90 -99.1 168.82 9.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 92' ' ' PHE . 17.7 m120 60.4 47.18 9.09 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.914 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.2 m -59.86 -39.8 86.45 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.698 ' HD1' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.53 92.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.926 . . . . 0.0 113.379 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.914 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 57.5 Cg_endo -86.94 -104.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.015 1.81 . . . . 0.0 112.479 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.848 HG13 ' HA ' ' A' ' 104' ' ' PRO . 23.6 t -132.3 136.18 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 122.15 -0.344 . . . . 0.0 111.112 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 1.074 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 96.0 m-20 -79.33 109.92 14.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.089 0.471 . . . . 0.0 110.345 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.78 -20.79 45.41 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.51 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.1 p -58.78 -41.28 86.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 0.0 111.621 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 1.4 p -124.9 17.66 8.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.022 0.439 . . . . 0.0 111.009 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 61.07 20.08 10.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.155 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -64.62 127.98 92.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.709 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.848 ' HA ' HG13 ' A' ' 97' ' ' VAL . 42.6 Cg_endo -110.93 83.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.173 2.582 . . . . 0.0 110.438 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.698 HD13 ' HD1' ' A' ' 95' ' ' TYR . 1.3 pp -97.0 120.99 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.58 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.94 23.12 14.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -143.35 167.03 16.88 Favored Pre-proline 0 N--CA 1.464 0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.961 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -115.18 80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 122.74 2.294 . . . . 0.0 111.11 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 16.9 t-20 -86.27 0.71 53.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.084 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.999 ' HA ' HG23 ' A' ' 113' ' ' VAL . 98.4 m-70 70.12 9.69 7.13 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.446 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -61.95 -37.29 84.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.565 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' A' ' 115' ' ' ARG . 13.6 tp -130.69 24.42 5.05 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 110' ' ' HIS . 72.9 t -61.74 -41.93 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.752 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 59.1 mtpt -61.33 -40.9 95.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.773 0.32 . . . . 0.0 111.496 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.887 ' HD3' ' OE1' ' A' ' 118' ' ' GLU . 33.6 mmt180 -65.14 -40.67 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.668 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.88 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 91.3 m-70 -62.78 -40.35 97.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.356 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' A' ' 128' ' ' PHE . 10.0 tp -70.63 -28.81 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.037 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.887 ' OE1' ' HD3' ' A' ' 115' ' ' ARG . 49.7 mt-10 -58.56 -39.53 80.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.694 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 1.007 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 15.2 ptm180 -60.86 -40.59 93.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.001 0.429 . . . . 0.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.897 HD12 HD12 ' A' ' 117' ' ' ILE . 86.9 mt -61.69 -40.05 93.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 123' ' ' ASN . 22.9 mttm -61.39 -35.6 77.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.083 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 119' ' ' ARG . 26.4 mttp -65.47 8.16 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.31 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 121' ' ' LYS . 7.9 p-10 43.58 76.57 0.52 Allowed Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 28.9 Cg_endo -113.31 77.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 124.402 3.401 . . . . 0.0 113.68 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 m120 63.19 19.08 11.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.73 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' A' ' 124' ' ' PRO . 81.3 p -143.75 149.33 36.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.049 0.452 . . . . 0.0 110.929 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 28.3 tttp -110.4 120.5 42.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.951 ' CE1' HD11 ' A' ' 117' ' ' ILE . 58.4 t80 -88.83 120.13 29.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.305 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' OE2' ' HE3' ' A' ' 127' ' ' LYS . 70.4 mm-40 -102.2 -76.23 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.833 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.3 m -129.96 136.84 49.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.882 ' HB2' ' CE1' ' A' ' 128' ' ' PHE . 64.7 t80 -120.28 134.92 55.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.801 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -109.79 110.6 21.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.638 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.674 ' O ' ' HE1' ' A' ' 110' ' ' HIS . . . -70.67 -38.7 73.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.776 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.56 -40.37 94.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.435 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 137' ' ' THR . 81.2 p -99.92 -9.02 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.485 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.84 -19.97 0.69 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.466 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 91' ' ' CYS . 66.5 m -79.52 139.98 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.772 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 4.1 p90 -127.53 155.78 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.583 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.83 120.35 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.004 0.43 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 138' ' ' TYR . 1.0 OUTLIER -121.28 149.02 43.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.789 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 84.8 mt -119.8 120.16 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.828 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.86 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.9 t -69.97 69.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.718 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' HD2' ' A' ' 127' ' ' LYS . 35.5 p-10 -61.41 -39.9 92.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.176 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.8 ' CE1' ' HA ' ' A' ' 147' ' ' GLU . 49.5 t-80 -82.51 71.89 9.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 111.002 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.898 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -68.21 -40.08 82.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.068 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 144' ' ' HIS . . . -100.19 129.9 46.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.8 ' HA ' ' CE1' ' A' ' 144' ' ' HIS . 50.1 mt-10 -103.75 130.65 51.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.99 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -89.84 120.32 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.56 0.695 . . . . 0.0 109.911 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.617 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.184 0 CA-C-O 120.158 -0.245 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.52 25.55 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.397 2.065 . . . . 0.0 112.278 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.8 m120 -72.91 133.66 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.21 -27.6 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.553 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.96 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 25.0 m120 -62.1 -39.38 92.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB3' ' ND1' ' A' ' 33' ' ' HIS . 54.4 p90 -135.27 147.68 49.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 110.974 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -140.79 157.23 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 11' ' ' SER . 1.5 mp -130.6 159.31 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.441 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 54.3 m -122.15 69.83 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.493 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 33.8 Cg_endo -115.62 -179.72 0.41 Allowed 'Cis proline' 0 N--CA 1.454 -0.832 0 C-N-CA 125.099 -0.792 . . . . 0.0 112.673 4.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.784 ' HA ' HD13 ' A' ' 8' ' ' ILE . 95.3 p -54.69 168.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.131 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.661 HD21 ' HA2' ' A' ' 57' ' ' GLY . 7.2 mp -61.39 -40.73 95.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.28 -44.53 91.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.565 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 90.4 m -60.48 -40.85 92.8 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.712 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.7 tp -61.87 -40.99 97.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.046 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -60.38 -39.7 88.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.897 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 t -59.39 -8.98 2.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.816 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m-30 -60.1 159.79 9.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.265 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 80.4 p -78.37 176.46 9.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.12 -47.5 85.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.58 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.552 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -70.37 -40.42 74.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.083 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.2 tt0 -62.52 -42.07 99.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.878 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.799 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 87.3 mt -61.65 -39.74 92.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.535 0.683 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 80.6 mtp180 -69.32 -38.72 78.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.455 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.7 mttt -110.48 84.9 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.613 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 44' ' ' PRO . 18.9 m -71.75 92.98 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.919 0.888 . . . . 0.0 111.762 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 17.7 Cg_endo -55.19 -95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.254 1.969 . . . . 0.0 112.659 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.62 108.97 21.67 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 26' ' ' VAL . 86.5 mt -110.4 119.7 40.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.103 HG13 ' HG2' ' A' ' 40' ' ' GLU . 44.9 t -121.14 119.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 8' ' ' ILE . 59.6 t -129.98 129.81 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.255 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.88 160.48 32.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.918 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.96 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 82.8 t60 -140.95 149.04 41.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.48 -40.33 94.18 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.044 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.885 ' HB2' ' HD2' ' A' ' 33' ' ' HIS . 58.6 m -65.16 -40.46 94.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.23 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HD1' ' HA ' ' A' ' 64' ' ' PRO . 90.6 m-85 -90.17 -73.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 0.0 111.461 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 165.46 175.32 35.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.221 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 90' ' ' THR . 98.8 mttt -95.11 119.78 34.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.672 0.272 . . . . 0.0 111.371 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 62' ' ' PHE . 84.4 mt -129.17 134.86 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.103 ' HG2' HG13 ' A' ' 30' ' ' VAL . 50.0 mt-10 -130.09 127.94 40.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.61 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 1.006 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 90.0 m-85 -110.15 129.02 55.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.261 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 42' ' ' LEU . 2.5 mm? -99.71 -0.95 39.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.829 0.823 . . . . 0.0 111.062 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -78.96 160.22 71.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.864 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.911 ' HA ' HG23 ' A' ' 26' ' ' VAL . 32.2 Cg_endo -115.79 178.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.576 2.851 . . . . 0.0 112.25 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -177.9 153.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.575 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.811 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . 96.0 m-20 -93.95 115.04 27.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' HD21 ' A' ' 15' ' ' LEU . 84.2 mt -106.96 -11.19 15.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.473 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.88 92.22 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.871 0.367 . . . . 0.0 110.645 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.841 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -80.25 -58.6 2.73 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.508 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 52' ' ' LEU . 27.5 pt -71.37 95.18 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.033 0 O-C-N 124.443 0.731 . . . . 0.0 112.003 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 55.8 Cg_endo -70.74 38.47 0.31 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 121.65 1.567 . . . . 0.0 111.814 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 50' ' ' ILE . 85.4 mt -60.62 -39.74 89.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 t -47.89 -36.7 12.62 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.902 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.1 t -61.04 -38.77 87.32 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.707 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.2 -40.08 96.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.592 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.16 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.607 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.661 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . -92.22 170.9 33.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.652 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.583 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 16.6 m -60.2 -49.79 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.016 0.408 . . . . 0.0 110.966 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.595 HD12 ' CD1' ' A' ' 52' ' ' LEU . 15.9 tt 167.18 29.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.357 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.0 130.1 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.672 0.272 . . . . 0.0 111.385 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.9 p -115.47 133.96 55.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.847 ' CE1' HD11 ' A' ' 39' ' ' ILE . 10.9 t80 -135.12 110.5 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.252 0.549 . . . . 0.0 112.301 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 1.004 ' HG3' ' HD2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -74.88 145.37 81.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.259 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 55.5 Cg_endo -70.25 54.46 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.687 1.592 . . . . 0.0 113.125 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 62.2 pttt 166.99 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.466 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 63' ' ' GLU . 73.2 m -137.75 139.97 40.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.491 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.931 ' HB3' HG21 ' A' ' 89' ' ' ILE . 38.7 t -118.37 126.31 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.444 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 71' ' ' ALA . 50.2 mm -119.8 119.27 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.953 HD12 HG13 ' A' ' 85' ' ' VAL . 84.2 mt -70.34 -40.9 78.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.617 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.773 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 64.8 m-85 -60.34 -40.51 90.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.518 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 62.78 66.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.235 0.541 . . . . 0.0 110.681 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.839 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 56.4 t30 60.93 29.8 19.24 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.142 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.773 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -69.51 93.19 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.868 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 56.5 Cg_endo -68.91 38.18 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.85 1.7 . . . . 0.0 112.57 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.807 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 33.4 m120 59.37 25.77 14.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.477 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.56 94.72 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.535 0.734 . . . . 0.0 111.925 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.807 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 64.5 Cg_endo -105.63 37.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.98 1.787 . . . . 0.0 111.457 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.33 -39.87 95.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 110.737 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 81' ' ' GLU . 73.2 mtp85 -72.81 140.27 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.986 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.69 18.69 1.01 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.421 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.811 ' OE1' ' HB2' ' A' ' 46' ' ' ASP . 46.9 mt-10 -100.25 139.99 35.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.15 131.76 10.79 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.547 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.25 120.5 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.351 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.794 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 98.1 m-20 -98.32 132.9 43.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 HD12 ' A' ' 69' ' ' ILE . 16.6 t -105.24 32.98 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.141 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.758 HH21 ' HB1' ' A' ' 145' ' ' ALA . 99.3 mtt180 -80.27 63.18 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.006 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -143.91 160.0 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.578 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.79 HH21 ' CG2' ' A' ' 139' ' ' VAL . 79.6 ttt180 -116.97 128.4 55.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.179 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.931 HG21 ' HB3' ' A' ' 67' ' ' CYS . 83.6 mt -110.55 129.9 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.117 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.681 ' OG1' HG12 ' A' ' 139' ' ' VAL . 94.3 m -119.81 130.38 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.3 p -138.21 160.21 40.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.99 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.848 ' CE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -149.91 169.41 21.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.321 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.873 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 25.0 t30 60.29 37.97 20.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.745 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 89.7 m -70.1 -40.0 75.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 109.957 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -45.12 -48.89 31.77 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.898 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.873 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 24.3 Cg_exo -63.81 21.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.509 2.139 . . . . 0.0 113.429 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 95' ' ' TYR . 16.6 t -144.33 98.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.0 t0 -89.39 117.82 28.6 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.19 -29.7 70.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 t -60.07 -53.95 51.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.644 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 5.8 p -126.38 16.57 7.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.918 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' ASP . 99.3 mtt180 60.49 36.42 20.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.428 0.632 . . . . 0.0 109.679 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.926 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 76.2 mttt -63.12 137.07 96.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 30.3 Cg_endo -112.58 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 123.53 2.82 . . . . 0.0 111.215 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 69.3 mt -91.61 104.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.811 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.54 68.29 2.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.701 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -149.76 166.26 15.63 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.922 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -109.33 76.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 124.307 3.338 . . . . 0.0 114.916 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.1 m-20 -115.58 123.01 47.37 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.464 0.65 . . . . 0.0 112.537 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.901 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 99.4 m-70 -75.04 14.12 0.58 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.477 ' CB ' HD12 ' A' ' 112' ' ' LEU . 57.6 tt0 -57.66 -39.2 76.51 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.238 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HH21 ' A' ' 115' ' ' ARG . 5.2 mp -131.2 19.2 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.901 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 59.4 t -73.22 -50.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.22 -39.83 93.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.577 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.966 HH21 ' HG ' ' A' ' 112' ' ' LEU . 50.6 mtm180 -62.28 -39.78 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.368 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -42.65 94.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.588 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 48.0 mm -66.43 -40.18 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.906 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.15 -41.67 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.735 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -60.69 -38.95 86.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.206 0.526 . . . . 0.0 110.913 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.14 -38.37 90.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.805 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.6 -40.94 93.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.817 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.3 mmtt -60.48 -41.3 93.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.536 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.85 99.91 0.23 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.54 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 97.2 Cg_endo -89.51 33.14 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.765 1.643 . . . . 0.0 111.491 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -100.97 -21.28 15.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.351 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.947 ' HA ' HG12 ' A' ' 142' ' ' VAL . 55.0 m -128.44 150.17 50.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 98.5 mttt -95.77 123.7 39.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 131' ' ' TYR . 64.9 t80 -83.92 117.74 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.731 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -93.03 -79.68 0.39 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.452 ' O ' HG22 ' A' ' 139' ' ' VAL . 53.8 m -139.91 139.87 36.3 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 117' ' ' ILE . 64.9 t80 -129.08 130.51 46.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.75 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.58 117.81 34.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.88 -39.81 76.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.363 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.31 -41.32 93.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.278 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.8 m -99.42 -16.57 18.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.676 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.74 5.63 61.29 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.645 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.5 m -72.78 130.03 39.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -118.66 119.48 34.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.79 ' CG2' HH21 ' A' ' 88' ' ' ARG . 18.9 m -120.64 122.35 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.323 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 43.0 p90 -139.98 149.54 43.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.831 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.855 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 84.0 mt -120.18 127.9 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.947 HG12 ' HA ' ' A' ' 126' ' ' SER . 16.3 m -120.18 78.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.617 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 58.8 t-20 -94.97 110.3 22.21 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.538 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.755 ' CE1' HG21 ' A' ' 85' ' ' VAL . 75.4 m80 -65.39 -40.14 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' HH21 ' A' ' 86' ' ' ARG . . . -60.83 -39.99 91.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.11 120.43 39.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.254 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -120.03 130.26 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.468 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.58 HE21 ' HE2' ' A' ' 127' ' ' LYS . 35.7 mt-30 -61.96 139.75 58.38 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 122.603 1.192 . . . . 0.0 110.372 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.3 -1.575 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.989 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.2 -83.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.067 1.844 . . . . 0.0 112.254 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.662 ' HA ' ' CE1' ' A' ' 6' ' ' TYR . 40.0 p-10 -110.04 19.59 18.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.335 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.64 -39.56 77.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.215 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HD1' ' A' ' 6' ' ' TYR . 34.7 p-10 -60.72 -39.61 89.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.951 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 50.9 p90 -111.14 141.43 44.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.572 ' O ' HD13 ' A' ' 8' ' ' ILE . 50.5 p90 -129.65 154.45 47.11 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.18 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.8 mm -125.07 143.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.88 0.848 . . . . 0.0 110.496 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 27.2 m -101.14 66.82 0.05 OUTLIER Pre-proline 0 CA--C 1.596 2.728 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.077 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.3 Cg_endo -117.07 -179.84 0.33 Allowed 'Cis proline' 0 N--CA 1.438 -1.782 0 N-CA-C 115.26 1.215 . . . . 0.0 115.26 5.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 92.5 p -47.06 165.94 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.146 0.578 . . . . 0.0 111.817 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.928 HD22 ' CG2' ' A' ' 59' ' ' ILE . 80.0 mt -61.63 -39.88 92.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.331 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.44 -40.24 89.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.607 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' PRO . 89.7 m -58.89 -40.7 85.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.319 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 29' ' ' LEU . 64.6 tp -60.46 -48.02 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -60.64 -40.03 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.994 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.7 m -64.46 -1.12 1.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.112 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.863 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.2 m-30 -60.42 160.04 9.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.087 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -76.2 174.86 9.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.73 -46.77 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.596 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.47 -40.28 73.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.3 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.758 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 51.6 tt0 -63.13 -43.52 98.16 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.037 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.008 HD22 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.62 -40.68 92.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 76.4 mtp85 -65.22 -39.82 93.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 36.7 ttmt -103.22 95.13 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.747 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.002 ' HB ' ' HA ' ' A' ' 44' ' ' PRO . 19.6 t -71.01 93.37 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 124.04 0.838 . . . . 0.0 112.508 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 19.0 Cg_endo -56.81 -156.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.306 2.004 . . . . 0.0 112.19 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.768 ' CE1' HD23 ' A' ' 42' ' ' LEU . 57.6 m170 -88.03 103.24 15.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.975 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 15' ' ' LEU . 7.0 mp -102.99 139.85 38.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.514 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.095 HG22 ' HG3' ' A' ' 40' ' ' GLU . 54.0 t -120.07 128.25 75.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.677 HG13 ' CD1' ' A' ' 8' ' ' ILE . 57.6 t -119.74 120.38 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.981 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.02 131.85 5.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.104 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 73.6 m80 -120.15 130.51 54.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.711 ' O ' ' HZ ' ' A' ' 92' ' ' PHE . 98.7 mttt -60.28 -40.8 91.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.943 0.401 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -70.61 -40.27 73.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.398 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.015 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 89.4 m-85 -91.73 -78.76 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.76 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.952 ' HA2' ' HE1' ' A' ' 92' ' ' PHE . . . 173.39 176.79 42.15 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.603 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.872 ' O ' ' HB ' ' A' ' 90' ' ' THR . 36.5 ttmt -99.89 120.55 39.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.616 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.871 HG21 ' SG ' ' A' ' 67' ' ' CYS . 45.7 pt -130.05 140.09 49.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.095 ' HG3' HG22 ' A' ' 30' ' ' VAL . 86.1 tt0 -135.0 129.9 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 0.0 111.407 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.801 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 54.4 p90 -120.01 123.81 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD23 ' CE1' ' A' ' 28' ' ' HIS . 9.6 mp -99.88 9.32 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.237 0.542 . . . . 0.0 111.587 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.834 ' OE2' ' HB3' ' A' ' 86' ' ' ARG . 27.8 tp10 -84.79 140.76 37.84 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 1.002 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 30.5 Cg_endo -115.31 179.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.433 2.756 . . . . 0.0 112.646 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.918 HG11 HD12 ' A' ' 83' ' ' ILE . 11.2 p 177.84 163.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.709 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.0 m-20 -86.23 116.99 24.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.77 ' HB3' HG13 ' A' ' 50' ' ' ILE . 69.4 mt -109.55 -23.47 11.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.515 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . . . 55.62 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.64 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.58 -30.03 19.86 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.115 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.008 HD11 HD22 ' A' ' 23' ' ' LEU . 2.4 mp 59.97 61.24 3.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.912 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.748 ' HG2' HH12 ' A' ' 79' ' ' ARG . 64.6 Cg_endo -103.59 33.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.33 2.687 . . . . 0.0 112.393 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.012 ' HB2' HG12 ' A' ' 59' ' ' ILE . 84.7 mt -66.63 -39.27 88.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.813 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.908 HG22 ' H ' ' A' ' 59' ' ' ILE . 18.6 p -49.9 -31.84 13.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.601 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.7 p -68.4 -29.86 68.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 HH21 ' A' ' 79' ' ' ARG . 86.1 mt -60.55 -40.54 91.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.518 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.44 -77.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.819 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.39 -39.43 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 12' ' ' LEU . 61.9 t -125.12 129.81 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.012 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -53.24 -7.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.89 0.376 . . . . 0.0 111.943 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 HG23 ' A' ' 59' ' ' ILE . 45.7 pt -139.97 140.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.198 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.9 t -129.82 140.15 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.657 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.015 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 6.4 t80 -129.22 109.03 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.174 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.8 mm-40 -78.2 137.55 60.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 58.8 Cg_endo -72.45 42.08 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.587 1.525 . . . . 0.0 112.186 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -166.49 -31.78 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.687 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -150.08 165.06 33.93 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 39' ' ' ILE . 76.9 m -114.66 131.19 56.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.796 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 71' ' ' ALA . 85.6 mt -119.82 120.06 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.679 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.4 mt -102.35 -32.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.959 ' HB3' ' CB ' ' A' ' 73' ' ' LEU . 86.3 m-85 -69.43 -32.58 71.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.578 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 65.75 67.18 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.326 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.705 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 28.6 m120 67.31 15.03 9.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.817 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.959 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 8.0 mt -69.27 94.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.016 0.926 . . . . 0.0 112.325 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 32.0 Cg_endo -111.89 83.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.293 2.662 . . . . 0.0 112.961 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.857 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 14.0 t-20 65.65 8.59 5.28 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.524 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 16.5 tpp180 -71.37 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 111.898 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.857 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 69.2 Cg_endo -101.0 33.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.674 2.249 . . . . 0.0 112.488 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -60.27 -40.51 90.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.121 0.486 . . . . 0.0 110.618 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.748 HH12 ' HG2' ' A' ' 51' ' ' PRO . 95.3 mtt-85 -68.93 -39.48 79.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.37 12.55 61.22 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -105.52 139.94 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 110.657 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.02 113.23 2.4 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.894 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG11 ' A' ' 45' ' ' VAL . 19.0 tt -109.83 128.27 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.681 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 81.0 m-20 -79.73 152.94 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.7 t -105.51 33.25 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.009 0.433 . . . . 0.0 111.081 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.834 ' HB3' ' OE2' ' A' ' 43' ' ' GLU . 21.8 ttt180 -75.74 63.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.621 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 41' ' ' PHE . . . -137.83 160.12 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 89.4 mtm-85 -105.77 133.64 50.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.598 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.835 HD13 ' HB2' ' A' ' 67' ' ' CYS . 85.4 mt -110.3 129.32 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.872 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 93.5 m -120.09 130.07 54.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.345 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -139.07 159.87 41.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.849 0.357 . . . . 0.0 111.186 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.952 ' HE1' ' HA2' ' A' ' 37' ' ' GLY . 22.7 p90 -140.12 168.74 19.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.554 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.3 t30 60.1 40.47 18.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.313 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.944 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 93.4 m -69.73 -22.78 63.35 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.189 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' OH ' ' HB2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -69.9 90.96 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.328 1.051 . . . . 0.0 112.924 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.944 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 66.1 Cg_endo -88.96 57.91 2.25 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.461 2.107 . . . . 0.0 112.946 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.953 ' HA ' HG22 ' A' ' 105' ' ' ILE . 11.3 p 49.75 166.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.468 0.707 . . . . 0.0 112.565 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.565 ' N ' HG22 ' A' ' 97' ' ' VAL . 96.1 m-20 -90.04 109.84 20.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.09 -27.9 64.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.121 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.7 p -59.83 -40.57 88.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.8 p -121.16 -0.29 9.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.2 mtt-85 60.25 22.24 11.64 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.695 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -70.87 93.46 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.129 0.893 . . . . 0.0 112.429 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 5.0 Cg_endo -46.8 109.38 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.45 2.1 . . . . 0.0 112.117 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.953 HG22 ' HA ' ' A' ' 97' ' ' VAL . 19.9 tt -97.16 105.6 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.337 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -111.1 20.43 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -145.0 166.78 16.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -114.84 83.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.627 2.885 . . . . 0.0 112.69 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.65 2.02 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.973 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.946 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 87.8 m-70 60.03 30.83 20.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.779 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' O ' HD23 ' A' ' 112' ' ' LEU . 78.4 mt-30 -61.09 -40.08 92.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.763 HD22 ' HD2' ' A' ' 115' ' ' ARG . 86.0 mt -132.95 18.17 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.284 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.946 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 77.3 t -62.78 -41.3 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.792 ' O ' HG22 ' A' ' 117' ' ' ILE . 98.6 mttt -60.48 -41.04 93.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.763 ' HD2' HD22 ' A' ' 112' ' ' LEU . 99.3 mtt180 -63.58 -40.86 98.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.685 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.942 HD11 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -67.04 -39.27 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 111.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.67 -39.85 89.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.836 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -60.52 -40.6 92.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.583 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.708 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 87.0 mt -62.0 -40.16 94.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.238 0.542 . . . . 0.0 110.468 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -60.66 -39.69 89.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.116 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 73.5 mmtt -60.4 -39.92 89.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.611 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -67.4 98.44 0.16 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.112 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.811 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.8 Cg_endo -86.55 31.56 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.287 1.991 . . . . 0.0 112.587 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -98.01 -19.28 18.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.81 ' CB ' HG22 ' A' ' 142' ' ' VAL . 87.4 p -139.89 159.84 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 140' ' ' PHE . 59.1 mtpt -99.79 134.51 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.942 ' CE2' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -83.55 118.44 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -83.37 -69.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.25 136.02 2.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.683 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 64.7 t80 -119.97 139.93 51.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.875 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.16 119.96 41.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.83 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.69 -39.67 76.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.568 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.57 -40.34 91.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.712 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m -100.15 -17.01 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.73 62.33 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.4 m -73.86 132.56 42.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.368 . . . . 0.0 111.337 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.708 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 7.6 t80 -116.96 119.49 35.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.515 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 48.6 t -120.89 124.24 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 40.8 p90 -139.82 150.17 44.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.869 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 85.6 mt -120.28 121.37 65.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.626 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.81 HG22 ' CB ' ' A' ' 126' ' ' SER . 23.8 t -100.58 74.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.332 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 146' ' ' ALA . 48.3 t-20 -90.19 101.67 14.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.115 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -75.04 -36.32 61.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.102 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.53 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.87 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . . . -83.27 115.86 22.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.0 111.171 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.48 140.05 51.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.975 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.75 119.77 30.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.55 0.69 . . . . 0.0 110.076 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.008 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.43 31.97 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.698 2.265 . . . . 0.0 112.567 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -74.54 129.66 38.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 13.5 pt-20 -92.95 103.41 15.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.99 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -92.79 0.05 57.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.471 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.97 ' CE2' ' HB2' ' A' ' 33' ' ' HIS . 87.7 m-85 -82.17 134.51 35.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HE2' HG11 ' A' ' 30' ' ' VAL . 50.6 p90 -145.32 157.27 44.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.3 mp -129.96 132.52 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.505 0.669 . . . . 0.0 110.728 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.944 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -94.9 64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.574 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.7 Cg_endo -119.03 -178.74 0.21 Allowed 'Cis proline' 0 N--CA 1.45 -1.065 0 CA-C-N 120.583 1.244 . . . . 0.0 113.591 6.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.544 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 22.7 t -49.7 169.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.651 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.828 HD21 ' CG2' ' A' ' 58' ' ' VAL . 7.1 mp -60.66 -40.35 91.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.191 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.4 -45.64 86.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.45 -40.2 90.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD12 ' CD2' ' A' ' 18' ' ' TYR . 60.0 tp -63.26 -40.65 98.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.214 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -59.93 -38.21 81.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -63.07 -2.82 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.354 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.82 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.4 m-30 -67.1 160.02 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 53.5 m -77.66 176.19 9.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.1 mp -59.95 -48.47 81.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.813 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.7 tt -70.45 -40.81 73.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.407 . . . . 0.0 110.937 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.781 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 56.4 tt0 -62.14 -40.27 95.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.922 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.82 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 85.7 mt -61.09 -39.99 92.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.166 0.508 . . . . 0.0 110.31 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.976 ' HE ' ' HB3' ' A' ' 46' ' ' ASP . 82.2 mtp180 -81.18 -10.27 59.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.821 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.759 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 64.3 tttm -128.43 84.92 2.28 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.268 -0.173 . . . . 0.0 111.269 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.757 ' CG1' ' HB2' ' A' ' 29' ' ' LEU . 18.2 t -70.6 91.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.211 1.004 . . . . 0.0 112.547 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.2 Cg_endo -57.9 -94.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.801 1.668 . . . . 0.0 111.943 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -96.68 100.59 12.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.685 0.279 . . . . 0.0 110.956 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 9.7 tt -112.83 123.77 51.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.944 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 40.4 t -120.1 119.8 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.389 . . . . 0.0 110.756 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 60' ' ' ILE . 11.6 p -139.13 136.62 42.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.17 -169.95 29.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.287 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.99 ' CE1' ' HB2' ' A' ' 5' ' ' ASN . 74.2 t60 -127.29 140.48 52.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -59.58 -41.15 89.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.853 ' HB3' ' HD2' ' A' ' 33' ' ' HIS . 47.2 t -67.63 -39.75 84.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.047 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.075 ' HE2' ' HB3' ' A' ' 64' ' ' PRO . 80.1 m-85 -87.1 -74.87 0.42 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.667 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.13 155.34 14.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.757 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HE3' ' OH ' ' A' ' 7' ' ' TYR . 62.5 mttp -100.5 129.55 46.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 111.615 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.053 HG23 HG22 ' A' ' 89' ' ' ILE . 85.3 mt -120.14 129.83 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.195 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.875 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 45.6 mt-10 -131.06 132.01 44.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.934 0.397 . . . . 0.0 111.445 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.906 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 93.3 m-85 -109.96 127.59 54.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.36 10.23 19.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.245 0.545 . . . . 0.0 111.374 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 1.029 ' HG3' ' H ' ' A' ' 86' ' ' ARG . 1.6 mm-40 -79.69 170.98 13.64 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.398 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 59.4 Cg_endo -99.21 73.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.193 2.595 . . . . 0.0 111.121 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.8 t -70.6 85.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.83 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.976 ' HB3' ' HE ' ' A' ' 24' ' ' ARG . 95.9 m-20 -67.47 92.74 0.31 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.738 0.78 . . . . 0.0 109.729 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD13 ' CG2' ' A' ' 50' ' ' ILE . 16.3 mt -87.67 -68.02 0.78 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.278 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 53.55 40.02 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 140.06 60.67 0.04 OUTLIER Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -69.29 91.34 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 113.649 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 9.7 Cg_exo -69.33 29.04 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.21 1.94 . . . . 0.0 112.045 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp -60.18 -39.48 86.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 p -49.9 -34.37 20.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.485 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -60.28 -49.53 77.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.065 HD11 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -69.59 -40.05 76.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.885 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.26 -10.01 75.63 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.949 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.991 ' H ' HD12 ' A' ' 55' ' ' LEU . . . -98.27 5.95 61.24 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.749 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.828 ' CG2' HD21 ' A' ' 12' ' ' LEU . 16.4 t 58.38 19.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.957 0.408 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.065 ' H ' HD11 ' A' ' 55' ' ' LEU . 20.6 mt 57.72 9.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.512 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG13 HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.93 120.2 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.914 0.387 . . . . 0.0 111.72 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -138.06 141.18 40.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.973 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 47.0 t80 -133.85 117.87 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.145 0.498 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 66' ' ' THR . 4.6 mm-40 -76.39 -179.41 1.17 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.327 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.075 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 63.4 Cg_endo -106.52 81.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.182 2.588 . . . . 0.0 109.308 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.687 ' HB3' ' NE2' ' A' ' 110' ' ' HIS . 34.6 mttp 106.31 13.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 112.097 -2.319 . . . . 0.0 107.732 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.862 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 64.8 m -148.29 140.07 23.81 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.64 120.76 40.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 111.183 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 48.6 mm -120.01 120.21 62.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' HZ ' ' A' ' 41' ' ' PHE . 35.5 mm -89.87 -79.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.171 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.88 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 63.7 t80 -60.38 -40.59 91.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 68' ' ' ILE . . . 66.06 121.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 31.3 m120 60.03 40.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.88 ' HG ' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp -64.26 98.96 0.17 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.853 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.826 ' HG2' ' CD ' ' A' ' 76' ' ' ARG . 91.8 Cg_endo -103.18 33.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.399 2.733 . . . . 0.0 112.547 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.6 8.27 1.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.64 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.826 ' CD ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -51.35 -53.08 53.19 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.72 ' HG3' ' CE2' ' A' ' 70' ' ' TYR . 71.6 Cg_endo -92.9 -74.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.773 2.315 . . . . 0.0 112.805 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' H ' ' HG2' ' A' ' 77' ' ' PRO . 22.8 ttmm 50.21 59.5 4.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.461 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.512 HH11 ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -77.47 120.05 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.793 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.74 -40.03 85.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 79' ' ' ARG . 51.6 tp10 -120.0 132.65 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.27 -50.14 0.87 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.714 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.4 mt -99.98 111.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 0.0 110.625 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 29.6 m120 -109.27 122.61 47.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.606 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 144' ' ' HIS . 11.7 m -105.09 32.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.558 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.029 ' H ' ' HG3' ' A' ' 43' ' ' GLU . 99.3 mtt180 -82.48 63.87 6.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 110.059 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.906 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -124.54 159.99 29.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 141' ' ' ILE . 99.2 mtt180 -101.67 120.17 39.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.566 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.053 HG22 HG23 ' A' ' 39' ' ' ILE . 45.7 pt -103.96 129.96 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.238 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.8 m -108.95 120.84 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.0 p -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.517 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.13 146.74 27.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.265 0.555 . . . . 0.0 111.506 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 21.3 m120 -118.59 119.98 36.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.305 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 58.1 m -61.13 -74.42 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.832 ' HA ' HD11 ' A' ' 105' ' ' ILE . 2.3 m-85 49.07 60.04 16.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.556 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 95' ' ' TYR . 60.3 Cg_endo -104.09 33.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.057 2.505 . . . . 0.0 114.052 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.987 ' HB ' ' CB ' ' A' ' 104' ' ' PRO . 22.5 t -146.35 -29.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.053 0.93 . . . . 0.0 112.782 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.762 ' N ' ' HB3' ' A' ' 104' ' ' PRO . 12.2 p-10 -66.78 132.21 47.57 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.764 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 14.1 ttmm 72.24 -28.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.912 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 98' ' ' ASP . 52.4 m -71.76 -50.08 33.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.8 p -124.61 -6.66 7.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.147 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 103' ' ' LYS . 84.1 mtm180 55.85 71.67 0.54 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.82 0.819 . . . . 0.0 111.194 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' HG11 ' A' ' 97' ' ' VAL . 3.9 mmtt 159.93 70.74 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.987 ' CB ' ' HB ' ' A' ' 97' ' ' VAL 0.257 25.6 Cg_endo -118.95 -179.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.293 2.662 . . . . 0.0 114.897 -174.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.832 HD11 ' HA ' ' A' ' 95' ' ' TYR . 1.1 mp 45.04 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.99 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.08 31.27 0.26 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.246 0.546 . . . . 0.0 110.053 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 5.1 m-20 -142.91 177.08 1.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.894 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.556 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 91.7 Cg_endo -114.27 -179.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.722 0 C-N-CA 123.874 3.049 . . . . 0.0 111.837 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 60.57 13.24 4.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.315 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.687 ' NE2' ' HB3' ' A' ' 65' ' ' LYS . 75.3 m80 -160.67 -6.81 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.806 ' HA ' HG21 ' A' ' 105' ' ' ILE . 57.0 tt0 -60.51 -40.24 90.68 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.711 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.055 HD23 ' HG3' ' A' ' 115' ' ' ARG . 5.2 tp -144.16 70.38 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.243 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.64 -36.4 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.042 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 117' ' ' ILE . 60.4 mttp -59.09 -32.82 70.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.849 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 1.055 ' HG3' HD23 ' A' ' 112' ' ' LEU . 35.7 mmt180 -69.71 -40.61 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.536 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.405 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 92.3 m-70 -71.15 -39.08 72.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.421 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 120' ' ' LEU . 9.8 tp -62.01 -38.63 81.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.749 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -60.81 -40.4 92.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.849 0.357 . . . . 0.0 110.484 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -61.94 -38.48 88.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.438 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.797 HD12 HD12 ' A' ' 117' ' ' ILE . 85.4 mt -60.52 -39.75 88.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.681 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.53 -41.64 90.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 29.3 mmmt -66.77 -39.9 88.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.243 0.544 . . . . 0.0 109.625 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.93 99.36 0.21 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.672 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 0.9 OUTLIER -84.49 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.048 1.832 . . . . 0.0 111.895 -178.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.74 -22.84 13.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.163 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -113.53 158.53 20.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.399 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . 58.2 mttm -99.9 119.91 38.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 111.428 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.771 ' HE2' HD11 ' A' ' 117' ' ' ILE . 64.8 t80 -90.65 125.89 35.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.5 mm-40 -89.84 -77.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 139' ' ' VAL . 79.5 p -166.9 141.41 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -119.94 126.14 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -113.02 109.84 19.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.51 75.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.72 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.911 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.3 m -100.38 -18.11 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.586 0.231 . . . . 0.0 111.478 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 78.2 0.07 75.85 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.6 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.0 m -72.47 129.99 39.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.889 0.376 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.507 ' CE2' ' CD1' ' A' ' 140' ' ' PHE . 4.7 t80 -122.18 129.96 52.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.658 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.85 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 9.7 p -127.01 130.07 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.942 ' CZ ' HD11 ' A' ' 89' ' ' ILE . 42.2 p90 -153.97 163.93 39.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.575 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 88' ' ' ARG . 83.3 mt -119.53 119.8 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.0 110.754 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.8 t -81.36 66.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.06 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -62.45 131.03 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.573 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 55.7 t-80 -99.75 -13.06 19.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.384 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.821 ' CB ' HH21 ' A' ' 86' ' ' ARG . . . -60.06 -39.72 86.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.389 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.81 160.12 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.413 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 60.49 45.82 10.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.681 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.681 ' HG2' ' O ' ' A' ' 145' ' ' ALA . 70.7 mm-40 -80.39 -0.1 35.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.942 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 CA-C-O 120.115 -0.269 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -118.91 -179.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.007 3.138 . . . . 0.0 113.296 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -87.28 116.81 25.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 35' ' ' SER . 50.2 mt-10 -99.01 109.28 22.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.484 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 1.134 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -100.86 109.94 21.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CB ' ' CD2' ' A' ' 33' ' ' HIS . 55.2 p90 -134.65 150.1 50.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.99 158.17 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 31' ' ' VAL . 3.4 mp -130.09 159.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 8' ' ' ILE . 54.6 m -124.71 74.26 63.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.742 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.646 ' CD ' HD22 ' A' ' 29' ' ' LEU . 36.0 Cg_endo -115.19 179.77 0.47 Allowed 'Cis proline' 0 C--N 1.354 0.817 0 C-N-CA 124.883 -0.882 . . . . 0.0 113.168 5.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -47.27 163.22 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.559 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 53' ' ' THR . 71.9 mt -60.07 -42.27 94.18 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.43 -39.15 91.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.474 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 10' ' ' PRO . 90.8 m -60.02 -39.7 86.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.594 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD12 ' CE2' ' A' ' 18' ' ' TYR . 43.2 tp -62.13 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 18' ' ' TYR . 42.4 t -60.28 -37.33 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.618 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m -63.74 1.86 0.56 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.542 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.878 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 m-30 -70.07 159.11 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -78.79 175.19 10.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.9 mp -56.95 -45.19 82.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 0.0 111.063 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.9 tt -69.56 -40.59 76.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.264 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 69.9 tp60 -66.7 -42.04 87.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.851 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.878 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 90.2 mt -63.27 -40.39 97.26 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.507 0.67 . . . . 0.0 110.727 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -62.29 -41.28 98.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.259 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -111.9 78.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.379 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.842 ' CG2' ' HA ' ' A' ' 44' ' ' PRO . 34.1 m -67.75 110.95 6.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.492 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD3' ' NE2' ' A' ' 22' ' ' GLN . 14.3 Cg_endo -56.02 -155.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.834 2.356 . . . . 0.0 112.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.622 ' CE1' HD23 ' A' ' 42' ' ' LEU . 75.6 m-70 -87.12 109.45 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 110.846 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD ' ' A' ' 10' ' ' PRO . 85.8 mt -101.05 138.27 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 40' ' ' GLU . 50.2 t -119.58 120.66 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -120.29 129.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 38' ' ' LYS . . . -132.63 133.58 7.14 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.71 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 6' ' ' TYR . 77.4 m80 -120.06 132.47 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.549 0.214 . . . . 0.0 110.612 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 1.134 ' HD2' ' HB2' ' A' ' 5' ' ' ASN . 68.6 mttm -68.59 -39.79 80.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.29 0.567 . . . . 0.0 111.406 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.63 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 79.1 p -66.68 -40.26 88.5 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.959 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 13.7 m-85 -109.18 -22.84 11.91 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.32 176.06 14.7 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.614 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 98.5 mttt -96.62 138.1 34.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.123 HG22 HG23 ' A' ' 89' ' ' ILE . 45.4 pt -129.89 159.88 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 0.0 111.29 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 49.9 mt-10 -140.28 152.61 46.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.793 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 54.9 p90 -163.12 123.75 2.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.622 HD23 ' CE1' ' A' ' 28' ' ' HIS . 7.1 mp -99.39 10.7 40.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.227 0.537 . . . . 0.0 112.013 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' OE2' HG23 ' A' ' 83' ' ' ILE . 3.2 pp20? -70.24 153.64 95.08 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.204 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.842 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 26.7 Cg_endo -114.75 178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.779 2.986 . . . . 0.0 113.001 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 26' ' ' VAL . 13.6 p 174.74 166.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.585 ' N ' HG22 ' A' ' 45' ' ' VAL . 52.7 t0 -99.9 120.04 39.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.516 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 50' ' ' ILE . 38.1 tp -99.71 1.66 43.57 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.172 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -40.26 93.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.863 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -95.79 -62.54 0.98 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.822 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 47' ' ' LEU . 9.8 mm -69.0 91.26 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.551 1.141 . . . . 0.0 112.608 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.863 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 69.5 Cg_endo -98.9 34.04 0.1 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.998 2.466 . . . . 0.0 112.376 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB2' HD11 ' A' ' 59' ' ' ILE . 88.8 mt -65.63 -39.72 91.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 HG21 ' A' ' 59' ' ' ILE . 6.8 p -47.73 -49.05 29.28 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.24 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -66.49 -39.8 88.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 52' ' ' LEU . 83.7 mt -60.36 -39.36 86.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.627 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.83 -170.8 43.65 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.407 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.07 19.04 8.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.722 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.6 t -60.82 -40.0 83.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 O-C-N 122.651 -0.323 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.828 HD11 ' HB2' ' A' ' 52' ' ' LEU . 48.4 mm -70.49 -40.56 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.02 119.92 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.163 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.5 p -129.55 140.22 51.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 36' ' ' TYR . 9.7 t80 -137.02 107.89 6.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.329 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 mm-40 -79.94 139.28 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.59 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.959 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 60.4 Cg_endo -72.99 44.84 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 121.806 1.671 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 98.6 mttt -164.16 -34.45 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 8.9 t -149.74 150.05 31.49 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.843 ' HB3' HD13 ' A' ' 89' ' ' ILE . 51.0 t -109.04 116.24 31.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.885 0.374 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 71' ' ' ALA . 82.9 mt -119.98 119.61 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.114 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.773 HD12 ' CG2' ' A' ' 83' ' ' ILE . 46.1 pt -84.3 -51.68 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 1.022 ' HA ' HD13 ' A' ' 73' ' ' LEU . 55.5 p90 -69.2 -40.39 78.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.562 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 68' ' ' ILE . . . 44.42 -89.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.707 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 51.0 t30 -80.74 -2.74 48.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.419 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.022 HD13 ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -68.58 102.99 0.44 Allowed Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 123.915 0.759 . . . . 0.0 109.038 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 85.6 Cg_endo -104.26 33.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.038 1.825 . . . . 0.0 109.994 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.923 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 98.4 m-20 -118.28 15.72 13.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.882 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 77' ' ' PRO . 2.5 mtp-105 -26.18 -49.87 0.17 Allowed Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 75' ' ' ASN . 31.4 Cg_endo -63.11 22.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.528 2.152 . . . . 0.0 113.661 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.923 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 10.0 mtmp? -69.51 70.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.138 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.638 ' HB3' ' HG3' ' A' ' 148' ' ' GLN . 37.5 mtp-105 -61.48 -39.25 90.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA2' ' OE1' ' A' ' 148' ' ' GLN . . . -71.54 -67.7 1.8 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.311 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 6.1 pm0 -130.61 150.03 51.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.034 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.71 ' HA3' ' HZ3' ' A' ' 78' ' ' LYS . . . 161.7 -169.98 37.3 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.642 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.791 HG23 ' OE2' ' A' ' 43' ' ' GLU . 36.0 mm -95.23 123.23 47.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.705 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 80.2 m-20 -91.13 109.69 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.378 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.796 HG12 ' HB ' ' A' ' 142' ' ' VAL . 10.5 t -60.3 9.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 84' ' ' ASN . 95.4 mtt-85 -70.19 70.19 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.828 ' O ' HG23 ' A' ' 141' ' ' ILE . . . -144.3 160.02 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.223 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.035 ' HE ' HG11 ' A' ' 139' ' ' VAL . 79.5 ttt180 -101.85 119.83 39.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.096 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.123 HG23 HG22 ' A' ' 39' ' ' ILE . 82.8 mt -114.87 129.72 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.388 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -119.54 130.13 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.933 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.6 p -140.07 160.05 40.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.242 0.544 . . . . 0.0 111.475 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 35' ' ' SER . 46.4 p90 -110.3 -178.45 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.672 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 92' ' ' PHE . 98.9 m-20 59.01 45.16 15.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.394 0.616 . . . . 0.0 110.94 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.919 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 71.3 m -62.49 -38.7 90.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.393 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.793 ' OH ' ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -67.85 92.01 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.919 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.3 Cg_endo -90.67 49.93 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.893 2.395 . . . . 0.0 113.142 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 96' ' ' PRO . 9.8 p 51.47 168.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.619 0.574 . . . . 0.0 112.148 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.588 ' H ' HG22 ' A' ' 97' ' ' VAL . 96.1 m-20 -100.22 115.73 30.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.08 -39.23 75.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.985 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.9 p -58.64 -30.64 67.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.069 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.8 p -120.51 -7.96 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.903 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 32.2 mmt180 60.4 21.68 11.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.341 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.692 ' O ' HG13 ' A' ' 105' ' ' ILE . 5.1 tptt -72.05 94.26 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 124.264 0.978 . . . . 0.0 112.316 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' ' O ' ' A' ' 102' ' ' ARG . 74.8 Cg_exo -48.12 104.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.803 1.669 . . . . 0.0 112.426 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 103' ' ' LYS . 84.3 mt -99.71 113.15 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.278 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -124.6 37.33 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.0 110.754 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 108' ' ' PRO . 38.1 m-20 -143.49 175.64 2.74 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.891 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 33.0 Cg_endo -114.32 81.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.048 2.499 . . . . 0.0 111.554 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 111' ' ' GLN . 51.4 t30 -116.65 119.36 35.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.684 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.808 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 55.3 p-80 -68.29 25.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.69 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' H ' ' C ' ' A' ' 109' ' ' ASN . 72.1 tp60 -60.93 -39.58 90.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.359 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.793 ' HG ' ' OH ' ' A' ' 95' ' ' TYR . 1.3 pp -131.7 11.67 4.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.808 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 61.8 t -66.54 -40.6 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.714 0.769 . . . . 0.0 111.532 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.99 -39.49 89.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.424 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -60.69 -41.8 95.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 0.0 111.002 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 86.2 t60 -62.66 -39.7 94.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.75 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 47.0 mm -67.62 -37.64 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.884 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.909 ' HA ' ' CE ' ' A' ' 121' ' ' LYS . 49.3 mt-10 -61.29 -40.63 94.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.788 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 54.0 mtm-85 -64.58 -40.65 95.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.234 0.54 . . . . 0.0 109.719 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 138' ' ' TYR . 86.4 mt -64.44 -38.97 92.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.757 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.909 ' CE ' ' HA ' ' A' ' 118' ' ' GLU . 54.2 mtmt -59.86 -41.05 90.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.833 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.871 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -86.43 -9.76 55.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.847 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 59.3 t30 -68.92 98.38 0.17 Allowed Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 124.388 1.075 . . . . 0.0 110.42 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 85.9 Cg_endo -91.17 33.55 0.3 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.435 1.423 . . . . 0.0 110.129 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -109.75 -21.77 12.23 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.323 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.622 ' HG ' ' HD2' ' A' ' 140' ' ' PHE . 15.6 t -140.14 159.59 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.88 ' HG2' HD22 ' A' ' 143' ' ' ASN . 57.1 tptt -99.93 126.04 46.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.495 ' CE2' ' CE2' ' A' ' 138' ' ' TYR . 65.3 t80 -89.27 120.0 30.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.837 ' OE2' HG13 ' A' ' 141' ' ' ILE . 46.0 mt-10 -85.56 -69.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.0 p -167.27 136.27 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 113' ' ' VAL . 64.8 t80 -119.93 133.99 55.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.05 119.83 40.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.63 -39.66 80.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.407 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.77 -44.28 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.846 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -97.44 -16.83 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.25 0.21 27.93 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.692 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.6 m -71.71 130.14 40.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.776 ' HE1' ' CG ' ' A' ' 140' ' ' PHE . 43.0 t80 -117.14 121.69 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.867 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 1.035 HG11 ' HE ' ' A' ' 88' ' ' ARG . 46.0 t -120.14 120.67 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.776 ' CG ' ' HE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -139.31 146.76 40.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 110.656 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.023 HG12 ' HA ' ' A' ' 88' ' ' ARG . 84.6 mt -119.88 124.31 72.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.655 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.796 ' HB ' HG12 ' A' ' 85' ' ' VAL . 21.6 t -73.18 75.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.414 0.626 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.88 HD22 ' HG2' ' A' ' 127' ' ' LYS . 82.1 m-20 -73.05 160.35 32.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.803 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.518 ' HA ' ' NH2' ' A' ' 86' ' ' ARG . 37.3 t-80 64.08 49.99 2.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.258 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -59.63 -23.2 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 77.94 95.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.217 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -139.77 159.76 41.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.925 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 79' ' ' ARG . 97.0 mt-30 -80.33 -0.03 34.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.305 0.574 . . . . 0.0 111.897 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.863 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 120.129 -0.262 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -118.93 -179.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.86 3.04 . . . . 0.0 113.264 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -100.17 18.37 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.49 -39.98 89.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 98.5 m-20 -110.26 17.47 20.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.681 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 39.9 t80 -100.59 121.18 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -140.96 153.81 45.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.683 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.956 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 2.6 mp -130.66 132.65 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.263 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.653 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 11.0 t -91.8 66.25 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.756 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.956 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 35.5 Cg_endo -117.88 -179.12 0.28 Allowed 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.727 1.295 . . . . 0.0 113.552 6.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 49.3 m -41.88 161.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.953 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.122 HD13 ' HA ' ' A' ' 53' ' ' THR . 84.0 mt -59.88 -40.3 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.545 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.37 -40.87 85.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 10' ' ' PRO . 92.4 m -60.18 -40.23 89.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.767 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.977 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 9.6 tt -60.99 -40.28 92.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.798 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -72.3 -10.46 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -73.99 -6.61 48.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.977 ' CZ ' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -78.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.794 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.768 ' O ' HD12 ' A' ' 23' ' ' LEU . 79.6 p -169.91 172.82 6.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.553 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 ' HB1' ' A' ' 48' ' ' ALA . 62.7 tp -60.3 -49.65 76.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.937 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -65.07 -40.66 95.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.601 ' HG2' ' OG ' ' A' ' 19' ' ' SER . 98.0 mm-40 -61.47 -37.17 82.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.892 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD21 ' OG ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -60.6 -39.95 89.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.837 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 58.9 mtp180 -86.42 -10.16 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.573 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 87.9 tttt -126.95 53.61 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.351 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 26' ' ' VAL . 14.6 p -70.48 95.14 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 9.7 Cg_endo -50.62 -81.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.441 2.094 . . . . 0.0 113.094 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -95.26 100.44 12.23 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.939 0.399 . . . . 0.0 111.438 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD22 HG11 ' A' ' 26' ' ' VAL . 59.5 tp -121.24 127.61 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 47.7 t -119.96 119.53 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 110.706 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' ILE . 60.7 t -130.28 130.18 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.561 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.78 -174.21 34.46 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.162 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 6' ' ' TYR . 93.4 m-70 -119.93 136.46 54.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.651 0.262 . . . . 0.0 110.365 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -60.53 -40.1 90.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -62.4 -40.18 95.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HD1' ' HB3' ' A' ' 64' ' ' PRO . 97.8 m-85 -89.68 -74.99 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.404 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.12 148.17 9.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.755 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.849 ' O ' ' HB ' ' A' ' 90' ' ' THR . 4.0 pttm -100.02 139.4 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.367 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 31' ' ' VAL . 19.4 tt -129.81 139.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.546 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.798 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 86.5 tt0 -122.14 124.9 44.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.047 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.938 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 94.9 m-85 -109.88 122.63 47.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.04 9.88 42.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.419 0.628 . . . . 0.0 110.947 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -79.15 -175.96 0.64 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.792 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.763 ' HD3' ' HB2' ' A' ' 84' ' ' ASN . 36.0 Cg_endo -112.69 83.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.855 3.036 . . . . 0.0 111.34 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG12 ' HG ' ' A' ' 47' ' ' LEU . 15.8 t -67.67 90.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.66 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.819 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 95.9 m-20 -59.92 87.33 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 50' ' ' ILE . 92.6 mt -100.27 -0.69 38.06 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.837 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . . . -60.53 -40.44 91.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.954 0.407 . . . . 0.0 110.685 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.859 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -87.22 -51.33 3.37 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.165 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 47' ' ' LEU . 12.7 pt -69.94 92.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 124.271 1.029 . . . . 0.0 112.803 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.859 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 58.9 Cg_endo -69.27 47.64 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.151 1.9 . . . . 0.0 112.617 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 59' ' ' ILE . 84.7 mt -60.2 -40.0 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.122 ' HA ' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -47.37 -49.63 24.09 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.661 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -61.3 -40.49 94.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.701 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' HB3' HG23 ' A' ' 58' ' ' VAL . 85.5 mt -69.08 -39.39 79.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.69 8.0 11.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.841 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 49.58 3.33 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.743 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 55' ' ' LEU . 62.8 t -60.78 -40.96 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 52' ' ' LEU . 70.0 mt -63.7 -39.72 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.09 120.04 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.075 ' HB ' ' HB ' ' A' ' 68' ' ' ILE . 62.5 m -127.98 139.99 52.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.79 ' HE1' ' HB3' ' A' ' 36' ' ' TYR . 63.6 t80 -136.43 159.9 40.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.858 ' CB ' ' HB ' ' A' ' 66' ' ' THR . 13.8 mt-10 -161.08 -172.98 0.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.189 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.844 ' HB3' ' HD1' ' A' ' 36' ' ' TYR . 97.3 Cg_endo -102.75 82.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.638 2.225 . . . . 0.0 109.514 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 54.1 mtmt 93.92 19.84 0.02 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 112.353 -2.203 . . . . 0.0 107.936 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.858 ' HB ' ' CB ' ' A' ' 63' ' ' GLU . 63.4 m -139.99 120.06 13.68 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.06 130.11 54.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.373 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.075 ' HB ' ' HB ' ' A' ' 61' ' ' THR . 46.3 mm -117.61 120.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.804 0.335 . . . . 0.0 110.963 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 70' ' ' TYR . 45.7 pt -140.42 -36.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' HG13 ' A' ' 69' ' ' ILE . 87.2 m-85 -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.655 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.12 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.956 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 27.3 m120 -94.92 -11.79 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.401 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -70.2 91.42 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.211 1.005 . . . . 0.0 112.959 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 71.4 Cg_endo -88.0 57.86 2.87 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.327 2.018 . . . . 0.0 112.294 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.948 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.4 m-20 59.8 37.82 21.76 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.432 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -70.41 91.72 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.285 1.034 . . . . 0.0 112.879 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.948 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 84.2 Cg_endo -79.94 30.26 0.49 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.026 1.818 . . . . 0.0 112.198 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.742 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 8.9 mtmm 52.34 56.12 8.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.84 -40.12 94.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.0 -40.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.569 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 46' ' ' ASP . 50.2 mt-10 -113.26 139.95 48.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.742 ' HA2' ' HD2' ' A' ' 78' ' ' LYS . . . -109.88 130.1 9.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.718 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 84.4 mt -100.0 119.78 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.651 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 98.5 m-20 -96.8 139.35 32.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.634 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG23 ' H ' ' A' ' 144' ' ' HIS . 15.8 m -104.99 32.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.424 . . . . 0.0 111.154 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.9 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 99.3 mtt180 -80.84 63.3 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.255 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.938 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -145.96 160.09 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.613 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.627 ' CG ' HD13 ' A' ' 141' ' ' ILE . 84.2 mtm180 -108.01 139.9 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 39' ' ' ILE . 21.0 mt -105.0 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.535 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 90.7 m -106.24 120.05 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.037 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 137' ' ' THR . 27.3 p -116.52 160.04 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 111.371 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.805 ' HE1' ' HA ' ' A' ' 64' ' ' PRO . 44.1 p90 -79.59 -165.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.94 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -59.79 101.91 0.13 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.332 0.587 . . . . 0.0 110.781 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.735 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 92.6 m -70.06 -13.96 62.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.544 ' HE1' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -63.25 98.55 0.15 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.954 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 67.9 Cg_endo -92.36 36.28 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.758 2.306 . . . . 0.0 112.595 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER 55.25 169.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.0 0.429 . . . . 0.0 111.028 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 57.2 t0 -92.09 106.02 18.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -69.85 -39.31 76.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -58.15 -34.93 70.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.736 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 11.5 p -123.05 6.54 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 102' ' ' ARG . 57.1 ttt85 59.97 25.58 14.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.457 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 7.8 mmpt? -60.95 133.49 92.43 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.624 ' HA ' HG22 ' A' ' 97' ' ' VAL . 38.7 Cg_endo -111.31 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.348 2.699 . . . . 0.0 111.134 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.594 HD11 ' OE1' ' A' ' 111' ' ' GLN . 59.2 mt -82.15 101.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.893 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -119.95 32.66 5.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.006 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 109' ' ' ASN . 12.5 m-20 -140.12 165.33 31.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.53 34.55 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.782 2.321 . . . . 0.0 112.869 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 107' ' ' ASP . 51.8 t30 -100.0 109.9 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.027 0.442 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 1.119 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 45.4 p-80 -80.04 69.46 6.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.594 ' OE1' HD11 ' A' ' 105' ' ' ILE . 64.0 tt0 -60.59 -40.64 92.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.65 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.544 HD21 ' HE1' ' A' ' 95' ' ' TYR . 1.3 pp -131.29 9.89 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.317 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.119 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 58.8 t -60.66 -40.53 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.899 ' HE3' ' NE2' ' A' ' 110' ' ' HIS . 98.6 mttt -60.31 -40.75 91.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.602 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -60.87 -44.76 96.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.019 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.688 ' NE2' HD11 ' A' ' 120' ' ' LEU . 86.2 t60 -61.48 -40.04 93.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.6 mm -64.96 -39.86 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.996 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 98.9 mt-10 -60.29 -41.09 92.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.138 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 99.2 mtt180 -67.74 -40.16 84.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.102 0.477 . . . . 0.0 110.376 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.896 HD22 ' CZ ' ' A' ' 140' ' ' PHE . 85.7 mt -67.87 -39.62 83.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 123' ' ' ASN . 27.2 tttt -59.22 -39.68 83.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.362 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 71.4 mmtt -65.4 2.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.472 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.877 HD21 ' HG2' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 53.35 58.41 13.69 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.522 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 90.4 Cg_endo -78.84 -100.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.164 1.91 . . . . 0.0 112.253 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.17 -40.17 78.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.905 0.383 . . . . 0.0 111.311 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 140' ' ' PHE . 15.4 t -140.39 159.77 41.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.899 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 34.2 mttm -85.3 138.06 32.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.809 ' CD2' ' HE1' ' A' ' 140' ' ' PHE . 64.2 t80 -90.19 120.06 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 50.1 mt-10 -86.04 -65.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 110.389 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -167.33 150.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.975 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.825 ' CD2' ' HB3' ' A' ' 138' ' ' TYR . 64.6 t80 -123.01 138.61 54.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.95 119.62 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.567 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.04 75.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.775 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 137' ' ' THR . 53.0 m -101.18 -14.16 17.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.696 0.284 . . . . 0.0 111.573 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.23 -20.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.246 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -81.1 139.87 35.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.825 ' HB3' ' CD2' ' A' ' 131' ' ' TYR . 43.1 p90 -129.69 155.69 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 16.1 m -104.75 132.4 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.44 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.896 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -119.3 140.09 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.969 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 9.1 tp -127.16 130.1 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.207 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 142' ' ' VAL . 11.0 p -131.62 52.41 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.9 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 61.4 t-20 -80.52 107.01 12.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.851 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 -60.47 -40.31 90.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.849 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HE ' ' A' ' 86' ' ' ARG . . . -60.23 -40.04 88.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.612 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.93 120.12 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.874 0.368 . . . . 0.0 111.233 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -120.04 140.0 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.688 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.34 -0.11 35.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.376 0.608 . . . . 0.0 111.899 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.915 179.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -116.56 179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.973 3.115 . . . . 0.0 113.002 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 1.106 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 80.8 m-20 -100.02 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -61.28 -39.37 90.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.237 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.88 ' ND2' ' HD2' ' A' ' 34' ' ' LYS . 98.6 m-20 -90.74 12.09 20.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.37 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.106 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 5.9 t80 -97.7 127.15 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.912 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.622 ' O ' HD13 ' A' ' 8' ' ' ILE . 51.8 p90 -138.85 157.66 45.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 30.9 mm -130.48 134.78 61.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.105 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 4.0 m -93.76 65.67 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.549 0.739 . . . . 0.0 112.203 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.969 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 28.4 Cg_endo -118.64 -178.77 0.23 Allowed 'Cis proline' 0 N--CA 1.451 -0.977 0 CA-C-N 120.672 1.276 . . . . 0.0 113.67 6.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 15.4 m -43.75 166.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.114 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.001 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.2 mm? -59.59 -40.84 88.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.446 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.25 -42.71 75.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' CG ' ' A' ' 10' ' ' PRO . 90.5 m -60.15 -40.83 91.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.748 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.54 -40.42 91.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.635 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -68.47 -19.79 64.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -79.48 -0.07 31.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.372 . . . . 0.0 110.988 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.934 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 4.3 m-30 -74.14 160.07 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.8 m -70.06 176.87 3.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.641 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.707 HD11 ' NH2' ' A' ' 24' ' ' ARG . 59.8 tp -59.75 -49.58 77.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.766 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -70.3 -40.06 74.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.435 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 50.4 tt0 -60.88 -43.77 97.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.432 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 23' ' ' LEU . 5.6 tt -69.98 -39.9 75.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.341 0.591 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.707 ' NH2' HD11 ' A' ' 20' ' ' LEU . 99.3 mtt180 -69.31 -39.65 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.69 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 87.9 tttt -125.3 80.74 1.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.742 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 29' ' ' LEU . 12.2 t -70.58 91.7 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.273 1.029 . . . . 0.0 112.772 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 5.3 Cg_endo -44.31 -83.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.66 2.24 . . . . 0.0 113.37 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -96.6 119.95 36.02 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -119.39 127.08 52.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 9' ' ' SER . 25.1 t -126.11 111.34 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 110.815 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.789 HG23 ' CD1' ' A' ' 8' ' ' ILE . 10.8 p -138.84 139.98 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.811 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 37' ' ' GLY . . . 155.66 -173.44 33.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.356 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.993 ' HB2' ' HD1' ' A' ' 6' ' ' TYR . 55.3 t-80 -149.62 160.61 43.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.096 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.88 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 98.8 mttt -60.02 -40.36 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.88 0.372 . . . . 0.0 110.901 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -66.99 -39.91 87.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.586 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.929 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 90.4 m-85 -90.26 -73.15 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.743 0.306 . . . . 0.0 111.433 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . . . 160.04 179.99 35.2 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' NZ ' ' HB2' ' A' ' 38' ' ' LYS . 4.4 ttmp? -98.03 129.21 44.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.946 HG23 HG12 ' A' ' 89' ' ' ILE . 38.6 mt -120.16 131.68 71.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.651 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.855 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 pt-20 -131.17 130.83 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 69' ' ' ILE . 89.7 m-85 -117.93 123.56 46.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.326 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' PRO . 9.6 mp -108.21 13.15 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.569 . . . . 0.0 111.068 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.793 ' CD ' ' HB2' ' A' ' 86' ' ' ARG . 44.7 mm-40 -85.53 179.86 1.71 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.867 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.69 ' HB3' ' HG3' ' A' ' 25' ' ' LYS . 33.4 Cg_endo -113.46 83.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.758 2.972 . . . . 0.0 111.597 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 83' ' ' ILE . 17.9 m -71.28 81.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.806 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 95.9 m-20 -64.68 99.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.396 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.86 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 89.5 mt -109.06 -37.08 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 55.83 39.77 30.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.693 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.834 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.71 -1.08 13.79 Favored Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.636 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 17.0 mm -70.15 93.68 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.257 0.623 . . . . 0.0 112.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.834 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 65.6 Cg_endo -102.64 33.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.733 2.289 . . . . 0.0 112.303 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' ' HA3' ' A' ' 57' ' ' GLY . 60.1 tp -61.82 -39.99 93.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.48 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.029 ' HB ' HD12 ' A' ' 60' ' ' ILE . 12.7 p -47.47 -49.38 25.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.609 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.001 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 46.9 t -64.03 -39.9 95.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.345 0.593 . . . . 0.0 109.548 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 52' ' ' LEU . 85.4 mt -60.94 -39.87 91.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.521 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.02 49.98 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.543 ' HA3' ' HG ' ' A' ' 52' ' ' LEU . . . -89.61 -168.39 43.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.205 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.81 -14.42 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' LEU . 86.4 mt -59.52 -43.72 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.509 0.195 . . . . 0.0 111.067 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.029 HD12 ' HB ' ' A' ' 53' ' ' THR . 86.2 mt -120.0 119.98 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.596 HG23 ' HB ' ' A' ' 68' ' ' ILE . 8.8 t -154.16 150.01 27.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.474 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.929 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -136.46 111.27 8.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 111.288 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.722 ' HB2' ' O ' ' A' ' 66' ' ' THR . 15.1 mm-40 -74.17 142.14 78.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.5 Cg_exo -70.05 53.99 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.017 1.811 . . . . 0.0 112.499 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 61.8 pttt 163.52 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.964 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.722 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 26.0 m -139.9 150.06 44.12 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.122 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 89' ' ' ILE . 49.7 t -103.38 126.44 50.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' OD1' ' A' ' 72' ' ' ASN . 84.2 mt -119.67 120.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.433 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 41' ' ' PHE . 82.1 mt -90.13 -79.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 74.7 t80 -65.77 -58.98 4.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.594 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 175.8 173.49 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 1.135 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.5 m-20 -60.37 -36.99 79.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.631 ' CD1' ' H ' ' A' ' 76' ' ' ARG . 2.1 tm? -79.82 79.07 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 125.359 1.463 . . . . 0.0 113.226 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 1.135 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 97.2 Cg_endo -94.03 31.56 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.193 1.929 . . . . 0.0 112.363 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.616 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.2 m120 -109.56 -36.28 6.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.631 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -130.27 78.64 74.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.046 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 67.5 Cg_endo -101.05 33.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.123 2.549 . . . . 0.0 112.472 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -60.4 -39.98 89.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -79.36 129.89 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.85 -148.3 18.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.658 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.3 mm-40 -107.0 160.0 15.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.07 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.28 44.38 2.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.299 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.782 ' H ' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -90.11 122.21 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.53 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.744 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 27.1 m120 -79.77 155.92 27.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.7 m -103.21 32.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.152 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.793 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 84.2 mtm180 -79.38 64.73 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -130.11 160.04 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.935 ' HA ' HG22 ' A' ' 141' ' ' ILE . 99.3 mtt180 -100.03 119.86 38.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.946 HG12 HG23 ' A' ' 39' ' ' ILE . 85.5 mt -112.99 129.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.67 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.0 m -113.41 114.31 26.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.711 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.9 m -128.16 130.04 47.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.602 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -111.6 14.54 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.706 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 65' ' ' LYS . 58.8 t-20 -100.07 103.62 15.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.4 p 179.69 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -49.41 -48.73 74.38 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.323 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 95' ' ' TYR . 67.3 Cg_endo -94.47 34.07 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.354 2.036 . . . . 0.0 113.211 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 16.9 t -152.17 93.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 56.9 t0 -80.0 118.87 22.12 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' NZ ' ' HD2' ' A' ' 119' ' ' ARG . 65.4 pttt -68.02 -28.92 67.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -60.26 -47.35 86.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 p -126.45 14.08 7.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.835 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 60.25 35.57 20.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.571 0.7 . . . . 0.0 109.638 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -63.32 131.0 94.65 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.515 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -111.04 82.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.792 HD11 ' HG2' ' A' ' 103' ' ' LYS . 32.7 mm -74.21 125.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.174 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -110.05 22.45 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.564 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 105' ' ' ILE . 57.9 m-20 -145.03 159.09 50.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.266 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -92.79 50.05 0.45 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.933 2.422 . . . . 0.0 112.606 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.565 ' HB3' HE21 ' A' ' 111' ' ' GLN . 98.6 m-20 -80.87 -7.41 59.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.361 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.621 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 78.6 m80 59.42 34.0 22.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.565 HE21 ' HB3' ' A' ' 109' ' ' ASN . 97.7 mm-40 -60.61 -40.17 90.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -129.85 19.73 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.499 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.621 ' CG1' ' HB3' ' A' ' 110' ' ' HIS . 13.9 p -60.42 -49.83 82.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.234 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.54 ' N ' HG13 ' A' ' 113' ' ' VAL . 98.6 mttt -63.32 -36.31 83.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.913 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.4 -40.44 90.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.465 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HG ' ' A' ' 112' ' ' LEU . 90.9 m-70 -61.75 -40.61 95.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.259 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.865 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.9 mm -69.17 -40.5 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.934 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 50.0 mt-10 -61.58 -41.15 97.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.539 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.577 ' HD2' ' NZ ' ' A' ' 99' ' ' LYS . 88.2 mmt-85 -64.12 -43.14 96.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.415 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.965 HD22 ' CE2' ' A' ' 138' ' ' TYR . 4.2 pp -70.28 -39.42 74.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.205 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.555 ' N ' HD12 ' A' ' 120' ' ' LEU . 15.5 tttm -60.45 -40.34 90.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.805 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 27.6 mmtm -60.9 -39.68 90.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.215 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.9 97.93 0.15 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.189 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.805 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 92.9 Cg_endo -84.66 29.93 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.109 1.873 . . . . 0.0 112.594 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -99.25 -19.77 16.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.504 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -126.51 153.24 45.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.515 ' HE3' HE22 ' A' ' 148' ' ' GLN . 87.8 tttt -99.8 120.32 39.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t80 -70.6 122.11 19.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 139' ' ' VAL . 70.4 mm-40 -91.53 -76.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.786 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.6 m -155.4 135.04 12.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.05 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.865 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.5 t80 -120.89 135.39 55.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -109.91 119.18 38.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.658 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.69 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.007 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.73 -40.31 91.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.8 m -101.85 -19.11 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.707 0.289 . . . . 0.0 111.641 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.5 6.03 86.34 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.3 m -74.39 130.03 38.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.91 0.386 . . . . 0.0 111.234 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.965 ' CE2' HD22 ' A' ' 120' ' ' LEU . 3.2 t80 -119.91 123.69 44.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 12.1 p -119.93 122.98 69.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 111.473 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 138' ' ' TYR . 42.5 p90 -148.96 160.01 43.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 88' ' ' ARG . 45.8 pt -117.58 120.49 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.145 0.498 . . . . 0.0 111.929 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.0 t -82.08 66.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.955 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.734 ' OD1' HD12 ' A' ' 141' ' ' ILE . 6.2 m120 -79.03 104.84 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 111.035 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 86.2 t60 -60.9 -40.3 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.4 88.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.669 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 59.82 78.1 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.978 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.21 -40.31 89.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.004 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.515 HE22 ' HE3' ' A' ' 127' ' ' LYS . 64.0 mt-30 -60.79 139.92 57.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.28 1.038 . . . . 0.0 110.659 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.966 179.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 120.165 -0.242 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.34 29.37 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.466 2.111 . . . . 0.0 112.423 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -77.18 136.26 38.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.039 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.78 -39.88 94.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.52 -40.08 90.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.549 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 33' ' ' HIS . 89.3 m-85 -102.42 131.99 48.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.402 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.84 122.64 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.343 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.912 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.2 mt -128.63 123.57 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.626 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.6 OUTLIER -93.72 69.07 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.871 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.912 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 36.5 Cg_endo -119.06 -174.93 0.16 OUTLIER 'Cis proline' 0 C--N 1.362 1.251 0 CA-C-N 119.852 0.983 . . . . 0.0 113.866 7.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -39.02 164.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.643 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.094 HD11 HD11 ' A' ' 55' ' ' LEU . 85.3 mt -59.41 -39.98 85.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.36 -43.82 76.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.533 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.694 ' HB ' ' HG2' ' A' ' 10' ' ' PRO . 7.1 m -60.26 -40.65 91.06 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.023 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.97 HD23 HD11 ' A' ' 52' ' ' LEU . 64.8 tp -69.79 -39.88 76.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.946 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.7 p -69.07 -19.89 64.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.885 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -62.43 -10.14 10.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 0.0 110.632 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.917 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 11.8 m-85 -69.93 140.04 53.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.7 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' HB2' ' A' ' 22' ' ' GLN . 52.3 m -66.95 -171.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.18 -40.6 90.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 110.971 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 25' ' ' LYS . 7.7 mt -82.45 -34.97 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.665 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.768 ' HB3' ' CD1' ' A' ' 18' ' ' TYR . 29.9 mm100 -60.67 -41.0 94.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.917 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 79.6 mt -69.14 -45.15 70.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 37.1 mtp-105 -70.49 -40.06 73.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.522 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HD2' HD22 ' A' ' 21' ' ' LEU . 59.2 mttp -107.7 30.22 6.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.196 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 29' ' ' LEU . 14.9 p -54.91 139.08 63.43 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 45.2 Cg_exo -56.91 -139.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.9 2.4 . . . . 0.0 112.755 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -88.04 104.08 16.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.013 0.435 . . . . 0.0 110.9 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 26' ' ' VAL . 86.4 mt -102.17 136.27 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.894 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' GLU . 47.2 t -119.94 119.96 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 57.4 t -124.79 130.05 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.5 170.16 37.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.708 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 1.061 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 70.2 m80 -109.71 19.97 18.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.08 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.765 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -59.98 -40.43 89.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 111.426 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.061 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 87.3 m-85 -69.59 -39.83 77.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.4 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.3 157.02 7.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 90' ' ' THR . 59.1 mtpt -99.82 133.02 44.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.729 HD11 ' HD2' ' A' ' 62' ' ' PHE . 85.5 mt -120.24 137.51 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.858 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.663 ' HG2' HG22 ' A' ' 30' ' ' VAL . 49.1 mt-10 -128.63 136.0 50.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.461 . . . . 0.0 111.921 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.554 ' HZ ' ' CD1' ' A' ' 60' ' ' ILE . 87.5 m-85 -109.97 153.75 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.825 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.923 HD22 ' H ' ' A' ' 86' ' ' ARG . 6.4 tp -78.54 -159.94 0.19 Allowed 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.2 mt-10 -83.09 -49.64 0.73 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.576 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.724 ' CG ' HG11 ' A' ' 85' ' ' VAL . 16.8 Cg_exo -68.12 52.43 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.513 2.142 . . . . 0.0 113.327 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.728 ' HB ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -80.76 66.97 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.419 . . . . 0.0 110.778 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 52.4 t0 -64.13 92.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 84.9 mt -105.19 -47.59 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.419 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . 39.56 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.778 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -66.79 -51.98 36.91 Favored Glycine 0 C--O 1.223 -0.594 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.781 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 36.3 pt -70.9 92.3 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.516 1.126 . . . . 0.0 111.813 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.957 ' HG2' HG22 ' A' ' 53' ' ' THR . 38.5 Cg_endo -114.03 179.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.955 2.436 . . . . 0.0 113.758 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.055 ' HB3' HD22 ' A' ' 12' ' ' LEU . 89.5 mt -59.39 -11.53 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.477 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.957 HG22 ' HG2' ' A' ' 51' ' ' PRO . 5.3 t -47.63 -34.25 7.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.033 0.444 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.76 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 22.5 t -127.94 78.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.712 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.094 HD11 HD11 ' A' ' 12' ' ' LEU . 85.3 mt -60.22 -40.31 89.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.855 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.57 124.45 7.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.29 -88.42 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.438 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.76 ' CG2' ' HB3' ' A' ' 54' ' ' SER . 28.6 m -61.28 -40.16 85.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.05 HG22 HG12 ' A' ' 60' ' ' ILE . 48.5 mm -89.83 -80.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.981 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.05 HG12 HG22 ' A' ' 59' ' ' ILE . 33.8 mm -131.47 130.24 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.7 m -120.01 129.71 54.39 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.918 ' CE1' ' HB3' ' A' ' 36' ' ' TYR . 20.1 t80 -138.34 111.31 7.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.437 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 66' ' ' THR . 76.1 mt-10 -75.05 146.07 81.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.348 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.987 ' HB3' ' HE2' ' A' ' 36' ' ' TYR . 57.1 Cg_endo -71.21 54.85 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.669 1.579 . . . . 0.0 112.748 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 88.0 tttt 168.28 -27.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.519 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.7 m -139.95 144.12 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.78 ' HB3' HG21 ' A' ' 89' ' ' ILE . 52.4 t -100.02 120.1 39.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 mm -104.98 120.05 54.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.112 0.482 . . . . 0.0 111.276 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 70' ' ' TYR . 19.6 tt -125.22 -41.43 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 74' ' ' PRO . 64.6 t80 -60.38 -40.42 90.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . 57.59 -171.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.879 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 14.6 t-20 -70.2 -20.13 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' HD2' ' A' ' 77' ' ' PRO . 9.8 tt -70.1 91.18 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.631 1.172 . . . . 0.0 112.608 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.879 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 59.1 Cg_endo -69.45 46.55 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.111 1.874 . . . . 0.0 112.447 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.849 ' H ' HD23 ' A' ' 73' ' ' LEU . 31.7 m120 60.03 29.27 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.533 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 85.2 mtt180 -50.5 -49.96 74.75 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.877 ' HD2' HD21 ' A' ' 73' ' ' LEU . 85.5 Cg_endo -81.23 42.45 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.374 2.05 . . . . 0.0 112.345 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.91 -40.22 88.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.843 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.51 -40.11 90.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -154.36 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.614 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -102.98 139.93 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.067 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.86 164.41 36.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.114 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 83' ' ' ILE . 45.6 pt -99.11 111.78 29.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.572 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.849 ' HB3' ' CB ' ' A' ' 144' ' ' HIS . 81.1 m-20 -139.76 106.95 5.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.16 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 44' ' ' PRO . 5.3 m -157.61 -168.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.305 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.923 ' H ' HD22 ' A' ' 42' ' ' LEU . 77.8 ttt-85 -71.48 83.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.163 0.506 . . . . 0.0 110.371 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -120.19 140.09 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 141' ' ' ILE . 39.1 ptt180 -122.93 146.23 47.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.398 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 67' ' ' CYS . 84.5 mt -109.66 129.85 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 38' ' ' LYS . 94.4 m -119.97 129.77 54.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.423 . . . . 0.0 110.512 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 27.5 p -144.12 160.04 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -96.93 151.75 19.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.965 0.412 . . . . 0.0 110.745 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.93 112.97 24.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.386 0.613 . . . . 0.0 110.891 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.749 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 94.8 m -104.92 112.1 25.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.178 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.817 ' CE2' HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.01 93.42 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.269 1.027 . . . . 0.0 112.723 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.749 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 28.2 Cg_endo -114.29 -179.03 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.728 2.952 . . . . 0.0 113.091 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 104' ' ' PRO . 60.2 t -59.21 140.09 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.972 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 57.3 t0 -77.9 110.04 12.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.262 0.553 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.02 -27.11 64.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.492 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 m -59.99 -39.68 86.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 103' ' ' LYS . 14.4 p -124.46 8.44 8.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.713 0.292 . . . . 0.0 111.516 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 71.85 -21.37 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 8.4 tmtm? -60.12 140.14 90.96 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.917 178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.707 ' HB3' HG13 ' A' ' 97' ' ' VAL . 40.8 Cg_endo -112.92 178.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.69 2.26 . . . . 0.0 112.576 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.817 HG21 ' CE2' ' A' ' 95' ' ' TYR . 41.8 mt -119.56 119.87 61.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.59 19.65 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.608 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -147.01 160.03 41.29 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.585 0.231 . . . . 0.0 111.462 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.23 54.1 4.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.646 2.23 . . . . 0.0 112.102 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -120.06 129.44 54.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.248 0.546 . . . . 0.0 109.961 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.973 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 48.3 p-80 -69.31 69.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.83 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' NE2' HG23 ' A' ' 105' ' ' ILE . 78.3 mt-30 -60.2 -40.06 88.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.368 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.852 ' CB ' HH21 ' A' ' 115' ' ' ARG . 2.2 pt? -131.55 17.09 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.728 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.973 ' HB ' ' HB2' ' A' ' 110' ' ' HIS . 63.0 t -68.22 -42.31 84.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.585 ' HB2' ' NZ ' ' A' ' 114' ' ' LYS . 4.8 ttmp? -60.35 -43.83 96.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.852 HH21 ' CB ' ' A' ' 112' ' ' LEU . 83.9 mtm180 -61.46 -40.15 93.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.812 ' CE1' HH21 ' A' ' 119' ' ' ARG . 86.3 t60 -59.91 -46.21 90.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.232 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.642 HD11 ' CE2' ' A' ' 131' ' ' TYR . 48.7 mm -69.88 -40.73 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 114' ' ' LYS . 50.0 mt-10 -62.06 -40.03 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.45 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.812 HH21 ' CE1' ' A' ' 116' ' ' HIS . 46.1 ptt85 -65.18 -40.19 93.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 116' ' ' HIS . 85.9 mt -60.53 -40.37 91.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.71 -41.35 95.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.815 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.792 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -61.76 -40.08 93.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.396 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.0 98.38 0.16 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.347 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 77.9 Cg_endo -87.13 31.16 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.252 1.968 . . . . 0.0 112.641 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -100.13 -25.09 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.336 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 142' ' ' VAL . 53.4 m -130.01 148.56 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.301 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 29.6 mmtm -96.98 132.16 43.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -69.86 118.57 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.635 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.85 ' HB2' HG12 ' A' ' 141' ' ' ILE . 3.9 tm-20 -90.28 -79.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.065 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -150.38 139.85 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.215 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.653 ' HD2' ' CD2' ' A' ' 138' ' ' TYR . 64.6 t80 -117.8 127.16 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.418 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.96 116.76 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.42 -40.08 19.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.347 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.7 -40.47 95.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.673 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 80.4 p -105.24 -17.4 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.429 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 1.35 87.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.735 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 m -70.84 132.57 45.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.325 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.653 ' CD2' ' HD2' ' A' ' 131' ' ' TYR . 0.6 OUTLIER -119.99 136.46 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.568 ' N ' ' HD1' ' A' ' 138' ' ' TYR . 44.8 t -119.89 129.81 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 138' ' ' TYR . 97.8 m-85 -120.02 141.49 49.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.85 HG12 ' HB2' ' A' ' 129' ' ' GLU . 48.9 mm -120.02 120.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 126' ' ' SER . 21.3 t -141.09 92.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.683 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -96.57 110.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.911 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.849 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 86.3 t60 -60.11 -40.46 89.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.0 93.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.45 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.19 92.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 59.52 39.95 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.26 120.02 31.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.645 0.736 . . . . 0.0 110.087 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.899 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.497 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.2 Cg_endo -118.8 -179.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.952 3.101 . . . . 0.0 113.312 -176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.781 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 98.5 m-20 -79.84 139.55 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -79.89 -12.05 59.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.366 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.33 -38.34 86.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.355 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.781 ' CE1' ' HB2' ' A' ' 3' ' ' ASN . 54.2 p90 -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.497 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -131.07 156.95 44.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' PRO . 2.4 mp -126.94 143.05 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 52.9 m -119.31 77.14 17.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 34.5 Cg_endo -115.26 179.54 0.48 Allowed 'Cis proline' 0 C--N 1.354 0.864 0 C-N-CA 124.915 -0.869 . . . . 0.0 112.98 5.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.7 p -58.64 164.75 2.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.803 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 53' ' ' THR . 7.2 mp -61.62 -39.76 92.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.459 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -67.0 -43.49 82.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 92.3 m -60.03 -40.36 89.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.698 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 15' ' ' LEU . 9.5 tt -61.74 -40.45 95.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -60.99 -20.12 62.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 m -75.95 -0.23 20.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.988 0.423 . . . . 0.0 110.631 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.89 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 4.7 m-30 -71.92 160.16 33.02 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.745 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -75.73 175.81 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.944 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 61.4 tp -60.46 -47.79 84.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.288 -178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.4 tt -70.52 -41.46 72.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.879 0.371 . . . . 0.0 110.539 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.841 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 73.0 tp60 -61.49 -40.84 96.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.162 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.89 ' CD2' ' HB2' ' A' ' 18' ' ' TYR . 65.7 mt -66.42 -40.38 89.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.62 ' HG3' ' HB2' ' A' ' 48' ' ' ALA . 94.3 mtt-85 -63.51 -40.74 97.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.633 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.911 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -118.11 103.05 9.5 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 29' ' ' LEU . 21.6 m -72.49 93.54 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 124.168 0.917 . . . . 0.0 111.545 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.911 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 12.8 Cg_exo -65.52 -84.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.739 1.626 . . . . 0.0 111.982 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.478 ' C ' HD12 ' A' ' 29' ' ' LEU . 96.8 m-70 -97.86 99.95 11.29 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.161 -0.337 . . . . 0.0 111.308 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' HB ' ' A' ' 26' ' ' VAL . 10.0 mp -122.17 124.28 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 111.131 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 40' ' ' GLU . 48.3 t -120.01 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.324 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -131.97 130.16 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.83 42.48 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.763 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 96.0 m-70 -117.82 27.66 8.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 62.12 -85.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.797 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 92' ' ' PHE . 58.5 m -60.14 -40.46 89.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.08 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.066 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 47.2 m-85 -61.6 -40.65 95.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.58 141.89 4.87 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.3 131.66 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 111.452 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.599 HD11 ' SG ' ' A' ' 67' ' ' CYS . 85.8 mt -129.28 139.91 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.27 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 30' ' ' VAL . 46.3 mt-10 -126.76 137.35 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 110.819 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.19 129.22 55.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.634 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 9.6 mp -111.74 14.31 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.29 0.567 . . . . 0.0 111.129 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.667 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 20.5 pt-20 -82.24 177.07 3.23 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.082 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 1.059 ' HG2' HD13 ' A' ' 83' ' ' ILE . 23.0 Cg_endo -102.89 77.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.84 3.026 . . . . 0.0 115.533 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.83 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 43.6 t -68.29 73.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.503 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 96.4 m-20 -46.54 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.468 . . . . 0.0 110.852 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' VAL . 97.7 mt -108.71 2.25 21.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . . . -58.87 -39.88 82.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.936 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -86.03 -76.91 1.23 Allowed Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.171 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.873 ' HB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -70.85 91.49 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 0.0 112.835 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 95.1 Cg_endo -81.09 29.9 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.062 1.841 . . . . 0.0 112.897 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.873 HD23 ' HB ' ' A' ' 50' ' ' ILE . 1.3 pp -59.91 -40.67 89.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.059 HG22 HG21 ' A' ' 59' ' ' ILE . 81.6 p -52.99 -33.67 52.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.882 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.7 m -80.61 -8.2 59.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 85.7 mt -60.52 -40.72 92.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.47 -21.91 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.123 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.86 18.03 6.17 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.697 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.12 -40.02 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.709 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 53' ' ' THR . 20.2 tt -59.79 -40.2 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.811 HG13 HG23 ' A' ' 59' ' ' ILE . 83.5 mt -103.0 119.3 51.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 110.962 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.4 m -130.17 140.09 50.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.267 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.949 ' CE2' ' HB3' ' A' ' 36' ' ' TYR . 60.5 t80 -129.32 104.94 7.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.424 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' O ' ' A' ' 66' ' ' THR . 4.5 mt-10 -79.94 140.03 53.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.065 ' HG3' ' HE2' ' A' ' 36' ' ' TYR . 7.3 Cg_exo -71.09 53.86 1.63 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.094 1.863 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.94 ' HG3' ' ND2' ' A' ' 93' ' ' ASN . 87.8 tttt 167.51 -26.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.82 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 24.7 m -139.83 150.06 44.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.466 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 89' ' ' ILE . 82.8 m -115.16 130.18 56.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.296 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.4 mm -115.02 119.98 63.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 111.045 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.6 pt -119.96 -20.37 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.107 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' HD22 ' A' ' 73' ' ' LEU . 86.7 m-85 -69.87 -39.13 76.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.038 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.93 76.41 0.27 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.884 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 16.7 p30 50.05 34.04 7.72 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -69.44 91.01 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 124.144 0.978 . . . . 0.0 113.079 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 74.3 Cg_endo -71.37 49.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.935 1.757 . . . . 0.0 112.885 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.94 33.43 21.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 6.7 mtt-85 -129.36 80.17 72.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.49 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.571 2.181 . . . . 0.0 112.735 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.53 -39.09 89.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.731 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 81' ' ' GLU . 99.6 mtt180 -60.86 139.67 57.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.56 7.7 2.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.787 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 59' ' ' ILE . 86.5 tt0 -100.89 129.99 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.836 0.35 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.13 73.7 0.75 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.224 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.059 HD13 ' HG2' ' A' ' 44' ' ' PRO . 19.3 tt -100.97 120.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 111.46 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . 81.1 m-20 -86.3 132.43 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.289 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.049 HG21 ' HD3' ' A' ' 44' ' ' PRO . 1.6 t -148.92 -162.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.054 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.802 ' H ' HG12 ' A' ' 85' ' ' VAL . 83.9 mtm180 -70.95 84.84 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.48 46.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG3' HD11 ' A' ' 141' ' ' ILE . 39.9 ttm180 -113.66 128.32 56.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.129 0.49 . . . . 0.0 111.238 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.802 HD11 ' SG ' ' A' ' 67' ' ' CYS . 19.3 tt -117.95 121.79 68.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.48 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.603 HG23 ' CG1' ' A' ' 139' ' ' VAL . 92.9 m -119.86 129.66 54.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 111.053 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.88 140.05 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.211 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HD1' ' H ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -92.67 12.03 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.597 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.94 ' ND2' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t30 -99.09 105.17 17.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.407 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.803 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 22.2 m -140.11 -55.37 0.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -70.91 93.06 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.187 179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.803 ' HD3' ' O ' ' A' ' 94' ' ' CYS . 36.4 Cg_endo -114.58 -178.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.591 2.194 . . . . 0.0 112.865 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 104' ' ' PRO . 42.4 t -93.28 139.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.169 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.958 ' CB ' ' HB2' ' A' ' 103' ' ' LYS . 56.1 t0 -81.68 99.93 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.555 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.08 -38.79 79.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.725 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 m -57.99 -32.54 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.37 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 103' ' ' LYS . 12.4 p -122.14 7.93 9.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 0.0 111.661 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 60.68 20.05 10.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.177 0.513 . . . . 0.0 110.536 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HB2' ' CB ' ' A' ' 98' ' ' ASP . 31.5 mmtt -65.79 120.63 70.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.036 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.551 ' HA ' HG13 ' A' ' 97' ' ' VAL . 41.4 Cg_endo -110.74 81.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.727 2.951 . . . . 0.0 111.233 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.536 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mt -68.22 119.84 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.679 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 88.0 tttt -119.52 19.87 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.275 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -146.73 159.84 42.73 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.256 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 95' ' ' TYR . 68.8 Cg_endo -91.42 69.04 1.1 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.869 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HB3' HE21 ' A' ' 111' ' ' GLN . 37.5 t30 -99.76 3.42 44.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.295 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.966 ' HA ' HG23 ' A' ' 113' ' ' VAL . 97.0 m-70 60.22 40.47 17.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.824 0.345 . . . . 0.0 110.95 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.48 HE21 ' HB3' ' A' ' 109' ' ' ASN . 97.6 mm-40 -60.48 -40.4 91.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -131.46 16.37 4.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 110' ' ' HIS . 61.5 t -60.06 -43.07 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.319 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.73 -40.35 96.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.25 -40.27 95.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.66 -40.34 94.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.979 HG22 ' HE2' ' A' ' 121' ' ' LYS . 48.6 mm -65.46 -40.6 88.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.61 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 122' ' ' LYS . 49.7 mt-10 -62.74 -40.32 96.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.914 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -60.89 -43.47 98.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.382 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 138' ' ' TYR . 4.6 pp -69.32 -37.99 78.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.124 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.979 ' HE2' HG22 ' A' ' 117' ' ' ILE . 68.6 mttm -60.03 -41.3 91.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.896 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 72.5 mmtt -60.43 -38.45 84.11 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -70.88 99.88 0.26 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.896 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 84.8 Cg_endo -88.86 32.39 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.258 1.306 . . . . 0.0 110.876 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.469 ' O ' HG13 ' A' ' 142' ' ' VAL . 98.8 m-20 -100.51 -20.12 15.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 142' ' ' VAL . 80.1 p -131.49 152.73 50.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 87.9 tttt -99.71 127.57 45.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HD2' ' HH ' ' A' ' 138' ' ' TYR . 64.7 t80 -69.85 124.63 24.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.698 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.836 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 51.5 tp10 -91.32 -77.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.206 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.9 p -159.69 149.83 18.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.729 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.581 ' OH ' HG13 ' A' ' 113' ' ' VAL . 65.1 t80 -120.21 132.68 55.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.04 114.7 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.461 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.69 -39.83 76.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -60.44 -40.46 91.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.6 m -100.21 -18.52 16.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.26 -0.11 42.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.503 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 55.9 m -77.08 130.85 37.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 111.139 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.872 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 8.7 t80 -117.05 128.21 54.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.836 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 27.8 m -130.01 135.59 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.492 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.552 ' HD2' ' OH ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.03 158.36 44.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.174 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.746 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 51.1 mm -119.73 120.43 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 126' ' ' SER . 22.3 t -103.05 74.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.145 0.497 . . . . 0.0 110.743 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 86' ' ' ARG . 60.5 t30 -87.95 96.09 10.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.982 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.601 ' CD2' ' HB3' ' A' ' 84' ' ' ASN . 87.8 m-70 -69.86 -40.82 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.56 91.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.366 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . . . 60.44 20.26 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -119.85 140.47 50.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.659 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.704 ' HA ' ' CZ ' ' A' ' 86' ' ' ARG . 7.2 pt20 -80.99 0.09 37.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.623 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.84 27.98 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.321 2.014 . . . . 0.0 112.338 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 1' ' ' GLY . 26.3 m120 -74.97 139.15 42.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.24 -39.08 78.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.857 ' HB3' ' HE1' ' A' ' 33' ' ' HIS . 98.6 m-20 -60.38 -40.32 90.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.675 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.04 136.33 47.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.273 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 8' ' ' ILE . 48.2 t80 -120.26 125.01 47.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.998 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.936 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.8 mm -132.88 126.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.022 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.727 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -92.96 65.78 0.01 OUTLIER Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.738 0.815 . . . . 0.0 112.66 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.936 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 34.0 Cg_endo -118.77 -178.84 0.23 Allowed 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 121.068 1.417 . . . . 0.0 112.975 7.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.7 m -38.12 161.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.471 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.31 -40.1 85.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.024 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.78 -41.35 75.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.475 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' PRO . 75.1 m -60.85 -40.24 92.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 59.5 tp -65.98 -40.14 90.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.651 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 46.8 t -60.02 -38.36 82.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.2 p -59.95 -10.04 3.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.859 ' CD2' ' HG2' ' A' ' 22' ' ' GLN . 3.1 m-30 -66.04 160.07 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.096 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HD23 ' A' ' 23' ' ' LEU . 81.4 p -68.34 169.04 11.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.595 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 85.4 mt -59.19 -47.37 85.57 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.841 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -70.12 -40.78 74.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' CD2' ' A' ' 18' ' ' TYR . 57.7 tt0 -61.7 -46.34 90.12 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 ' H ' ' A' ' 49' ' ' GLY . 3.0 pp -69.73 -40.08 76.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.845 ' CB ' ' HA ' ' A' ' 46' ' ' ASP . 99.4 mtt180 -63.2 -40.34 97.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 98.6 mttt -112.0 85.63 2.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.103 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.917 HG11 HD22 ' A' ' 29' ' ' LEU . 12.7 t -71.27 92.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 124.034 0.934 . . . . 0.0 112.532 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 21.4 Cg_endo -58.44 -87.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.966 1.777 . . . . 0.0 112.027 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HE1' ' OE2' ' A' ' 40' ' ' GLU . 86.3 t60 -95.76 100.35 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.819 0.342 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.917 HD22 HG11 ' A' ' 26' ' ' VAL . 58.9 tp -120.04 129.69 54.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.459 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.97 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.4 t -121.41 112.13 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.847 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.879 HG13 HD12 ' A' ' 8' ' ' ILE . 61.8 t -129.83 129.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.752 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.11 -176.13 43.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.814 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.857 ' HE1' ' HB3' ' A' ' 5' ' ' ASN . 8.1 t60 -115.16 131.09 57.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.82 -40.19 91.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.189 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.787 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 58.3 m -60.24 -40.6 90.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.762 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 22.9 m-85 -91.33 -79.64 0.36 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.45 155.15 26.39 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.574 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -102.62 131.51 49.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 111.722 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 90' ' ' THR . 45.8 pt -129.86 159.97 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.288 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HG2' HG22 ' A' ' 30' ' ' VAL . 40.9 mt-10 -126.85 137.49 53.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.463 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.875 ' HA ' ' CB ' ' A' ' 87' ' ' ALA . 89.0 m-85 -109.17 120.09 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.365 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.66 12.04 29.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.097 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.855 ' OE2' ' HB2' ' A' ' 87' ' ' ALA . 5.9 pm0 -73.61 161.38 79.12 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 84' ' ' ASN . 34.7 Cg_endo -113.0 81.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.592 2.862 . . . . 0.0 111.459 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 83' ' ' ILE . 19.5 m -72.68 69.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.535 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.845 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . 33.7 p-10 -57.72 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.018 0.437 . . . . 0.0 110.33 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.019 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 71.4 mt -107.14 -17.94 14.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.027 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.732 ' CB ' HH21 ' A' ' 24' ' ' ARG . . . 58.37 40.04 24.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.106 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.684 ' H ' HD13 ' A' ' 23' ' ' LEU . . . 130.01 9.28 3.12 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.937 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.57 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.4 mp 50.15 76.93 0.49 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 Cg_endo -103.15 33.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.373 2.716 . . . . 0.0 111.742 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.828 HD23 HD12 ' A' ' 55' ' ' LEU . 85.8 mt -64.23 -38.76 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 p -46.66 -48.99 19.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.527 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -65.95 -39.73 90.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.828 HD12 HD23 ' A' ' 52' ' ' LEU . 85.7 mt -60.85 -40.14 91.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.793 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.12 -75.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.12 -19.61 4.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.527 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.4 p -69.84 -30.01 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 59' ' ' ILE . 9.7 tp 45.7 40.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.0 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 59' ' ' ILE . 20.8 mt 76.24 134.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.832 HG23 ' HB ' ' A' ' 68' ' ' ILE . 9.1 t -140.01 159.98 40.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.149 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HE1' ' CB ' ' A' ' 36' ' ' TYR . 64.2 t80 -129.81 110.44 11.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 111.489 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 66' ' ' THR . 3.4 mm-40 -69.97 177.47 1.32 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.97 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.872 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 64.0 Cg_endo -106.85 82.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 109.309 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 92' ' ' PHE . 50.3 mtmt 106.13 12.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 111.944 -2.389 . . . . 0.0 107.925 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.718 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 28.3 m -149.16 149.79 31.59 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.278 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 93.8 m -119.96 129.95 54.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.935 0.398 . . . . 0.0 111.256 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.832 ' HB ' HG23 ' A' ' 61' ' ' THR . 85.5 mt -120.06 120.16 62.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.076 HG21 HG12 ' A' ' 85' ' ' VAL . 82.4 mt -101.5 -69.15 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.621 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.826 ' OH ' ' HB2' ' A' ' 78' ' ' LYS . 65.3 t80 -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 70' ' ' TYR . . . 178.0 161.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 111.28 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.872 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 98.7 m-20 -60.57 -39.49 88.23 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 76' ' ' ARG . 1.3 tt -69.83 92.14 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 O-C-N 124.402 1.064 . . . . 0.0 112.318 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 69.6 Cg_endo -72.54 31.11 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.962 1.774 . . . . 0.0 112.656 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.931 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 98.5 m-20 -108.98 -36.32 6.12 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.092 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.83 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.8 mmp_? -70.6 92.39 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.074 0.95 . . . . 0.0 112.629 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.931 ' HD3' ' O ' ' A' ' 75' ' ' ASN . 78.2 Cg_endo -90.46 31.43 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.129 1.886 . . . . 0.0 112.313 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.826 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 73.2 mmtt -59.53 -39.96 85.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.218 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 59.85 -89.93 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.75 -179.91 44.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.596 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -118.76 140.06 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 0.0 110.95 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . 130.02 -51.17 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.709 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.758 ' HA ' HG12 ' A' ' 45' ' ' VAL . 19.5 tt -100.08 111.61 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.442 . . . . 0.0 111.003 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.702 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 31.6 m120 -97.18 146.87 24.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.076 HG12 HG21 ' A' ' 69' ' ' ILE . 19.4 m -105.13 32.95 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 72.3 ttt180 -80.21 65.09 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.495 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.875 ' CB ' ' HA ' ' A' ' 41' ' ' PHE . . . -136.2 160.02 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.547 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.909 ' HG2' ' CG1' ' A' ' 141' ' ' ILE . 99.3 mtt180 -107.37 130.32 54.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 45.7 pt -107.56 130.04 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.708 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.92 ' H ' HG22 ' A' ' 39' ' ' ILE . 78.5 m -106.5 119.96 40.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.457 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.865 ' O ' HG23 ' A' ' 137' ' ' THR . 92.3 m -85.06 148.0 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.276 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 36' ' ' TYR . 53.9 p90 -76.15 166.97 22.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -76.0 107.65 8.36 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.817 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.2 m -89.68 0.15 57.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 109' ' ' ASN . 5.1 t80 -48.74 -45.86 71.84 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 104' ' ' PRO . 65.4 Cg_endo -93.28 32.48 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.559 2.173 . . . . 0.0 113.858 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 94' ' ' CYS . 10.6 p -137.52 72.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.479 0.657 . . . . 0.0 112.063 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.986 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 56.8 t0 -71.89 120.03 16.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.63 -28.52 69.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -60.0 -55.73 30.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 103' ' ' LYS . 4.3 p -126.84 18.01 7.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.352 . . . . 0.0 111.749 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 mtm105 60.33 37.27 20.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 109.715 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.986 ' HB2' ' HB3' ' A' ' 98' ' ' ASP . 69.3 mttt -61.62 137.08 94.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.25 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.858 ' HA ' ' O ' ' A' ' 96' ' ' PRO . 28.7 Cg_endo -112.78 82.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.526 2.818 . . . . 0.0 111.509 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.788 ' H ' ' HA ' ' A' ' 96' ' ' PRO . 26.0 mt -84.82 109.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.243 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -106.59 69.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.91 151.8 42.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -94.04 64.98 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 112.35 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 98.6 m-20 -109.96 169.9 8.42 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.736 0.779 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.787 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 95.8 m-70 -109.84 24.47 13.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.59 -39.79 85.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.761 HD12 ' NE2' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -131.78 14.45 4.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.399 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.787 ' CG2' ' HA ' ' A' ' 110' ' ' HIS . 65.9 t -66.31 -41.28 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.463 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.81 -40.29 92.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -60.65 -40.48 92.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.501 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.761 ' NE2' HD12 ' A' ' 112' ' ' LEU . 91.4 m-70 -61.42 -40.77 95.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.802 HD11 ' CG ' ' A' ' 131' ' ' TYR . 48.7 mm -69.7 -40.84 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.78 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.42 -40.35 94.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.333 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.841 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 68.7 mtt85 -65.59 -40.88 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.293 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 140' ' ' PHE . 4.6 pp -71.22 -39.86 71.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.412 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 120' ' ' LEU . 30.9 tttt -60.72 -40.33 91.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.448 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 119' ' ' ARG . 17.3 pttt -69.31 -37.28 77.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.593 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -64.64 100.51 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.926 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.737 ' HD3' ' O ' ' A' ' 122' ' ' LYS . 88.9 Cg_endo -89.51 32.05 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.059 1.839 . . . . 0.0 112.249 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.73 -25.03 12.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.298 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.506 ' OG ' ' HD2' ' A' ' 140' ' ' PHE . 47.5 t -129.94 140.05 51.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.343 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 141' ' ' ILE . 58.4 mttm -85.18 135.35 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.668 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 64.7 t80 -82.95 117.39 22.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.74 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 86.5 tt0 -91.13 -79.97 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.8 m -141.93 139.78 32.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.407 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.802 ' CG ' HD11 ' A' ' 117' ' ' ILE . 64.7 t80 -120.74 131.05 54.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.467 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.93 113.45 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.717 ' HB1' ' CE1' ' A' ' 110' ' ' HIS . . . -69.95 -39.97 75.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.567 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.34 -40.2 89.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 137' ' ' THR . 0.3 OUTLIER -99.72 -11.89 20.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.507 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.93 -21.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' CYS . 21.7 m -80.16 139.88 36.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.758 ' HB3' ' CD1' ' A' ' 131' ' ' TYR . 42.2 p90 -129.55 156.03 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.734 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 49.3 t -109.83 123.81 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.004 0.43 . . . . 0.0 110.635 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -112.99 141.88 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.909 ' CG1' ' HG2' ' A' ' 88' ' ' ARG . 84.8 mt -119.78 125.73 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 144' ' ' HIS . 20.7 t -127.35 81.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.822 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -98.18 115.02 27.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.766 ' H ' HG23 ' A' ' 85' ' ' VAL . 73.6 m80 -102.43 7.95 40.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.61 93.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.679 0.276 . . . . 0.0 111.424 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -107.54 -23.65 12.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.409 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 46.9 tp10 59.78 39.08 21.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -60.83 139.92 57.8 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.251 1.024 . . . . 0.0 110.756 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 C--N 1.297 -1.679 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.864 -179.946 . . . . . . . . 0 0 . 1 stop_ save_